Processing 00000000.tx.1: Regulation of translation initiation by insulin and amino acids in skeletal muscle of neonatal pigs Pamela M. 

Phrase: "Regulation of translation initiation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   982   C1157543:regulation of translational initiation [Cell Function]
   909   C1157519:regulation of translation [Cell Function]
   783   C3537096:Translational Regulation [Genetic Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids in skeletal muscle of neonatal pigs Pamela M."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0001128:Acids [Chemical]
   726 E C2917660:Amino Acid [Pharmacologic Substance]
   706 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.2: J. 

Phrase: "J."
Processing 00000000.tx.3: O'Connor,1 Scot R. 

Phrase: "O'Connor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "1 Scot R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.4: Kimball,2 Agus Suryawan,1 Jill A. 

Phrase: "Kimball,"

Phrase: "2 Agus Suryawan,"

Phrase: "1 Jill A."
Processing 00000000.tx.5: Bush,1 Hanh V. 

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "1 Hanh V."
Processing 00000000.tx.6: Nguyen,1 Leonard S. 

Phrase: "Nguyen,"

Phrase: "1 Leonard S."
Processing 00000000.tx.7: Jefferson,2 and Teresa A. 

Phrase: "Jefferson,"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "Teresa A."
Processing 00000000.tx.8: Davis1 1United States Department of Agriculture/Agricultural Research Service, Children's Nutrition Research Center, and Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030; 

Phrase: "Davis1 1United"

Phrase: "States"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "Department of Agriculture/Agricultural Research Service,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0085410:Agriculture Department [Organization]
   753   C1704729:Department [Organization]

Phrase: "Children's Nutrition Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0683939:research center [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Section of Neonatology,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205155:Section [Spatial Concept]
   790   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   790   C1522472:Section [Substance]
   790   C1552923:Section [Quantitative Concept]
   790   C1705191:Section [Physical Object]

Phrase: "Department of Pediatrics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587482:department pediatrics [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Baylor College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "Houston,"

Phrase: "Texas 77030"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039711:Texas [Geographic Area]

Phrase: ";"
Processing 00000000.tx.9: and 2Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 Submitted 23 December 2002 ; accepted in final form 3 March 2003  ABSTRACT TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  Previous studies have shown that intravenous infusion of insulin and/or amino acids reproduces the feeding-induced stimulation of muscle protein synthesis in neonates and that insulin and amino acids act independently to produce this effect. 

Phrase: "and"

Phrase: "2Department of Cellular"

Phrase: "and"

Phrase: "Molecular Physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]

Phrase: "Pennsylvania State University College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0557806:College [Manufactured Object]

Phrase: "Hershey,"

Phrase: "Pennsylvania 17033"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030853:Pennsylvania [Geographic Area]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "23 December 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: ";"

Phrase: "accepted in final form 3 March 2003  ABSTRACT TOP ABSTRACT METHODS RESULTS DISCUSSION"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   735   C0000857:Abstract [Occupational Activity]
   735   C0025663:Methods [Intellectual Product]
   735   C0025664:methods [Intellectual Product]
   735   C0205088:Final [Temporal Concept]
   735   C0348078:Form [Qualitative Concept]
   735   C0376315:Form [Manufactured Object]
   735   C0449851:Methods [Functional Concept]
   735   C0557061:Discussion [Therapeutic or Preventive Procedure]
   735   C0600678:Abstract [Intellectual Product]
   735   C1272684:Accepted [Qualitative Concept]
   735   C1522492:Form [Functional Concept]
   735   C1546485:Final [Idea or Concept]
   735   C1548435:Accepted [Idea or Concept]
   735   C1552863:Abstract [Idea or Concept]
   735   C1704458:Top [Spatial Concept]
   735   C2584313:Discussion [Social Behavior]
   702 E C0871511:METHOD [Intellectual Product]
   702   C1274040:Result [Functional Concept]
   702   C1546471:Result [Idea or Concept]
   702 E C1548601:Accept [Idea or Concept]
   702   C2825142:Result [Finding]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that intravenous infusion of insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0199782:Infusion of insulin [Therapeutic or Preventive Procedure]
           insulin infusion
   806   C0021440:Intravenous infusion [Therapeutic or Preventive Procedure]
   806   C1272892:Intravenous infusion [Biomedical or Dental Material]
   806   C1621368:Intravenous Infusion [Functional Concept]
   760   C0348016:Intravenous [Spatial Concept]
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]

Phrase: "and/or"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "reproduces"

Phrase: "the feeding-induced stimulation of muscle protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C1709098:STIMULATION OF MUSCLE [Finding]
           Muscle Stimulation
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in neonates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0021289:Neonates [Age Group]
   966 E C2239178:Neonate [Finding]
   966 E C2939425:Neonate, NOS [Temporal Concept]

Phrase: "and"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "independently to"

Phrase: "produce"

Phrase: "this effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.10: The goal of the present study was to delineate the regulatory roles of insulin and amino acids on muscle protein synthesis in neonates by examining translational control mechanisms, specifically the eukaryotic translation initiation factors (eIFs), which enable coupling of initiator methionyl-tRNAi and mRNA to the 40S ribosomal subunit. 

Phrase: "The goal of the present study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018017:Goal [Intellectual Product]
   753   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "delineate"

Phrase: "the regulatory roles of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "amino acids on muscle protein synthesis"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   814   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "in neonates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0021289:Neonates [Age Group]
   966 E C2239178:Neonate [Finding]
   966 E C2939425:Neonate, NOS [Temporal Concept]

Phrase: "by examining translational control mechanisms,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0243148:control [Qualitative Concept]
   812   C0441712:Mechanisms [Functional Concept]
   812   C1519614:Translational [Genetic Function]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779 E C1706376:Mechanism [Manufactured Object]
   741 E C0040712:Translation [Intellectual Product]
   741 E C0597295:translation [Molecular Function]

Phrase: "specifically"

Phrase: "the eukaryotic translation initiation factors (eIFs),"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C1136317:Translation Initiation Factors, Eukaryotic [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Eukaryotic Initiation Factors
   890   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Initiation Factors
   861   C1519613:Translation Initiation [Genetic Function]
   858   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040712:Translation [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C0597295:translation [Molecular Function]
   812   C1158830:Initiation [Genetic Function]
   812   C1519614:Translation [Genetic Function]
   812   C1704686:Initiation [Functional Concept]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "coupling of initiator methionyl-tRNAi"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1444748:Initiator [Qualitative Concept]
   760   C1948027:Coupling [Functional Concept]
   726 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "mRNA to the 40S ribosomal subunit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.11: Insulin secretion was blocked by somatostatin in fasted 7-day-old pigs (n = 812/group), insulin was infused to achieve plasma levels of 0, 2, 6, and 30 U/ml, and amino acids were clamped at fasting or fed levels or, at the high insulin dose, below fasting. 

Phrase: "Insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "blocked by somatostatin"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0028778:Blocked [Pathologic Function]
   790   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0332206:Blocked [Functional Concept]
   790   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
   706 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "in fasted 7-day-old pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0039005:Pigs [Mammal]
   804   C1135183:pigs [Mammal]
   771 E C1136016:PIG [Mammal]
   771 E C1265533:Pig [Mammal]
   771 E C1270360:Pig [Mammal]

Phrase: "(n = 812/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "infused"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "plasma levels of 0,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0032105:Plasma [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6,"

Phrase: "and"

Phrase: "30 U/ml,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "clamped at fasting"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015663:Fasting [Finding]
   790   C1550565:fasting [Intellectual Product]
   756   C0175721:Clamp [Medical Device]
   756 E C0456962:Fast [Qualitative Concept]
   756   C1705942:Clamp [Manufactured Object]
   756   C1883710:Clamp [Functional Concept]

Phrase: "or"

Phrase: "fed levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: ","

Phrase: "at the high insulin dose,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0444956:High dose [Quantitative Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   734   C0020459:high insulin [Disease or Syndrome]

Phrase: "below fasting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]
Processing 00000000.tx.12: Both insulin and amino acids increased the phosphorylation of ribosomal protein S6 kinase (S6K1) and the eIF4E-binding protein (4E-BP1), decreased the binding of 4E-BP1 to eIF4E, increased eIF4E binding to eIF4G, and increased fractional protein synthesis rates but did not affect eIF2B activity. 

Phrase: "Both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the phosphorylation of ribosomal protein S6 kinase (S6K1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "the eIF4E-binding protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   947   C1149297:eukaryotic initiation factor 4E binding [Genetic Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   734   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the binding of 4E-BP1"

Phrase: "to eIF4E,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "eIF4E binding to eIF4G,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1149297:eukaryotic initiation factor 4E binding [Genetic Function]
   774   C1622039:eIF4G binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "increased fractional protein synthesis rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0871208:Rate [Activity]
   771   C1521828:Rate [Quantitative Concept]
   722   C1372531:Increased Protein Synthesis [Molecular Function]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "eIF2B activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.13: In the absence of insulin, amino acids had no effect on these translation initiation factors but increased the protein synthesis rates. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "had"

Phrase: "no effect on these translation initiation factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the protein synthesis rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   734   C0597295:Protein Synthesis [Molecular Function]
Processing 00000000.tx.14: Raising insulin from below fasting to fasting levels generally did not alter translation initiation factor activity but raised protein synthesis rates. 

Phrase: "Raising insulin from"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "below fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "to fasting levels generally"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "translation initiation factor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "raised protein synthesis rates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.15: The phosphorylation of S6K1 and 4E-BP1 and the amount of 4E-BP1 bound to eIF4E and eIF4E bound to eIF4G were correlated with insulin level, amino acid level, and protein synthesis rate. 

Phrase: "The phosphorylation of S6K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "the amount of 4E-BP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "bound to eIF4E"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332297:bound [Spatial Concept]
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1145667:Bound [Activity]
   753   C1158830:Initiation [Genetic Function]
   753   C1167622:Bound [Molecular Function]
   753   C1521761:Factor [Functional Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2349209:Bound [Conceptual Entity]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "bound to eIF4G"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "were"

Phrase: "correlated with insulin level,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0202098:Insulin level [Laboratory Procedure]
   833   C0428405:insulin level [Laboratory or Test Result]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1547707:Level [Geographic Area]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1707520:Correlated [Qualitative Concept]
   770   C2946261:Level [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "amino acid level,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "and"

Phrase: "protein synthesis rate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   734   C0597295:Protein Synthesis [Molecular Function]
Processing 00000000.tx.16: Thus insulin and amino acids regulate muscle protein synthesis in skeletal muscle of neonates by modulating the availability of eIF4E for 48S ribosomal complex assembly, although other processes also must be involved. protein synthesis; 

Phrase: "Thus insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "regulate"

Phrase: "muscle protein synthesis in skeletal muscle of neonates"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0597295:Protein Synthesis [Molecular Function]
   744   C0026845:Muscle [Tissue]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   731 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "by modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "the availability of eIF4E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "for 48S ribosomal complex assembly,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C1156141:ribosome assembly [Cell Function]
   812   C1706853:Assembly [Activity]
   812   C1879748:Assembly [Manufactured Object]

Phrase: "although"

Phrase: "other processes also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "must"

Phrase: "be"

Phrase: "involved. protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: ";"
Processing 00000000.tx.17: nutrition; 

Phrase: "nutrition"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0028707:Nutrition [Biomedical Occupation or Discipline]
  1000   C0392209:nutrition [Organism Attribute]
  1000   C1442959:Nutrition [Organism Function]
   928 E C1521739:Nutritional [Qualitative Concept]
   928 E C2707262:Nutritional [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.18: growth; 

Phrase: "growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.19: eukaryotic initiation factor 4E; 

Phrase: "eukaryotic initiation factor 4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.20: S6 kinase-1 THE NEONATAL PERIOD is characterized by high rates of protein deposition and growth (9, 13, 19), with the most rapid gains in protein mass occurring in skeletal muscle (58). 

Phrase: "S6 kinase-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1419024:S6 [Gene or Genome]
   827   C1419741:S6 [Gene or Genome]
   827   C1861424:S6 [Gene or Genome]
   827   C2348600:S6+ [Element, Ion, or Isotope]

Phrase: "THE NEONATAL PERIOD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0935562:neonatal period [Temporal Concept]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "is"

Phrase: "characterized by high rates of protein deposition"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0333584:Protein deposition [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205250:High [Qualitative Concept]
   748   C0333562:Deposition [Functional Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1880022:Characterized [Activity]
   748   C2700149:HIGH [Intellectual Product]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "(9,"

Phrase: "13,"

Phrase: "19"

Phrase: ")"

Phrase: ","

Phrase: "with the most rapid gains"

Phrase: "in protein mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "occurring in skeletal muscle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0242692:Muscle, Skeletal [Tissue]
   833   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   770   C0026845:Muscle [Tissue]
   770   C0037253:skeletal [Body System]
   770   C0521324:Skeletal [Spatial Concept]
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.21: Previous studies in neonatal rats and pigs have revealed high efficiency rates of dietary protein utilization (11), which are likely due to the higher protein synthesis rates of neonates in response to feeding than those of older animals (4, 10). 

Phrase: "Previous studies in neonatal rats"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039005:Pigs [Mammal]
  1000   C1135183:pigs [Mammal]
   966 E C1136016:PIG [Mammal]
   966 E C1265533:Pig [Mammal]
   966 E C1270360:Pig [Mammal]

Phrase: "have"

Phrase: "revealed high efficiency rates of dietary protein utilization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "likely due to the higher protein synthesis rates of neonates"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   760   C0597295:Protein Synthesis [Molecular Function]
   760   C0678226:Due to [Functional Concept]
           due
   739   C0021289:Neonates [Age Group]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0220781:synthesis [Biologic Function]
   739   C0332148:Likely [Qualitative Concept]
   739   C0750492:Likely [Idea or Concept]
   739   C1883254:Synthesis [Activity]
   739   C3146286:Due [Idea or Concept]
   722 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   706   C0205250:High [Qualitative Concept]
   706   C0871208:Rate [Activity]
   706   C1299351:High [Qualitative Concept]
   706   C1521828:Rate [Quantitative Concept]
   706 E C2239178:Neonate [Finding]
   706   C2700149:HIGH [Intellectual Product]
   706 E C2939425:Neonate, NOS [Temporal Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "than those"

Phrase: "of older animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(4,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.22: The feeding-induced stimulation of protein synthesis occurs in virtually all tissues of the neonate but is most dramatic in skeletal muscle. 

Phrase: "The feeding-induced stimulation of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "occurs in virtually"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "all tissues of the neonate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C2983684:ALL TISSUES [Body Substance]
   760   C0040300:Tissues [Tissue]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "but"

Phrase: "is"

Phrase: "most dramatic in skeletal muscle."
Processing 00000000.tx.23: The developmental decline in the protein synthesis response to feeding in muscle parallels the fall in the feeding-induced activation of translation initiation factors that regulate the binding of mRNA to the 40S ribosomal subunit (4, 12, 27, 31). 

Phrase: "The developmental decline in the protein synthesis response"

Phrase: "to feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "parallels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "the fall in the feeding-induced activation of translation initiation factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0085639:Fall [Finding]
   738   C0238715:Fall [Temporal Concept]

Phrase: "that"

Phrase: "regulate"

Phrase: "the binding of mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1148853:mRNA binding [Genetic Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to the 40S ribosomal subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1753319:40S ribosomal subunit [Cell Component]
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "(4,"

Phrase: "12,"

Phrase: "27,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.24: Both insulin and amino acids play key roles in the regulation of skeletal muscle protein synthesis in the neonate (6, 7, 55, 56). 

Phrase: "Both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "key roles in the regulation of skeletal muscle protein synthesis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0035820:Roles [Social Behavior]
   706 E C1705810:Role [Conceptual Entity]

Phrase: "in the neonate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]

Phrase: "(6,"

Phrase: "7,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.25: Our studies (55) in neonatal pigs have shown that insulin stimulates whole body amino acid disposal and that the insulin sensitivity and responsiveness of amino acid disposal decreases with development. 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: "in neonatal pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "whole body amino acid disposal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1707797:Disposal [Activity]

Phrase: "and"

Phrase: "that"

Phrase: "the insulin sensitivity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "responsiveness of amino acid disposal"

Phrase: "decreases with development."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0243107:development [Physiologic Function]
   790   C0392756:Decrease [Qualitative Concept]
   790   C0547047:Decrease [Quantitative Concept]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.26: Raising insulin to fed levels by infusion increases muscle protein synthesis to within the range normally present in the fed state, even when amino acids and glucose are maintained at fasting levels (6, 56). 

Phrase: "Raising insulin to fed levels"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0202098:insulin levels [Laboratory Procedure]
   797   C0428405:insulin levels [Laboratory or Test Result]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0574032:Infusion [Therapeutic or Preventive Procedure]
  1000   C1827465:Infusion [Functional Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "muscle protein synthesis to within the range normally"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0597295:Protein Synthesis [Molecular Function]
   744   C0026845:Muscle [Tissue]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   731 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "present in the fed state,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0150312:Present [Quantitative Concept]
   760   C0342895:FED [Disease or Syndrome]
   760   C0449450:Present [Idea or Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]
   726 E C0204695:Feed [Health Care Activity]
   726 E C2987508:Feed [Activity]

Phrase: "even"

Phrase: "when"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "are"

Phrase: "maintained at fasting levels"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0015663:Fasting [Finding]
   770   C0441889:Levels [Qualitative Concept]
   770   C1314677:Maintained [Functional Concept]
   770   C1550565:fasting [Intellectual Product]
   737 E C0024501:Maintain [Activity]
   737 E C0456079:Level [Classification]
   737 E C0456962:Fast [Qualitative Concept]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(6,"

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.27: The infusion of amino acids at a dose that reproduces fed-state amino acid levels, alone or concurrent with insulin infusion, increases protein synthesis in skeletal muscle of the neonate, and the magnitude of the amino acid-stimulated increase is similar to that which occurs with insulin infusion alone and to that which occurs in response to feeding (7). 

Phrase: "The infusion of amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1273690:Amino acid infusion [Pharmacologic Substance]
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]

Phrase: "at a dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "that"

Phrase: "reproduces"

Phrase: "fed-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]

Phrase: "state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "amino acid levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "concurrent with insulin infusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205420:Concurrent [Temporal Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "protein synthesis in skeletal muscle of the neonate,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0597295:Protein Synthesis [Molecular Function]
   767   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   731 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "the magnitude of the amino acid-stimulated increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449286:magnitude [Quantitative Concept]
   744   C1704240:Magnitude [Quantitative Concept]

Phrase: "is"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "which"

Phrase: "occurs with insulin infusion"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0199782:insulin infusion [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0574032:Infusion [Therapeutic or Preventive Procedure]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1709305:Occur [Activity]
   770   C1827465:Infusion [Functional Concept]
   770   C2745955:OCCUR [Temporal Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "which"

Phrase: "occurs in response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   790   C2911692:Response [Mental Process]

Phrase: "to feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.28: These responses to insulin and amino acids decrease with development. 

Phrase: "These responses to insulin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "decrease with development."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0243107:development [Physiologic Function]
   790   C0392756:Decrease [Qualitative Concept]
   790   C0547047:Decrease [Quantitative Concept]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.29: Taken together, the results imply that insulin and amino acids may be interacting with the same signaling pathway within skeletal muscle of the neonate. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "imply"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "interacting with the same signaling pathway"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0037083:signaling pathway [Cell Function]
           Signaling
   790   C0086982:Signaling Pathway [Molecular Function]
   783 E C0037080:pathway signaling [Molecular Function]
   753   C0445247:Same [Qualitative Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C3537152:signaling [Biologic Function]
   719 E C1710082:Signal [Phenomenon or Process]

Phrase: "within skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "of the neonate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]
Processing 00000000.tx.30: Using pancreatic glucose-amino acid clamps, we recently demonstrated that both insulin and amino acids independently stimulate muscle protein synthesis in the neonate (44). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pancreatic glucose-amino acid clamps,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C0079318:Glucose Clamps [Research Device]
   804   C0175721:clamps [Medical Device]
   771 E C1705942:Clamp [Manufactured Object]
   771 E C1883710:Clamp [Functional Concept]

Phrase: "we recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids independently"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "stimulate"

Phrase: "muscle protein synthesis in the neonate"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0597295:Protein Synthesis [Molecular Function]
   753   C0026845:Muscle [Tissue]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.31: However, the intracellular mechanisms by which insulin and amino acids regulate muscle protein synthesis were not explored. 

Phrase: "However,"

Phrase: "the intracellular mechanisms by which insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "regulate"

Phrase: "muscle protein synthesis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0026845:Muscle [Tissue]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explored."
Processing 00000000.tx.32: Rapid changes in the rate of protein synthesis, including those due to insulin and amino acid stimulation, are regulated by changes in the rate of translation of mRNA via alterations in the rate of peptide chain initiation (21, 30, 36). 

Phrase: "Rapid changes in the rate of protein synthesis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those due to insulin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3146286:Due [Idea or Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acid stimulation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "are"

Phrase: "regulated by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]

Phrase: "of mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "via alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of peptide chain initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0589507:Initiation [Mental Process]
   827   C1158830:Initiation [Genetic Function]
   827   C1704686:Initiation [Functional Concept]

Phrase: "(21,"

Phrase: "30,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.33: The first important regulatory step in translation initiation is the binding of initiator methionyl-tRNAi (met-tRNAi) to the 40S ribosomal subunit, a reaction that is mediated by eukaryotic initiation factor (eIF)2 and results in the formation of the 43S preinitiation complex (33, 46). 

Phrase: "The first important regulatory step in translation initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C1519613:Translation Initiation [Genetic Function]
   795   C0589507:Initiation [Mental Process]
   795   C1158830:Initiation [Genetic Function]
   795   C1704686:Initiation [Functional Concept]

Phrase: "is"

Phrase: "the binding of initiator methionyl-tRNAi (met-tRNAi)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to the 40S ribosomal subunit,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1753319:40S ribosomal subunit [Cell Component]
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "a reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "that"

Phrase: "is"

Phrase: "mediated by eukaryotic initiation factor (eIF)2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0083982:Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0589507:Initiation [Mental Process]
   753   C1158830:Initiation [Genetic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "results in the formation of the 43S preinitiation complex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C0439855:Complex [Qualitative Concept]
   742   C1274040:Result [Functional Concept]
   742   C1522492:Formation [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]
   742   C2825142:Result [Finding]

Phrase: "(33,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.34: The eIF2-mediated binding of met-tRNAi to the 40S subunit is regulated by modulation of the activity of eIF2B, which exchanges GDP for GTP on eIF2 (34). 

Phrase: "The eIF2-mediated binding of met-tRNAi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "to the 40S subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "regulated by modulation of the activity of eIF2B,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0443264:Modulation [Spatial Concept]
   744   C0606869:EIF 2B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "exchanges"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678640:exchange [Social Behavior]

Phrase: "GDP for GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "on eIF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013729:EIF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1166851:eIF-2 [Cell Component]
  1000   C3539639:EIF2 [Gene or Genome]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.35: The second regulatory process in translation initiation is the binding of mRNA to the 43S preinitiation complex, which is mediated by the eIF4F complex of proteins (36, 47, 49). 

Phrase: "The second regulatory process in translation initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1327622:Regulatory Process [Biologic Function]
   774   C1519614:Translation Process [Genetic Function]
   748   C1184743:Process [Body Part, Organ, or Organ Component]
   748   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "the binding of mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1148853:mRNA binding [Genetic Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to the 43S preinitiation complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "which"

Phrase: "is"

Phrase: "mediated by the eIF4F complex of proteins"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   757   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1523872:protein complex [Cell Component]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0058989:EIF4F [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C2826592:EIF4F [Gene or Genome]
   748   C3273427:EIF4F [Gene or Genome]
   748   C3539643:EIF4F [Gene or Genome]

Phrase: "(36,"

Phrase: "47,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.36: Proteins comprising the eIF4F complex are eIF4A, an RNA helicase, eIF4E, the protein that binds to the m7GTP cap structure at the 5' end of mRNA, and eIF4G, a scaffolding protein that binds to the 40S ribosomal subunit. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "comprising"

Phrase: "the eIF4F complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "are"

Phrase: "eIF4A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1414349:EIF4A [Gene or Genome]
  1000   C3273427:EIF4A [Gene or Genome]
  1000   C3539640:EIF4A [Gene or Genome]

Phrase: "an RNA helicase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0084378:RNA Helicase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0920283:helicase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "eIF4E,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "binds to the m7GTP cap structure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0179586:Cap [Manufactured Object]
   753   C0678594:Structure [Spatial Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1657858:CAP [Medical Device]
   753   C1706092:Cap [Medical Device]

Phrase: "at the 5' end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "of mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "eIF4G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a scaffolding protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1179132:Scaffolding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "binds to the 40S ribosomal subunit."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1753319:40S ribosomal subunit [Cell Component]
   790   C1956015:ribosomal subunit [Cell Component]
   753   C0035553:Ribosomal [Cell Component]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.37: Phosphorylation (43) and availability (45) of eIF4E regulate the assembly of the eIF4F complex. 

Phrase: "Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "(43"

Phrase: ")"

Phrase: "and"

Phrase: "availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Availability [Functional Concept]

Phrase: "(45"

Phrase: ")"

Phrase: "of eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "regulate"

Phrase: "the assembly of the eIF4F complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3157044:eIF4F assembly [Molecular Function]
   753   C1706853:Assembly [Activity]
   753   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.38: Phosphorylation of eIF4E increases its association with eIF4G and eIF4A and influences its affinity for the m7GTP cap at the 5' end of mRNA (40, 42, 43). 

Phrase: "Phosphorylation of eIF4E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "its association with eIF4G"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "eIF4A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1414349:EIF4A [Gene or Genome]
  1000   C3273427:EIF4A [Gene or Genome]
  1000   C3539640:EIF4A [Gene or Genome]

Phrase: "and"

Phrase: "influences"

Phrase: "its affinity for the m7GTP cap"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "at the 5' end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "of mRNA (40,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0439509:/40 [Temporal Concept]

Phrase: "42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.39: Availability of eIF4E for assembly of the eIF4F complex is limited by its binding to eIF4E-binding protein-1 (4E-BP1), a repressor binding protein that competes with eIF4G for binding to eIF4E (45). 

Phrase: "Availability of eIF4E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0470187:Availability of [Functional Concept]
           Availability
   716   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "of the eIF4F complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "limited by its binding"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0243122:binding [Functional Concept]
   770   C0439801:Limited [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "to eIF4E-binding protein-1"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   913   C1149297:eukaryotic initiation factor 4E binding [Genetic Function]
   911   C0013728:Eukaryotic Initiation Factor-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0243122:binding [Functional Concept]
   795   C0450378:4e [Intellectual Product]
   795   C0589507:Initiation [Mental Process]
   795   C1145667:Binding [Activity]
   795   C1158830:Initiation [Genetic Function]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1704686:Initiation [Functional Concept]
   795   C2827422:Factor [Conceptual Entity]

Phrase: "(4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "a repressor binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "that"

Phrase: "competes with eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.40: Phosphorylation of 4E-BP1 results in decreased affinity for eIF4E and thus enhanced formation of the active eIF4GeIF4E complex (18). 

Phrase: "Phosphorylation of 4E-BP1 results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]

Phrase: "in decreased affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "thus enhanced formation of the active eIF4GeIF4E complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.41: These translation initiation events may be modulated through the phosphatidylinositol 3-kinase-mammalian target of rapamycin (mTOR)-70-kDa ribosomal protein S6 kinase (S6K)1 signal transduction pathway (29). 

Phrase: "These translation initiation events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]
   734   C1519613:Translation Initiation [Genetic Function]

Phrase: "may"

Phrase: "be"

Phrase: "modulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulated [Spatial Concept]

Phrase: "through the phosphatidylinositol 3-kinase-mammalian target of rapamycin (mTOR)-70-kDa ribosomal protein S6 kinase (S6K)1 signal transduction pathway"
Meta Candidates (Total=34; Excluded=2; Pruned=0; Remaining=32)
   831   C0033640:kinase protein [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0293060:mammalian target of rapamycin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1307407:Mammalian Target of Rapamycin [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1414805:MAMMALIAN TARGET OF RAPAMYCIN [Gene or Genome]
   798   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   798   C0073336:Ribosomal Protein S6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   798   C0086982:Signal Transduction Pathway [Molecular Function]
   798   C1419741:RIBOSOMAL PROTEIN S6 [Gene or Genome]
           S6
   795   C0037080:Signal Pathway [Molecular Function]
   790   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0037083:Signal Transduction [Cell Function]
   790   C1622856:ribosomal protein [Genetic Function]
   783   C0024660:Mammalian [Mammal]
   783   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   783   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0035553:Ribosomal [Cell Component]
   783   C0072980:Rapamycin [Antibiotic,Organic Chemical]
   783   C0332273:Through [Functional Concept]
   783   C1160185:transduction [Organism Function]
   783   C1419024:S6 [Gene or Genome]
   783   C1521840:Target [Functional Concept]
   783   C1532717:kDa [Quantitative Concept]
   783   C1550549:through [Idea or Concept]
   783   C1704259:Pathway [Molecular Function]
   783   C1705987:Pathway [Conceptual Entity]
   783   C1710082:Signal [Phenomenon or Process]
   783   C1861424:S6 [Gene or Genome]
   783   C2348046:Phosphatidylinositol [Lipid]
   783   C2348600:S6+ [Element, Ion, or Isotope]
   783   C2986546:TARGET [Diagnostic Procedure]
   770 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   712 E C2984240:Ribosome [Functional Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.42: Previous studies in our laboratory (4) have shown that the postprandial increase in protein synthesis in the neonate is associated with an increase in translational efficiency via marked increases in the activation of translation initiation factors involved in the binding of mRNA, but not met-tRNAi, to the 40S ribosomal subunit (12, 27, 31). 

Phrase: "Previous studies in our laboratory"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0681827:Laboratory studies [Laboratory Procedure]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "(4"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the postprandial increase in protein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in the neonate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]

Phrase: "is"

Phrase: "associated with an increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0442805:Increase [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in translational efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "via marked increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "in the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of translation initiation factors"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   966   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Initiation Factors
   901   C1519613:Translation Initiation [Genetic Function]
   896   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040712:Translation [Intellectual Product]
   827   C0589507:Initiation [Mental Process]
   827   C0597295:translation [Molecular Function]
   827   C1158830:Initiation [Genetic Function]
   827   C1519614:Translation [Genetic Function]
   827   C1704686:Initiation [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "involved in the binding of mRNA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1148853:mRNA binding [Genetic Function]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1314939:Involved [Functional Concept]

Phrase: "but"

Phrase: "not met-tRNAi,"

Phrase: "to the 40S ribosomal subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1753319:40S ribosomal subunit [Cell Component]
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "(12,"

Phrase: "27,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.43: Thus, in the neonate, feeding increases the phosphorylation of S6K1 and the repressor protein 4E-BP1, thereby releasing eIF4E from the inactive 4E-BP1eIF4E complex and increasing the association of eIF4E with eIF4G. 

Phrase: "Thus,"

Phrase: "in the neonate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]

Phrase: "feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the phosphorylation of S6K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "the repressor protein 4E-BP1,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   839   C0033618:Protein Binding [Molecular Function]
   827   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0450378:4e [Intellectual Product]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1336789:Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "thereby"

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "eIF4E from the inactive 4E-BP1eIF4E complex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0450378:4e [Intellectual Product]
   739   C0589507:Initiation [Mental Process]
   739   C1158830:Initiation [Genetic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1704686:Initiation [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the association of eIF4E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with eIF4G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.44: All of these responses to feeding decline with development in skeletal muscle (12) in parallel with the developmental decline in the postprandial activation of the insulin-signaling pathway (50). 

Phrase: "All of these responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0444868:All [Quantitative Concept]
   770   C0871261:responses [Organism Attribute]
   770   C3539085:All [Idea or Concept]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "to feeding decline"

Phrase: "with development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "(12"

Phrase: ")"

Phrase: "in parallel with the developmental decline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "in the postprandial activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of the insulin-signaling pathway"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1512804:Insulin Signaling Pathway [Molecular Function]
  1000   C2984300:Insulin signaling pathway [Molecular Function]
   913   C2984427:Insulin Pathway [Functional Concept]
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.45: These postprandial changes in translation initiation in the neonate are rapamycin dependent (31). 

Phrase: "These postprandial changes in translation initiation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "in the neonate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]

Phrase: "are"

Phrase: "rapamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072980:Rapamycin [Antibiotic,Organic Chemical]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.46: However, feeding does not alter eIF2B activity, which regulates the binding of met-tRNAi to the 40S ribosomal subunit, although eIF2B activity declines with development (12). 

Phrase: "However,"

Phrase: "feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "eIF2B activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "regulates"

Phrase: "the binding of met-tRNAi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to the 40S ribosomal subunit,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1753319:40S ribosomal subunit [Cell Component]
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "although"

Phrase: "eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "declines with development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.47: In the present study, we wished to determine whether insulin and amino acids independently regulate skeletal muscle protein synthesis in the neonate by modulation of the activation of specific translation initiation factors. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "wished"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1423524:WISH [Gene or Genome]
   966   C3273411:WISH [Gene or Genome]
   966   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids independently"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "regulate"

Phrase: "skeletal muscle protein synthesis in the neonate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0597295:Protein Synthesis [Molecular Function]
   748   C0220781:synthesis [Biologic Function]
   748   C1883254:Synthesis [Activity]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "by modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulation [Spatial Concept]

Phrase: "of the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of specific translation initiation factors."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   890   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Initiation Factors
   861   C1519613:Translation Initiation [Genetic Function]
   858   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040712:Translation [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C0597295:translation [Molecular Function]
   812   C1158830:Initiation [Genetic Function]
   812   C1519614:Translation [Genetic Function]
   812   C1704686:Initiation [Functional Concept]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.48: Specifically, we wished to determine whether insulin and amino acids independently regulate the binding of mRNA to the 43S preinitiation complex, mediated through the formation of the eIF4F complex. 

Phrase: "Specifically,"

Phrase: "we"

Phrase: "wished"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1423524:WISH [Gene or Genome]
   966   C3273411:WISH [Gene or Genome]
   966   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids independently"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "regulate"

Phrase: "the binding of mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1148853:mRNA binding [Genetic Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to the 43S preinitiation complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "mediated through the formation of the eIF4F complex."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0058989:EIF4F [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C2826592:EIF4F [Gene or Genome]
   744   C3273427:EIF4F [Gene or Genome]
   744   C3539643:EIF4F [Gene or Genome]
Processing 00000000.tx.49: To address these issues, pancreatic glucose-amino acid clamps were used in fasted neonatal pigs to block insulin secretion; 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "these issues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0033213:Issue [Finding]
   966   C1706387:Issue [Intellectual Product]

Phrase: "pancreatic glucose-amino acid clamps"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C0079318:Glucose Clamps [Research Device]
   804   C0175721:clamps [Medical Device]
   771 E C1705942:Clamp [Manufactured Object]
   771 E C1883710:Clamp [Functional Concept]

Phrase: "were"

Phrase: "used in fasted neonatal pigs to"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   753   C0039005:Pigs [Mammal]
   753   C1135183:pigs [Mammal]
   753   C1273517:used [Finding]
   753   C1552240:Neonatal [Professional or Occupational Group]
   753   C1552264:Neonatal [Professional or Occupational Group]
   753   C2939425:Neonatal [Temporal Concept]
   719   C0015663:Fast [Finding]
   719 E C0042153:use [Functional Concept]
   719   C0456962:Fast [Qualitative Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1136016:PIG [Mammal]
   719 E C1265533:Pig [Mammal]
   719 E C1270360:Pig [Mammal]
   719 E C1947944:Use [Intellectual Product]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.50: insulin was infused to achieve levels simulating less-than-fasting, fasting, intermediate, and fed conditions; 

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "infused"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "simulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulating [Biomedical or Dental Material]

Phrase: "less-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than-fasting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: ","

Phrase: "intermediate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "fed conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.51: and amino acids were clamped at fasting, fed, or (at the high insulin dose only) below fasting levels. 

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "clamped at fasting,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015663:Fasting [Finding]
   790   C1550565:fasting [Intellectual Product]
   756   C0175721:Clamp [Medical Device]
   756 E C0456962:Fast [Qualitative Concept]
   756   C1705942:Clamp [Manufactured Object]
   756   C1883710:Clamp [Functional Concept]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: ","

Phrase: "or (at the high insulin dose only"

Phrase: ")"

Phrase: "below fasting levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.52: The results showed that the stimulation of protein synthesis by insulin and amino acids involves mechanisms that regulate the binding of mRNA to the 40S ribosomal subunit as well as pathways that are independent of the activation of these translation initiation factors.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the stimulation of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "involves"

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "regulate"

Phrase: "the binding of mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1148853:mRNA binding [Genetic Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to the 40S ribosomal subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1753319:40S ribosomal subunit [Cell Component]
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "as well as"

Phrase: "pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "are independent of the activation of these translation initiation factors."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   777   C2249873:activation of translational initiation [Cell Function]
   760   C0030943:Initiation Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Translation Initiation Factor
   760   C0332291:Independent of [Functional Concept]
   760   C1519613:Translation Initiation [Genetic Function]
   741   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0040712:Translation [Intellectual Product]
   739   C0085862:Independent [Idea or Concept]
   739   C0589507:Initiation [Mental Process]
   739   C0597295:translation [Molecular Function]
   739   C1158830:Initiation [Genetic Function]
   739   C1299583:Independent [Finding]
   739   C1519614:Translation [Genetic Function]
   739   C1551058:Are [Quantitative Concept]
   739   C1704686:Initiation [Functional Concept]
   739   C1879547:Activation [Activity]
   722   C1519616:Translational Activation [Genetic Function]
   706   C1521761:Factor [Functional Concept]
   706   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.53: METHODS TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  Animals. 

Phrase: "METHODS TOP ABSTRACT METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.54: Eleven multiparous crossbred (Yorkshire x Landrace x Hampshire x Duroc) sows (Agriculture Head-quarters, Texas Department of Criminal Justice, Huntsville, TX) were housed in lactation crates in individual, environmentally controlled rooms, maintained on a commercial diet (no. 5084, PMI Feeds, Richmond, IN), and provided water ad libitum throughout the lactation period. 

Phrase: "Eleven multiparous crossbred"

Phrase: "(Yorkshire x Landrace x Hampshire x Duroc) sows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0684075:sows [Mammal]

Phrase: "(Agriculture Head-quarters,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C2825406:Quarter [Quantitative Concept]
   793   C2986716:QUARTER [Body Part, Organ, or Organ Component]

Phrase: "Texas Department of Criminal Justice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Huntsville,"

Phrase: "TX)"

Phrase: "were"

Phrase: "housed in lactation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0006147:Lactation [Organism Function]
   790   C0020056:Housed [Manufactured Object]
   790   C0022925:Lactation [Organ or Tissue Function]
   756 E C0442519:house [Conceptual Entity]
   756 E C2003847:House [Manufactured Object]

Phrase: "crates in individual,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0027361:Individual [Population Group]
   790   C0237401:Individual [Human]

Phrase: "environmentally controlled rooms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1547703:Room [Spatial Concept]

Phrase: "maintained on a commercial diet"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0012155:Diet [Food]
   760   C0680536:commercial [Intellectual Product]
   760   C1314677:Maintained [Functional Concept]
   760   C1442959:Diet [Organism Function]
   760   C1519433:DIET [Therapeutic or Preventive Procedure]
   760   C2983588:DIET [Food]
   760   C3272563:Commercial [Intellectual Product]
   726 E C0024501:Maintain [Activity]

Phrase: "("

Phrase: "no. 5084,"

Phrase: "PMI Feeds,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1510670:Feeds [Functional Concept]
   827 E C0204695:Feed [Health Care Activity]
   827 E C2987508:Feed [Activity]

Phrase: "Richmond,"

Phrase: "IN"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "provided water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "ad libitum throughout the lactation period."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879743:ad libitum [Qualitative Concept]
Processing 00000000.tx.55: After farrowing, piglets remained with the sow and were not given supplemental creep feed. 

Phrase: "After farrowing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314680:Farrowing [Organism Function]

Phrase: "piglets"

Phrase: "remained with the sow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0684075:sow [Mammal]

Phrase: "and"

Phrase: "were"

Phrase: "not given supplemental creep feed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0204695:Feed [Health Care Activity]
   804   C2987508:Feed [Activity]
Processing 00000000.tx.56: Piglets were studied at 58 days of age (2.1  0.4 kg). 

Phrase: "Piglets"

Phrase: "were"

Phrase: "studied at 58 days of age (2.1  0.4 kg"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   738   C0001779:Age [Organism Attribute]
   738   C0022718:KG [Geographic Area]
   738   C0439209:kg [Quantitative Concept]
   738   C0439228:days [Temporal Concept]
   737   C0439418:kg/day [Quantitative Concept]
   721   C2826182:Study Day [Temporal Concept]
   704 E C0332173:/day [Temporal Concept]
   704 E C0439505:/day [Temporal Concept]
   704   C0557651:Study [Manufactured Object]
   704   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.57: Three to five days before the infusion study, pigs were anesthetized, and catheters were surgically inserted into a jugular vein and a carotid artery, using sterile techniques as described previously (55). 

Phrase: "Three to five days before the infusion study,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   754   C1708065:FIVE-DAY [Intellectual Product]
   750   C2826182:Study Day [Temporal Concept]
   744   C0439228:days [Temporal Concept]
   711 E C0332173:/day [Temporal Concept]
   711 E C0439505:/day [Temporal Concept]

Phrase: "pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039005:Pigs [Mammal]
  1000   C1135183:pigs [Mammal]
   966 E C1136016:PIG [Mammal]
   966 E C1265533:Pig [Mammal]
   966 E C1270360:Pig [Mammal]

Phrase: "were"

Phrase: "anesthetized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720436:Anesthetized [Finding]

Phrase: ","

Phrase: "and"

Phrase: "catheters"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085590:Catheters [Medical Device]
   966 E C1704454:Catheter [Medical Device]

Phrase: "were"

Phrase: "surgically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543467:Surgically [Health Care Activity]

Phrase: "inserted into a jugular vein"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0022427:Jugular vein [Body Part, Organ, or Organ Component]
   806   C1280188:Jugular vein [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C0441587:Inserted [Health Care Activity]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "a carotid artery,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0007272:Carotid artery [Body Part, Organ, or Organ Component]
  1000   C0162859:Carotid artery [Body Part, Organ, or Organ Component]
   861   C0003842:Artery [Body Part, Organ, or Organ Component]
   861   C0226004:artery [Body System]
   861   C0741968:Carotid [Body Part, Organ, or Organ Component]
   789 E C0221464:Arterial [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "sterile techniques"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025664:techniques [Intellectual Product]
   861   C0232920:Sterile [Qualitative Concept]
   861   C0449851:Techniques [Functional Concept]
   861   C0678108:Sterile [Pathologic Function]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.58: Piglets were returned to the sow until studied. 

Phrase: "Piglets"

Phrase: "were"

Phrase: "returned to the sow"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C0332156:Return to [Qualitative Concept]
           Return
   770   C0684075:sow [Mammal]

Phrase: "until"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.59: The previously described protocol (44) was approved by the Animal Care and Use Committee of Baylor College of Medicine. 

Phrase: "The previously described protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]

Phrase: "(44"

Phrase: ")"

Phrase: "was"

Phrase: "approved by the Animal Care"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0178478:animal care [Occupation or Discipline]
   760   C0003062:Animal [Animal]
   760   C0205540:Approved [Qualitative Concept]
   760   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee of Baylor College of Medicine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2699414:Committee [Group]
Processing 00000000.tx.60: The study was conducted in accordance with the National Research Council's Guide for the Care and Use of Laboratory Animals. 

Phrase: "The study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "conducted in accordance with the National Research Council's Guide"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0027472:National Research Council [Organization]
   742   C0035168:research [Research Activity]
   742   C0181090:Guide [Professional or Occupational Group]
   742   C0242481:Research [Research Activity]
   742   C0302614:Guide [Medical Device]
   742   C1551807:Council [Population Group]
   742   C1706050:Guide [Manufactured Object]
   742   C3245503:national [Intellectual Product]
   708   C0004927:Conduct [Individual Behavior]

Phrase: "for the Care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use of Laboratory Animals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]
Processing 00000000.tx.61: Pancreatic glucose-amino acid clamps. 

Phrase: "Pancreatic glucose-amino acid clamps."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C0079318:Glucose Clamps [Research Device]
   804   C0175721:clamps [Medical Device]
   771 E C1705942:Clamp [Manufactured Object]
   771 E C1883710:Clamp [Functional Concept]
Processing 00000000.tx.62: The clamp procedure has been previously described by O'Connor et al. 

Phrase: "The clamp procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "described by O'Connor et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1552738:described [Idea or Concept]
Processing 00000000.tx.63: (44). 

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.64: Briefly, pigs were placed awake in a sling restraint system after an overnight fast. 

Phrase: "Briefly,"

Phrase: "pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039005:Pigs [Mammal]
  1000   C1135183:pigs [Mammal]
   966 E C1136016:PIG [Mammal]
   966 E C1265533:Pig [Mammal]
   966 E C1270360:Pig [Mammal]

Phrase: "were"

Phrase: "placed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0442504:Place [Spatial Concept]
   966   C1704765:Place [Functional Concept]
   966   C1882509:Place [Activity]
   966   C3496241:place [Disease or Syndrome]

Phrase: "awake in a sling restraint system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0234422:Awake [Finding]

Phrase: "after an overnight fast."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015663:Fast [Finding]
   861   C0456962:Fast [Qualitative Concept]
Processing 00000000.tx.65: The average basal concentration of blood glucose (YSI 2300 STAT Plus; Yellow Springs Instruments, Yellow Springs, OH) and plasma branched-chain amino acid (BCAA) concentrations (3) to be used in the subsequent pancreatic glucose-amino acids clamp procedure were established during a 30-min basal period. 

Phrase: "The average basal concentration of blood glucose"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C2585282:Blood glucose concentration [Finding]
   774   C0427728:Blood concentration [Laboratory or Test Result]
   774   C0427743:Glucose concentration [Laboratory Procedure]
   774   C0699870:blood concentration [Quantitative Concept]
   774   C1287281:Glucose concentration [Laboratory or Test Result]
   774   C1313904:Blood concentration [Laboratory Procedure]
   774   C2827768:Average Concentration [Quantitative Concept]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "(YSI 2300 STAT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205548:Stat [Temporal Concept]

Phrase: "Plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "; Yellow Springs Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0348000:instruments [Medical Device]

Phrase: "Yellow Springs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0241232:Spring [Temporal Concept]
   827   C1705204:Spring [Manufactured Object]

Phrase: "OH)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "plasma branched-chain amino acid (BCAA) concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   878   C0683150:plasma concentration [Quantitative Concept]
   799   C0086045:Concentrations [Mental Process]
   766 E C1446561:Concentration [Quantitative Concept]
   734   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "used in the subsequent pancreatic glucose-amino acids"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0332282:Subsequent [Temporal Concept]
   744   C1273517:used [Finding]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0042153:use [Functional Concept]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "clamp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175721:Clamp [Medical Device]
  1000   C1705942:Clamp [Manufactured Object]
  1000   C1883710:Clamp [Functional Concept]

Phrase: "procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "established during a 30-min basal period."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0456693:/30 min [Temporal Concept]
   778   C1442458:30 min [Temporal Concept]
   748   C0205112:Basal [Spatial Concept]
   748   C0439531:/period [Temporal Concept]
   748   C0443211:Established [Qualitative Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1272684:Established [Qualitative Concept]
   748   C1948053:Period [Temporal Concept]
Processing 00000000.tx.66: The clamp was initiated with a primed (20 g/kg), continuous (100 gkg-1h-1) somatostatin (BACHEM, Torrance, CA) infusion. 

Phrase: "The clamp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175721:Clamp [Medical Device]
  1000   C1705942:Clamp [Manufactured Object]
  1000   C1883710:Clamp [Functional Concept]

Phrase: "was"

Phrase: "initiated with a primed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0871133:primed [Functional Concept]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]

Phrase: "(20 g/kg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1300563:g/kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "continuous"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0549178:Continuous [Idea or Concept]
   928 E C0456391:Continuities [Temporal Concept]
   928 E C0595960:Continuity [Qualitative Concept]

Phrase: "(100 gkg-1h-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442450:1H [Temporal Concept]

Phrase: ")"

Phrase: "somatostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "(BACHEM,"

Phrase: "Torrance,"

Phrase: "CA) infusion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]
Processing 00000000.tx.67: After a 10-min infusion of somatostatin, a continuous infusion of replacement glucagon (150 ngkg-1h-1; Eli Lilly, Indianapolis, IN) was initiated and continued to the end of the clamp period. 

Phrase: "After a 10-min infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0574032:Infusion [Therapeutic or Preventive Procedure]
   812   C1827465:Infusion [Functional Concept]

Phrase: "of somatostatin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "a continuous infusion of replacement glucagon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444889:Continuous infusion [Therapeutic or Preventive Procedure]
   753   C0574032:Infusion [Therapeutic or Preventive Procedure]
   753   C1827465:Infusion [Functional Concept]

Phrase: "(150 ngkg-1h-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442450:1H [Temporal Concept]

Phrase: "; Eli Lilly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331851:Eli Lilly [Health Care Related Organization]

Phrase: "Indianapolis,"

Phrase: "IN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]

Phrase: "was"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "continued to the end of the clamp period."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0175721:Clamp [Medical Device]
   744   C0439531:/period [Temporal Concept]
   744   C0444930:End [Spatial Concept]
   744   C0549178:Continued [Idea or Concept]
   744   C1705942:Clamp [Manufactured Object]
   744   C1883710:Clamp [Functional Concept]
   744   C1948053:Period [Temporal Concept]
   744   C2746065:End [Temporal Concept]
Processing 00000000.tx.68: Insulin was infused at 0, 10, 22, or 110 ngkg-0.66min-1 to achieve plasma insulin concentrations of 0, 2, 6, and 30 U/ml to simulate less-than-fasting, fasting, intermediate, and fed insulin levels (4). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "infused at 0,"

Phrase: "10,"

Phrase: "22,"

Phrase: "or"

Phrase: "110 ngkg-0.66min-1 to"

Phrase: "achieve"

Phrase: "plasma insulin concentrations of 0,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0683150:concentrations plasma [Quantitative Concept]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6,"

Phrase: "and"

Phrase: "30 U/ml to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439340:U/ml [Quantitative Concept]
   861   C1880521:U/mL [Quantitative Concept]
   861   C2945590:U/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "simulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulate [Biomedical or Dental Material]

Phrase: "less-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than-fasting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: ","

Phrase: "intermediate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "fed insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.69: At each dose of insulin, amino acids were clamped at either the fasting (500 nmol BCAA/ml) or fed (1,000 nmol BCAA/ml) level by monitoring the BCAA every 5 min and adjusting the infusion rate of a balanced amino acid mixture (7) to maintain the plasma BCAA concentration within 10% of the desired level (6, 7). 

Phrase: "At each dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "of insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "clamped at either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0175721:Clamp [Medical Device]
   756   C1705942:Clamp [Manufactured Object]
   756   C1883710:Clamp [Functional Concept]

Phrase: "the fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "(500 nmol BCAA/ml)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C0439300:nmol/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]
   710   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "fed (1,000 nmol BCAA/ml) level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441889:Level [Qualitative Concept]
   790   C0456079:Level [Classification]
   790   C1547707:Level [Geographic Area]
   790   C2946261:Level [Pharmacologic Substance]

Phrase: "by monitoring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150369:Monitoring [Health Care Activity]
  1000   C1516647:monitoring [Research Activity]

Phrase: "the BCAA"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "every 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "adjusting"

Phrase: "the infusion rate of a balanced amino acid mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C2964135:Infusion Rate [Temporal Concept]
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "(7"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the plasma BCAA concentration within 10%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0683150:concentration plasma [Quantitative Concept]
   742   C0086045:Concentration [Mental Process]
   742   C1446561:Concentration [Quantitative Concept]

Phrase: "of the desired level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.70: At the highest insulin dose only, amino acids were also allowed to fall below fasting levels by omitting the amino acid clamp. 

Phrase: "At the highest insulin dose only,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0444956:High dose [Quantitative Concept]
   812   C0178602:Dose [Quantitative Concept]
   812   C0869039:Dose [Quantitative Concept]
   812   C1114758:Dose # [Clinical Attribute]

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fall below fasting levels"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0015663:Fasting [Finding]
   770   C0085639:Fall [Finding]
   770   C0238715:Fall [Temporal Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550565:fasting [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C0456962:Fast [Qualitative Concept]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "by omitting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitting [Idea or Concept]

Phrase: "the amino acid clamp."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0175721:Clamp [Medical Device]
   827   C1705942:Clamp [Manufactured Object]
   827   C1883710:Clamp [Functional Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]
Processing 00000000.tx.71: Blood glucose concentrations were measured at 5-min intervals, and the dextrose infusion rate was adjusted to maintain the glucose concentration at a constant value (14). 

Phrase: "Blood glucose concentrations"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   983   C2585282:Blood glucose concentration [Finding]
   913   C0427728:blood concentrations [Laboratory or Test Result]
   913   C0699870:blood concentrations [Quantitative Concept]
   913   C1313904:blood concentrations [Laboratory Procedure]
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0005802:Blood Glucose [Carbohydrate]

Phrase: "were"

Phrase: "measured at 5-min intervals,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0444706:Measured [Qualitative Concept]
   760   C0702093:/min [Temporal Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]

Phrase: "and"

Phrase: "the dextrose infusion rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2964135:Infusion Rate [Temporal Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the glucose concentration at a constant value"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0427743:Glucose concentration [Laboratory Procedure]
   778   C1287281:Glucose concentration [Laboratory or Test Result]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.72: Blood samples also were taken at intervals for later determination of circulating insulin, glucagon, and individual essential and nonessential amino acid concentrations (11). 

Phrase: "Blood samples also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0178913:blood samples [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "taken at intervals"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1272706:intervals [Temporal Concept]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
   756 E C1552654:Interval [Idea or Concept]
   756 E C1552713:Interval [Intellectual Product]

Phrase: "for later determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]

Phrase: "of circulating insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "individual essential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "nonessential amino acid concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   756   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.73: Tissue protein synthesis in vivo. 

Phrase: "Tissue protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.74: The fractional rate of protein synthesis was measured with a flooding dose of L-[4-3H]phenylalanine (17) injected 90 min after the initiation of the clamp procedure for a 30-min labeling period. 

Phrase: "The fractional rate of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "measured with a flooding dose of L-[4-3H"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   742   C0016248:Flooding [Natural Phenomenon or Process]
   742   C0021114:flooding [Therapeutic or Preventive Procedure]
   742   C0178602:Dose [Quantitative Concept]
   742   C0444706:Measured [Qualitative Concept]
   742   C0869039:Dose [Quantitative Concept]
   742   C1114758:Dose # [Clinical Attribute]
   742   C1442460:3H [Temporal Concept]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]
   708 E C0375741:Flood [Injury or Poisoning]

Phrase: "]phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(17"

Phrase: ")"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "90 min after the initiation of the clamp procedure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0702093:/min [Temporal Concept]

Phrase: "for a 30-min labeling period."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.75: Pigs were killed at 2 h, samples of longissimus dorsi muscle were collected and rapidly frozen, and fractional rates of protein synthesis were determined as previously described (9). 

Phrase: "Pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039005:Pigs [Mammal]
  1000   C1135183:pigs [Mammal]
   966 E C1136016:PIG [Mammal]
   966 E C1265533:Pig [Mammal]
   966 E C1270360:Pig [Mammal]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "at 2 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "samples of longissimus dorsi muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "fractional rates of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "determined as previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.76: Plasma hormones and substrates. 

Phrase: "Plasma hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.77: The concentrations of individual amino acids from frozen plasma samples obtained at 0 and 90 min of the insulin infusions were measured with an HPLC method (PICO-TAG reverse-phase column; Waters, Milford, MA) as previously described (11). 

Phrase: "The concentrations of individual amino acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "from frozen plasma samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0444263:Plasma sample [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "obtained at 0"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "90 min of the insulin infusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "were"

Phrase: "measured with an HPLC method"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0025663:Method [Intellectual Product]
   760   C0444706:Measured [Qualitative Concept]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(PICO-TAG reverse-phase column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "; Waters,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043047:Waters [Inorganic Chemical,Pharmacologic Substance]
   966 E C0599638:WATER [Substance]
   966 E C1550678:Water [Inorganic Chemical]
   916 E C0443350:Watery [Qualitative Concept]

Phrase: "Milford,"

Phrase: "MA)"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.78: Plasma radioimmunoreactive insulin concentrations were measured using a porcine insulin radioimmunoassay kit (Linco, St. Charles, MO) that used porcine insulin antibody and human insulin standards. 

Phrase: "Plasma radioimmunoreactive insulin concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   886   C0683150:plasma concentration [Quantitative Concept]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]
   708   C0857690:plasma insulin [Laboratory Procedure]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a porcine insulin radioimmunoassay kit (Linco,"

Phrase: "St. Charles,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "that used porcine insulin antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021644:Insulin antibody [Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "human insulin standards."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0038137:standards [Intellectual Product]
   827   C0175675:Standards [Qualitative Concept]
   793 E C1442989:Standard [Qualitative Concept]
   793 E C2828392:Standard [Intellectual Product]
   734   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.79: Plasma radioimmunoreactive glucagon concentrations were measured using a porcine glucagon radioimmunoassay kit (Linco) that used porcine glucagon antibody and human glucagon standards. 

Phrase: "Plasma radioimmunoreactive glucagon concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   886   C0683150:plasma concentration [Quantitative Concept]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a porcine glucagon radioimmunoassay kit (Linco"

Phrase: ")"

Phrase: "that used porcine glucagon antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "human glucagon standards."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0038137:standards [Intellectual Product]
   827   C0175675:Standards [Qualitative Concept]
   793 E C1442989:Standard [Qualitative Concept]
   793 E C2828392:Standard [Intellectual Product]
Processing 00000000.tx.80: Protein immunoblot analysis. 

Phrase: "Protein immunoblot analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1514534:Protein Analysis [Molecular Biology Research Technique]
   901   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.81: Blots were developed using an Amersham enhanced chemiluminescence (ECL) Western blotting kit, as described previously (33). 

Phrase: "Blots"

Phrase: "were"

Phrase: "developed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Amersham enhanced chemiluminescence (ECL) Western blotting kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0812225:KIT [Medical Device]
   799   C1150635:KIT [Molecular Function]
   799   C1705212:Kit [Medical Device]
   799   C1705213:KIT [Medical Device]
   799   C3273202:Kit [Manufactured Object]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.82: Chemiluminescence was measured using a Gene Genome imaging system (Syngene) and quantitated using GeneTools software (Syngene). 

Phrase: "Chemiluminescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162524:Chemiluminescence [Natural Phenomenon or Process]
  1000   C1450278:Chemiluminescence [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Gene Genome imaging system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C2697665:Imaging System [Manufactured Object]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Syngene"

Phrase: ")"

Phrase: "and"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GeneTools software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Syngene"

Phrase: ")."
Processing 00000000.tx.83: Results are expressed as arbitrary units, which represent the integrated pixel intensity of the band being analyzed. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as arbitrary units,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "which"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the integrated pixel intensity of the band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "being"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.84: Examination of 4E-BP1 phosphorylation on Thr70. 

Phrase: "Examination of 4E-BP1 phosphorylation"

Phrase: "on Thr70."
Processing 00000000.tx.85: Aliquots of muscle homogenates (supernatants) were heated at 100C for 10 min, cooled to room temperature, and then centrifuged at 10,000 g for 10 min at 4C. 

Phrase: "Aliquots of muscle homogenates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "(supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "were"

Phrase: "heated at 100C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "cooled to room temperature,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]
   737   C1548792:Cool [Qualitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged at 10,000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.86: The supernatants were diluted with SDS sample buffer and then subjected to protein immunoblot analysis, as described previously (12, 33). 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "diluted with SDS sample buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to protein immunoblot analysis,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.87: The membranes were incubated with a polyclonal anti-body that specifically recognizes phosphorylation of 4E-BP1 at Thr70. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with a polyclonal anti-body"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0242821:body [Human]
   753   C0460148:Body [Anatomical Structure]
   753   C1268086:Body [Anatomical Structure]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "that specifically"

Phrase: "recognizes"

Phrase: "phosphorylation of 4E-BP1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "at Thr70."
Processing 00000000.tx.88: Quantitation of 4E-BP1eIF4E and eIF4GeIF4E complexes. 

Phrase: "Quantitation of 4E-BP1eIF4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "and"

Phrase: "eIF4GeIF4E complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.89: The association of eIF4E with 4E-BP1 or eIF4G was quantitated as described previously (12, 34). 

Phrase: "The association of eIF4E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with 4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "or"

Phrase: "eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "quantitated"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.90: Briefly, eIF4E was immunoprecipitated from 10,000-g supernatants of muscle homogenates by use of a monoclonal antibody to eIF4E (28). 

Phrase: "Briefly,"

Phrase: "eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "immunoprecipitated from 10,000-g supernatants of muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0026845:Muscle [Tissue]
   744   C0439267:g% [Quantitative Concept]
   711   C0301871:Immunoprecipitate [Immunologic Factor]
   711   C1550101:Supernatant [Body Substance]

Phrase: "homogenates by use of a monoclonal antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C1524063:Use of [Functional Concept]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C0746619:monoclonal [Finding]
   748   C1947944:Use [Intellectual Product]

Phrase: "to eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.91: Next, proteins in the immunoprecipitate were resolved by SDS-polyacrylamide gel electrophoresis and then transferred to PVDF membranes. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "proteins in the immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "resolved by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred to PVDF membranes."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0025255:Membranes [Tissue]
   770   C0071710:PVDF [Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.92: The membranes were then probed with either anti-4E-BP1 or anti-eIF4G antibodies and subsequently developed using an ECL Western blotting kit (Amersham Pharmacia Biotech). 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed with either anti-4E-BP1"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C0033618:Protein Binding [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C0450378:4e [Intellectual Product]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   711   C0182400:Probe [Medical Device]
   711   C1704681:Probe [Gene or Genome]
   711   C2347609:Probe [Chemical Viewed Functionally]
   711   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "anti-eIF4G antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "subsequently"

Phrase: "developed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ECL Western blotting kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.93: The horseradish peroxidase coupled to the anti-rabbit secondary antibody was then inactivated by incubating the blot in 15% hydrogen peroxide for 30 min at room temperature, and the membranes were reprobed with the monoclonal anti-eIF4E antibody (32). 

Phrase: "The horseradish peroxidase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0330510:Horseradish [Food]
   861   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   861   C1110641:Horseradish [Plant]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "coupled to the anti-rabbit secondary antibody"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0175668:Secondary to [Temporal Concept]
           Secondary
   774   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027627:secondary [Neoplastic Process]
   748   C0034493:Rabbit [Mammal]
   748   C0205436:Secondary [Quantitative Concept]
   748   C1948027:Coupled [Functional Concept]
   714 E C0010222:couple [Family Group]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "inactivated by incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:incubating [Laboratory Procedure]

Phrase: "the blot in 15% hydrogen peroxide"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "reprobed with the monoclonal anti-eIF4E antibody"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0450378:4e [Intellectual Product]
   739   C0589507:Initiation [Mental Process]
   739   C0746619:monoclonal [Finding]
   739   C1158830:Initiation [Genetic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1704686:Initiation [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.94: Values obtained using the anti-4E-BP1 and anti-eIF4G antibodies were normalized for the amount of eIF4E in the immunoprecipitates. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the anti-4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C0450378:4e [Intellectual Product]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "anti-eIF4G antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "normalized for the amount of eIF4E"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0450378:4e [Intellectual Product]
   742   C0589507:Initiation [Mental Process]
   742   C1158830:Initiation [Genetic Function]
   742   C1265611:Amount [Quantitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1704686:Initiation [Functional Concept]
   742   C1882115:Normalized [Research Activity]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "in the immunoprecipitates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.95: Measurement of eIF4E phosphorylation and content. 

Phrase: "Measurement of eIF4E phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0242485:Measurement [Functional Concept]

Phrase: "and"

Phrase: "content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.96: The phosphorylated and unphosphorylated forms of eIF4E in tissue extracts were separated by isoelectric focusing of 10,000-g supernatants on a slab gel and were quantitated by protein immunoblot analysis with a monoclonal antibody against eIF4E, as previously described (12, 28). 

Phrase: "The phosphorylated"

Phrase: "and"

Phrase: "unphosphorylated forms of eIF4E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "in tissue extracts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040291:Tissue Extracts [Biologically Active Substance]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "separated by isoelectric focusing of 10,000-g supernatants"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   764   C0022169:Isoelectric Focusing [Laboratory Procedure]
   742   C0000936:focusing [Clinical Attribute]
   742   C0086972:Separated [Finding]
   742   C0439267:g% [Quantitative Concept]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C2981153:Focusing [Finding]
   708 E C0205234:Focus [Spatial Concept]
   708 E C1285542:focus [Functional Concept]
   708   C1550101:Supernatant [Body Substance]

Phrase: "on a slab gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "were"

Phrase: "quantitated by protein immunoblot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "with a monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "against eIF4E,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(12,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.97: Measurement of S6K1 phosphorylation. 

Phrase: "Measurement of S6K1 phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.98: Muscle homogenates were combined with an equal volume of SDS sample buffer, and the diluted samples were subjected to electrophoresis on a 7.5% polyacrylamide gel (37). 

Phrase: "Muscle homogenates"

Phrase: "were"

Phrase: "combined with an equal volume of SDS sample buffer,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   784   C0427785:Volume of sample [Laboratory Procedure]
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0205163:Equal [Qualitative Concept]
   742   C0205195:Combined [Qualitative Concept]
   742   C0370003:Sample [Substance]
   742   C0449468:*Volume [Quantitative Concept]
   742   C1549782:Equal [Idea or Concept]
   742   C1690016:% volume [Qualitative Concept]
   742   C1705102:Volume [Intellectual Product]
   742   C2347026:Sample [Conceptual Entity]
   742   C2700258:Volume [Laboratory Procedure]
   708 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "the diluted samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "on a 7.5% polyacrylamide gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.99: The samples were then subjected to protein immunoblot analysis by use of rabbit anti-rat S6K polyclonal antibodies, as previously described (12). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to protein immunoblot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of rabbit anti-rat S6K polyclonal antibodies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   877   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   876   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   860 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   785   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.100: Measurement of eIF2B activity. 

Phrase: "Measurement of eIF2B activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.101: eIF2B activity in fresh muscle postmitochondrial supernatants was measured as the exchange of [3H]GDP bound to eIF2 for unlabeled GDP or GTP, as previously described (12, 26). 

Phrase: "eIF2B activity in fresh muscle postmitochondrial supernatants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   738   C0231484:Muscular activity [Organ or Tissue Function]

Phrase: "was"

Phrase: "measured as the exchange of [3H"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0444706:Measured [Qualitative Concept]
   753   C0678640:exchange [Social Behavior]
   753   C1442460:3H [Temporal Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "]GDP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "bound to eIF2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0013729:EIF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1166851:eIF-2 [Cell Component]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
   790   C3539639:EIF2 [Gene or Genome]

Phrase: "for unlabeled GDP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(12,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.102: Briefly, an eIF2[3H]GDP binary complex was formed in the absence of magnesium chloride. 

Phrase: "Briefly,"

Phrase: "an eIF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013729:EIF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1166851:eIF-2 [Cell Component]
  1000   C3539639:EIF2 [Gene or Genome]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]GDP binary complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "formed in the absence of magnesium chloride."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0024472:Magnesium Chloride [Inorganic Chemical,Pharmacologic Substance]
   748   C0008203:Chloride, NOS [Inorganic Chemical]
   748   C0024467:Magnesium [Element, Ion, or Isotope]
   748   C0205431:Formed [Functional Concept]
   748   C0332197:absence [Quantitative Concept]
   748   C0596019:Chloride [Element, Ion, or Isotope]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C2348270:MAGNESIUM [Element, Ion, or Isotope]
   714 E C0348078:Form [Qualitative Concept]
   714 E C0376315:Form [Manufactured Object]
   714 E C1522492:Form [Functional Concept]
Processing 00000000.tx.103: The eIF2[3H]GDP complex was then stabilized by the addition of magnesium chloride to a final concentration of 2 mM. 

Phrase: "The eIF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013729:EIF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1166851:eIF-2 [Cell Component]
  1000   C3539639:EIF2 [Gene or Genome]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]GDP complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stabilized by the addition of magnesium chloride"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0024472:Magnesium Chloride [Inorganic Chemical,Pharmacologic Substance]
   748   C0008203:Chloride, NOS [Inorganic Chemical]
   748   C0024467:Magnesium [Element, Ion, or Isotope]
   748   C0184512:Stabilized [Qualitative Concept]
   748   C0596019:Chloride [Element, Ion, or Isotope]
   748   C1883712:Addition [Functional Concept]
   748   C2348270:MAGNESIUM [Element, Ion, or Isotope]

Phrase: "to a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 2 mM."
Processing 00000000.tx.104: The eIF2[3H] GDP complex was incubated with samples containing eIF2B in the presence of a 100-fold molar excess of unlabeled, HPLC-purified GTP at 30C for various times. 

Phrase: "The eIF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013729:EIF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1166851:eIF-2 [Cell Component]
  1000   C3539639:EIF2 [Gene or Genome]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "] GDP complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "incubated with samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1439852:Incubated [Laboratory Procedure]
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "eIF2B in the presence of a 100-fold molar excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0606869:EIF 2B [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of unlabeled, HPLC-purified GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at 30C"

Phrase: "for various times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.105: The reaction mixture was filtered through a nitrocellulose filter, the filters were washed, and radioactivity bound to the filter was quantitated using a liquid scintillation counter. 

Phrase: "The reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "filtered through a nitrocellulose filter,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   726   C0180860:Filter [Manufactured Object]
   726   C0581406:Filter [Medical Device]
   726   C1522664:Filter [Intellectual Product]
   726   C1704449:Filter [Conceptual Entity]
   726   C1704684:Filter [Medical Device]
   726   C1875155:FILTER [Medical Device]

Phrase: "the filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "bound to the filter"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0180860:Filter [Manufactured Object]
   770   C0332297:bound [Spatial Concept]
   770   C0581406:Filter [Medical Device]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1522664:Filter [Intellectual Product]
   770   C1689898:% bound [Quantitative Concept]
   770   C1704449:Filter [Conceptual Entity]
   770   C1704684:Filter [Medical Device]
   770   C1875155:FILTER [Medical Device]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "was"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a liquid scintillation counter."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0036405:Scintillation Counter [Medical Device]
   901   C1710025:Scintillation Counter [Manufactured Object]
   827   C0677601:Counter [Manufactured Object]
   827   C0678573:scintillation [Natural Phenomenon or Process]
   827   C1705206:Counter [Medical Device]
Processing 00000000.tx.106: Calculations and statistics. 

Phrase: "Calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441506:Calculation [Activity]

Phrase: "and"

Phrase: "statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.107: The fractional rate of protein synthesis (Ks; percentage of protein mass synthesized in a day) was calculated as where Sb (dpm/min) is the specific radioactivity of the protein-bound phenylalanine; 

Phrase: "The fractional rate of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "(Ks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541894:ks [Quantitative Concept]

Phrase: "; percentage of protein mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1709500:Mass Percentage [Quantitative Concept]
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "synthesized in a day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C1883254:Synthesized [Activity]

Phrase: ")"

Phrase: "was"

Phrase: "calculated as where Sb (dpm/min)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0444686:Calculated [Functional Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1512024:DPM [Intellectual Product]
   753   C1634619:dpm [Quantitative Concept]

Phrase: "is"

Phrase: "the specific radioactivity of the protein-bound phenylalanine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.108: Sa (dpm/min) is the specific radioactivity of the tissue-free phenylalanine at the time of tissue collection and the linear regression of the blood specific radioactivity of the animal at 5, 15, and 30 min against time; 

Phrase: "Sa (dpm/min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "is"

Phrase: "the specific radioactivity of the tissue-free phenylalanine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1955394:Tissue specific [Body Substance]
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of tissue collection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040278:Tissue Collection [Health Care Related Organization,Manufactured Object]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "and"

Phrase: "the linear regression of the blood specific radioactivity of the animal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0023733:Linear Regression [Quantitative Concept]
   756   C2346679:Linear Regression [Intellectual Product]
   738   C0205132:Linear [Spatial Concept]
   738   C0684320:Regression [Pathologic Function]
   738   C0684321:Regression [Mental Process]
   704   C2826596:Vascular Regression [Finding]

Phrase: "at 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "15,"

Phrase: "and"

Phrase: "30 min against time"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.109: and t is the time of labeling in minutes. 

Phrase: "and"

Phrase: "t"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "is"

Phrase: "the time of labeling"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "in minutes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439232:minute [Temporal Concept]
  1000   C0700321:minute [Quantitative Concept]
  1000   C0702093:/minute [Temporal Concept]
  1000   C1282918:Minute [Quantitative Concept]
  1000   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.110: We have previously demonstrated (8) that the specific radioactivity of the tissue-free phenylalanine after a flooding dose of phenylalanine is in equilibrium with the aminoacyl-tRNA specific radioactivity; 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "demonstrated"

Phrase: "(8"

Phrase: ")"

Phrase: "that"

Phrase: "the specific radioactivity of the tissue-free phenylalanine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1955394:Tissue specific [Body Substance]
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]

Phrase: "after a flooding dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0178602:Dose [Quantitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]

Phrase: "of phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is in equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014653:Equilibrium [Organism Function]
   790   C1547026:Equilibrium [Quantitative Concept]

Phrase: "with the aminoacyl-tRNA specific radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034553:Radioactivity [Natural Phenomenon or Process]
   812   C0205369:Specific [Qualitative Concept]
   812   C1552740:specific [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.111: hence, the tissue-free phenylalanine reflects the specific radioactivity of the tissue precursor pool. 

Phrase: "hence,"

Phrase: "the tissue-free phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the specific radioactivity of the tissue precursor pool."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1955394:Tissue specific [Body Substance]
   744   C0034553:Radioactivity [Natural Phenomenon or Process]
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]
Processing 00000000.tx.112: Analysis of variance (general linear modeling) was used to assess the effect of insulin, amino acids, and their interaction and to determine whether or not there was a linear and/or quadratic relationship between insulin or BCAA and translation initiation factor activity, and between translation initiation factor activity and protein synthesis. 

Phrase: "Analysis of variance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "(general linear modeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870071:Modeling [Intellectual Product,Research Activity]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effect of insulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "their interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "or"

Phrase: "not there"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "was"

Phrase: "a linear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205132:Linear [Spatial Concept]

Phrase: "and/or"

Phrase: "quadratic relationship between insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "or"

Phrase: "BCAA"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "and"

Phrase: "translation initiation factor activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and between translation initiation factor activity"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   882   C1148909:translation initiation factor activity [Genetic Function]
   833   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Initiation Factor
   820   C1152945:translation factor activity [Genetic Function]
   790   C1519613:Translation Initiation [Genetic Function]
   783   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0040712:Translation [Intellectual Product]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0589507:Initiation [Mental Process]
   753   C0597295:translation [Molecular Function]
   753   C1158830:Initiation [Genetic Function]
   753   C1515981:And [Idea or Concept]
   753   C1519614:Translation [Genetic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "protein synthesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.113: Student's t-test was used to test for specific differences between groups. 

Phrase: "Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for specific differences"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0205369:Specific [Qualitative Concept]
   770   C0392366:test [Intellectual Product]
   770   C1552740:specific [Intellectual Product]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.114: To determine the effectiveness of the clamp procedure, amino acid and insulin concentrations in each treatment group were compared with their basal concentrations by use of the t-test. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the effectiveness of the clamp procedure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1280519:Effectiveness [Qualitative Concept]

Phrase: "amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "insulin concentrations in each treatment group"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "compared with their basal concentrations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0086045:Concentrations [Mental Process]
   760   C0205112:Basal [Spatial Concept]
   760   C1707455:Compared [Activity]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of the t-test."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0871472:t-Test [Intellectual Product]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.115: Values of P < 0.05 were considered statistically significant.  

Phrase: "Values of P < 0.05"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.116: RESULTS TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  Infusions, hormones, and substrates. 

Phrase: "RESULTS TOP ABSTRACT METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Infusions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0574032:infusions [Therapeutic or Preventive Procedure]
   966 E C1827465:Infusion [Functional Concept]

Phrase: "hormones,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.117: Fasted 7-day-old pigs were infused with somatostatin (to block insulin secretion), glucagon (at replacement levels), and glucose (as needed to maintain fasting levels). 

Phrase: "Fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "7-day-old pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0039005:Pigs [Mammal]
   812   C1135183:pigs [Mammal]
   779 E C1136016:PIG [Mammal]
   779 E C1265533:Pig [Mammal]
   779 E C1270360:Pig [Mammal]

Phrase: "were"

Phrase: "infused with somatostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   706 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "("

Phrase: "at replacement levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: "as"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "fasting levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.118: Insulin was infused at four doses to achieve levels that simulated 1) less-than-fasting, 2) fasting, 3) intermediate between fasting and fed, and 4) fed conditions. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "infused at four doses to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0178602:Doses [Quantitative Concept]
   760   C0205450:Four [Quantitative Concept]
   726 E C0869039:Dose [Quantitative Concept]
   726 E C1114758:Dose # [Clinical Attribute]
   726 E C1428722:DOS [Gene or Genome]

Phrase: "achieve"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "simulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulated [Biomedical or Dental Material]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "less-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than-fasting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "fasting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "intermediate between fasting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205103:Intermediate [Spatial Concept]
   790   C1550465:intermediate [Idea or Concept]
   790   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "fed,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "fed conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.119: As shown in Table 1, targeted plasma insulin levels, i.e., 0, 2, 6, and 30 U/ml, were largely achieved in all treatment groups. 

Phrase: "As"

Phrase: "shown in Table 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "targeted plasma insulin levels,"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   890   C1276042:Plasma insulin level [Laboratory Procedure]
   861   C0202098:insulin levels [Laboratory Procedure]
   861   C0428405:insulin levels [Laboratory or Test Result]
   861   C0857690:plasma insulin [Laboratory Procedure]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "0,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6,"

Phrase: "and"

Phrase: "30 U/ml,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "largely"

Phrase: "achieved in all treatment groups."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.120: Amino acids were clamped at fasting or fed levels, resulting in BCAA of 500 and 1,000 nmol/ml, respectively; 

Phrase: "Amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "clamped at fasting"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015663:Fasting [Finding]
   790   C1550565:fasting [Intellectual Product]
   756   C0175721:Clamp [Medical Device]
   756 E C0456962:Fast [Qualitative Concept]
   756   C1705942:Clamp [Manufactured Object]
   756   C1883710:Clamp [Functional Concept]

Phrase: "or"

Phrase: "fed levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "resulting in BCAA of 500"
Meta Candidates (Total=18; Excluded=6; Pruned=0; Remaining=12)
   833   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0332294:Resulting in [Functional Concept]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   750   C1253959:Branch of [Body Part, Organ, or Organ Component]
           branched
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0337112:Chain [Manufactured Object]
   744   C0678226:resulting [Functional Concept]
   744   C1524075:Chain [Idea or Concept]
   744   C2700384:Branched [Spatial Concept]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C1881507:Branch [Chemical Viewed Structurally]
   711 E C2700383:Branch [Plant]
   711 E C2825142:Result [Finding]
   711 E C2826234:BRANCH [Intellectual Product]

Phrase: "and"

Phrase: "1,000 nmol/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439300:nmol/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.121: at the highest insulin dose, amino acids were also allowed to fall to less than the fasting levels of 250 nmol/ml. 

Phrase: "at the highest insulin dose,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   896   C0444956:High dose [Quantitative Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   717   C0020459:high insulin [Disease or Syndrome]

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085639:Fall [Finding]
  1000   C0238715:Fall [Temporal Concept]

Phrase: "to less than the fasting levels of 250 nmol/ml."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0439300:nmol/mL [Quantitative Concept]
   739   C0015663:Fasting [Finding]
   739   C0439191:NMOLE [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C1550565:fasting [Intellectual Product]
   739   C1883351:To [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C0456962:Fast [Qualitative Concept]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.122: Concentrations of total, essential, nonessential, and branched-chain amino acids compared with baseline (time 0) values are shown in Table 1. 

Phrase: "Concentrations of total,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "essential,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205224:Essential [Qualitative Concept]

Phrase: "nonessential,"

Phrase: "and"

Phrase: "branched-chain amino acids"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "compared with baseline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0168634:baseline [Biomedical or Dental Material]
   790   C1442488:Baseline [Quantitative Concept]
   790   C1707455:Compared [Activity]

Phrase: "(time 0"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: ")"

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "shown in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.123: Circulating glucose and glucagon concentrations were largely maintained at baseline fasting levels during the infusion of somatostatin, glucagon, insulin, and/or amino acids (data not shown). 

Phrase: "Circulating glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "largely"

Phrase: "maintained at baseline fasting levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C0015663:Fasting [Finding]
   760   C0168634:baseline [Biomedical or Dental Material]
   760   C0441889:Levels [Qualitative Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1442488:Baseline [Quantitative Concept]
   760   C1550565:fasting [Intellectual Product]
   726 E C0024501:Maintain [Activity]
   726 E C0456079:Level [Classification]
   726 E C0456962:Fast [Qualitative Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "during the infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0574032:Infusion [Therapeutic or Preventive Procedure]
  1000   C1827465:Infusion [Functional Concept]

Phrase: "of somatostatin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and/or"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.125: Plasma insulin and AA levels in response to insulin and AA infusion during pancreatic glucose-AA clamps in 7-day-old pigs  Insulin dose response of translation initiation factors during euaminoacidemia and hyperaminoacidemia. 

Phrase: "Plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "AA levels in response"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   802   C1547597:Response level [Idea or Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "AA infusion during pancreatic glucose-AA clamps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0574032:Infusion [Therapeutic or Preventive Procedure]
   748   C1827465:Infusion [Functional Concept]

Phrase: "in 7-day-old pigs  Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "dose response of translation initiation factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "during euaminoacidemia"

Phrase: "and"

Phrase: "hyperaminoacidemia."
Processing 00000000.tx.126: We have recently demonstrated in neonatal pigs (44) that insulin and amino acids independently stimulate protein synthesis in skeletal muscle. 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated in neonatal pigs"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0039005:Pigs [Mammal]
   770   C1135183:pigs [Mammal]
   770   C1552240:Neonatal [Professional or Occupational Group]
   770   C1552264:Neonatal [Professional or Occupational Group]
   770   C2939425:Neonatal [Temporal Concept]
   737 E C1136016:PIG [Mammal]
   737 E C1265533:Pig [Mammal]
   737 E C1270360:Pig [Mammal]

Phrase: "(44"

Phrase: ")"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids independently"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "stimulate"

Phrase: "protein synthesis in skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0597295:Protein Synthesis [Molecular Function]
   797   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]
Processing 00000000.tx.127: The purpose of the present study was to identify the translational control mechanisms involved in this response. 

Phrase: "The purpose of the present study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   820   C0681832:purpose of study [Research Activity]
   753   C1285529:Purpose [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the translational control mechanisms"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0243148:control [Qualitative Concept]
   827   C0441712:Mechanisms [Functional Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1706376:Mechanism [Manufactured Object]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]

Phrase: "involved in this response."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0871261:Response [Organism Attribute]
   770   C1314939:Involved [Functional Concept]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]
Processing 00000000.tx.128: For the purpose of comparison, we have included the previously reported (44) muscle protein synthesis data herein. 

Phrase: "For the purpose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "of comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "we"

Phrase: "have"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(44"

Phrase: ")"

Phrase: "muscle protein synthesis data herein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]
Processing 00000000.tx.129: Figure 1A compares the dose-response effect of insulin on muscle protein synthesis in the presence of fasting and fed amino acid levels. 

Phrase: "Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "compares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the dose-response effect of insulin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1280500:Effect [Qualitative Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2348382:Effect [Qualitative Concept]
   753   C2911692:Response [Mental Process]

Phrase: "on muscle protein synthesis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0026845:Muscle [Tissue]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "fed amino acid levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.130: There was a progressive increase in protein synthesis rates as the concentration of insulin was increased (P < 0.005). 

Phrase: "There"

Phrase: "was"

Phrase: "a progressive increase in protein synthesis rates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "as the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.131: Amino acids increased muscle protein synthesis (P < 0.05) at each dose of insulin, including the 0 U/ml insulin/ml dose; 

Phrase: "Amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "muscle protein synthesis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0026845:Muscle [Tissue]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "at each dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "of insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the 0 U/ml insulin/ml dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0178602:Dose [Quantitative Concept]
   799   C0869039:Dose [Quantitative Concept]
   799   C1114758:Dose # [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.132: at the highest insulin dose, there was a tendency for amino acids to stimulate muscle protein synthesis (P = 0.06). 

Phrase: "at the highest insulin dose,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   896   C0444956:High dose [Quantitative Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   717   C0020459:high insulin [Disease or Syndrome]

Phrase: "there"

Phrase: "was"

Phrase: "a tendency for amino acids to"

Phrase: "stimulate"

Phrase: "muscle protein synthesis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0026845:Muscle [Tissue]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "(P = 0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.133: Thus there was a dose-response effect of insulin on muscle protein synthesis in the presence of fasting and fed amino acid levels. 

Phrase: "Thus there"

Phrase: "was"

Phrase: "a dose-response effect of insulin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1280500:Effect [Qualitative Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2348382:Effect [Qualitative Concept]
   753   C2911692:Response [Mental Process]

Phrase: "on muscle protein synthesis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0026845:Muscle [Tissue]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "fed amino acid levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.134: The effects of insulin and amino acids were additive until maximal rates of protein synthesis were achieved at fed insulin and amino acid levels. 

Phrase: "The effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "additive until maximal rates of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0442796:Additive [Qualitative Concept]
   748   C1550602:Additive [Substance]

Phrase: "were"

Phrase: "achieved at fed insulin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0342895:FED [Disease or Syndrome]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0204695:Feed [Health Care Activity]
   737 E C2987508:Feed [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acid levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]
Processing 00000000.tx.135: View larger version (57K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(57K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.136: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.137: Fractional protein synthesis rates (Ks; A) and translation initiation factor activity (B-F) in longissimus dorsi muscle of 7-day-old pigs at 0, 2, 6, and 30 U/ml plasma insulin levels during euaminoacidemia [500 nmol branched-chain amino acid (BCAA)/ml] and hyperaminoacidemia (1,000 nmol BCAA/ml). 

Phrase: "Fractional protein synthesis rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "(Ks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541894:ks [Quantitative Concept]

Phrase: "; A)"

Phrase: "and"

Phrase: "translation initiation factor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(B-F) in longissimus dorsi muscle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C1553038:[f] [Quantitative Concept]

Phrase: "of 7-day-old pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0039005:Pigs [Mammal]
   812   C1135183:pigs [Mammal]
   779 E C1136016:PIG [Mammal]
   779 E C1265533:Pig [Mammal]
   779 E C1270360:Pig [Mammal]

Phrase: "at 0,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6,"

Phrase: "and"

Phrase: "30 U/ml plasma insulin levels during euaminoacidemia"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0202098:insulin levels [Laboratory Procedure]
   770   C0428405:insulin levels [Laboratory or Test Result]
   770   C0857690:plasma insulin [Laboratory Procedure]
   767   C1276042:Plasma insulin level [Laboratory Procedure]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0032105:Plasma [Body Substance]
   744   C0441889:Levels [Qualitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "[500 nmol branched-chain amino acid"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   901   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C2917660:Amino Acid [Pharmacologic Substance]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]
   799   C0337112:Chain [Manufactured Object]
   799   C1253959:branched [Body Part, Organ, or Organ Component]
   799   C1524075:Chain [Idea or Concept]
   799   C2700384:Branched [Spatial Concept]
   766 E C1881507:Branch [Chemical Viewed Structurally]
   766 E C2700383:Branch [Plant]
   766 E C2826234:BRANCH [Intellectual Product]

Phrase: "(BCAA"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: ")"

Phrase: "/ml]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "hyperaminoacidemia"

Phrase: "(1,000 nmol BCAA/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   864   C0439300:nmol/mL [Quantitative Concept]
   793   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.138: Values are means  SE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE"

Phrase: ";"
Processing 00000000.tx.139: n = 812 per treatment group. 

Phrase: "n = 812 per treatment group."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   797   C0441848:Group N [Intellectual Product]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441833:Group [Idea or Concept]
   760   C0441922:N+ [Intellectual Product]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1552516:Group [Health Care Related Organization]
   760   C1553036:[n] [Quantitative Concept]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.140: Insulin increased Ks (P < 0.005), eukaryotic translation initiation factor (eIF)4E-binding protein-1 (4E-BP1) phosphorylation at Thr70 (P < 0.005), eIF4GeIF4E content (P < 0.001), and ribosomal protein S6 kinase-1 (S6K1) phosphorylation (P < 0.05) and decreased eIF4E4E-BP1 content (P < 0.001). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "Ks (P < 0.005"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3541894:ks [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "eukaryotic translation initiation factor"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Initiation Factor
   875   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1519613:Translation Initiation [Genetic Function]
   812   C0040712:Translation [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C0597295:translation [Molecular Function]
   812   C1158830:Initiation [Genetic Function]
   812   C1519614:Translation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(eIF)4E-binding protein-1 (4E-BP1) phosphorylation at Thr70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0031715:Phosphorylation [Molecular Function]

Phrase: "(P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "eIF4GeIF4E content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ribosomal protein S6 kinase-1"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   937   C0073337:Ribosomal Protein S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           S6 Kinase
   933   C1419742:RIBOSOMAL S6 KINASE 1 [Gene or Genome]
   933   C3539803:Ribosomal S6 Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0073336:Ribosomal Protein S6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1419741:RIBOSOMAL PROTEIN S6 [Gene or Genome]
           S6
   853   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1622856:ribosomal protein [Genetic Function]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0035553:Ribosomal [Cell Component]
   804   C1419024:S6 [Gene or Genome]
   804   C1861424:S6 [Gene or Genome]
   804   C2348600:S6+ [Element, Ion, or Isotope]
   733 E C2984240:Ribosome [Functional Concept]

Phrase: "(S6K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "decreased eIF4E4E-BP1 content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.141: Amino acids increased Ks (P < 0.05), 4E-BP1 phosphorylation at Thr70 (P < 0.01), eIF4GeIF4E content (P < 0.05), and S6K1 phosphorylation (P < 0.05) and decreased eIF4E4E-BP1 content (P < 0.05). 

Phrase: "Amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "Ks (P < 0.05"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3541894:ks [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "4E-BP1 phosphorylation at Thr70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "eIF4GeIF4E content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "decreased eIF4E4E-BP1 content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.142: *Statistically significantly different from 0 U/ml insulin dose within the same amino acid level (P < 0.05). 

Phrase: "*Statistically significantly different from 0 U/ml insulin dose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705242:Different [Qualitative Concept]

Phrase: "within the same amino acid level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.143: Significantly different from euaminoacidemic group within same insulin group (P < 0.05).  

Phrase: "Significantly different from euaminoacidemic group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "within same insulin group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.144: To examine the underlying mechanisms that independently regulate the stimulation of protein synthesis by insulin and amino acids in neonatal muscle, the dose-response effect of insulin, in the presence of fasting and fed amino acid levels, on translation initiation factor content and/or phosphorylation was examined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the underlying mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "that independently"

Phrase: "regulate"

Phrase: "the stimulation of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids in neonatal muscle,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "the dose-response effect of insulin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1280500:Effect [Qualitative Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2348382:Effect [Qualitative Concept]
   753   C2911692:Response [Mental Process]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "fed amino acid levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "on translation initiation factor content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and/or"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.145: The binding of met-tRNAi to the 40S ribosomal subunit is primarily regulated by changes in eIF2B activity (44). 

Phrase: "The binding of met-tRNAi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to the 40S ribosomal subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1753319:40S ribosomal subunit [Cell Component]
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "primarily"

Phrase: "regulated by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.146: The response of guanine nucleotide exchange activity of eIF2B to insulin doses of 0, 2, 6, and 30 U/ml, when amino acids were either at fasted or fed levels, was measured. 

Phrase: "The response of guanine nucleotide exchange activity of eIF2B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "to insulin doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "of 0,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6,"

Phrase: "and"

Phrase: "30 U/ml,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "when"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "either at fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0015663:Fast [Finding]
   756   C0456962:Fast [Qualitative Concept]

Phrase: "or"

Phrase: "fed levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.147: There were no differences in eIF2B activity regardless of insulin or amino acid dose (Fig. 1B). 

Phrase: "There"

Phrase: "were"

Phrase: "no differences in eIF2B activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "regardless of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "amino acid dose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0178602:Dose [Quantitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.148: Studies in cell culture have shown that eIF4E plays a critical role in the binding of mRNA to the 43S preinitiation complex (47, 49) and that the function of eIF4E may be influenced by either its phosphorylation state or its availability (43, 45). 

Phrase: "Studies in cell culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007585:Cell Culture [Laboratory Procedure]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C2242979:Culture [Laboratory Procedure]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a critical role in the binding of mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "to the 43S preinitiation complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(47,"

Phrase: "49"

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "the function of eIF4E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "influenced by either"

Phrase: "its phosphorylation state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "or"

Phrase: "its availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Availability [Functional Concept]

Phrase: "(43,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.149: To determine whether insulin and/or amino acids affected eIF4E phosphorylation status, the amount of eIF4E present in the phosphorylated form, as a percentage of the total eIF4E, was examined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and/or"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "eIF4E phosphorylation status,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0449438:Status [Qualitative Concept]
   734   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the amount of eIF4E present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "in the phosphorylated form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "as"

Phrase: "a percentage of the total eIF4E,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0439165:Percentage [Quantitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.150: There was no significant effect of insulin or amino acids on eIF4E phosphorylation (data not shown). 

Phrase: "There"

Phrase: "was"

Phrase: "no significant effect of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "amino acids on eIF4E phosphorylation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.151: The availability of eIF4E can be regulated through changes in the amount of eIF4E bound to 4E-BP1 such that phosphorylation of 4E-BP1 causes disassembly of the 4E-BP1eIF4E complex (32). 

Phrase: "The availability of eIF4E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "can"

Phrase: "be"

Phrase: "regulated through changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "bound to 4E-BP1"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783 E C0033618:Protein Binding [Molecular Function]
   783   C0522527:Protein bound [Qualitative Concept]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C0332297:bound [Spatial Concept]
   753   C0450378:4e [Intellectual Product]
   753   C1145667:Binding [Activity]
           Bound
   753   C1167622:Binding [Molecular Function]
           Bound
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]

Phrase: "such"

Phrase: "that phosphorylation of 4E-BP1 causes disassembly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "of the 4E-BP1eIF4E complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.152: Phosphorylation of 4E-BP1 at the Thr70 site has been shown to be important in regulating its association with eIF4E (31, 32). 

Phrase: "Phosphorylation of 4E-BP1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "at the Thr70 site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important in"

Phrase: "regulating"

Phrase: "its association with eIF4E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.153: Both insulin (P < 0.005) and amino acids (P < 0.01) stimulated 4E-BP1 phosphorylation at the Thr70 site (Fig. 1C). 

Phrase: "Both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "stimulated 4E-BP1 phosphorylation at the Thr70 site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   757   C1519063:Phosphorylation Site [Amino Acid Sequence]
   739   C0031715:Phosphorylation [Molecular Function]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.154: There was a tendency for an interaction between the effects of insulin and amino acids on 4E-BP1 phosphorylation (P = 0.08). 

Phrase: "There"

Phrase: "was"

Phrase: "a tendency for an interaction"

Phrase: "between the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids on 4E-BP1 phosphorylation"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   804   C0033618:protein amino acid binding [Molecular Function]
   804   C1158886:protein amino acid phosphorylation [Molecular Function]
   789   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   776   C1148572:amino acid binding [Molecular Function]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "(P = 0.08"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.155: Examination of specific differences among individual groups revealed that the effect of insulin on 4E-BP1 phosphorylation occurred at the intermediate (P < 0.05) and high (P < 0.01) doses of insulin in the presence of hyperaminoacidemia. 

Phrase: "Examination of specific differences"

Phrase: "among individual groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on 4E-BP1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "occurred at the intermediate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205103:Intermediate [Spatial Concept]
   770   C1550465:intermediate [Idea or Concept]
   770   C1709305:Occurred [Activity]
   770   C2827755:INTERMEDIATE [Laboratory or Test Result]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "doses of insulin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0178602:Doses [Quantitative Concept]
   756 E C0869039:Dose [Quantitative Concept]
   756 E C1114758:Dose # [Clinical Attribute]
   756 E C1428722:DOS [Gene or Genome]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperaminoacidemia."
Processing 00000000.tx.156: The effect of amino acids on 4E-BP1 phosphorylation occurred at the highest dose of insulin (P < 0.05). 

Phrase: "The effect of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on 4E-BP1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "occurred at the highest dose of insulin"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   762   C0444956:High dose [Quantitative Concept]
   757   C0020459:high insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1522410:Highest [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1709305:Occurred [Activity]
   714 E C0205250:High [Qualitative Concept]
   714 E C1299351:High [Qualitative Concept]
   714 E C2700149:HIGH [Intellectual Product]
   714 E C2745955:OCCUR [Temporal Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.157: Phosphorylation of 4E-BP1 in cells in culture and in vitro decreases the association of 4E-BP1 with eIF4E, thereby allowing eIF4E to bind to eIF4G (12, 32, 38). 

Phrase: "Phosphorylation of 4E-BP1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the association of 4E-BP1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with eIF4E,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "thereby"

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "eIF4E to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0450378:4e [Intellectual Product]
   804   C0589507:Initiation [Mental Process]
   804   C1158830:Initiation [Genetic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1704686:Initiation [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "bind to eIF4G"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "(12,"

Phrase: "32,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.158: To examine the effect of amino acids on the insulin dose response of 4E-BP1 modulation, eIF4E was immunoprecipitated with an anti-eIF4E antibody, followed by immunoblot analysis with an anti-4E-BP1 antibody. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effect of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "dose response of 4E-BP1 modulation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "immunoprecipitated with an anti-eIF4E antibody,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0450378:4e [Intellectual Product]
   742   C0589507:Initiation [Mental Process]
   742   C1158830:Initiation [Genetic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1704686:Initiation [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   708   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "followed by immunoblot analysis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with an anti-4E-BP1 antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   839   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.159: Both insulin (P < 0.001) and amino acids (P < 0.05) decreased the amount of 4E-BP1 present in the eIF4E immunoprecipitate (Fig. 1D). 

Phrase: "Both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the amount of 4E-BP1 present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "in the eIF4E immunoprecipitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0301871:Immunoprecipitate [Immunologic Factor]
   771   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.160: Although there was no interaction between the effects of insulin and amino acids, by analysis of individual treatment groups, insulin's effect on the association of eIF4E with 4E-BP1 occurred at the highest dose of insulin (P < 0.05) and tended to occur at the intermediate dose (P < 0.10) in the presence of euaminoacidemia. 

Phrase: "Although"

Phrase: "there"

Phrase: "was"

Phrase: "no interaction between the effects of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "by analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of individual treatment groups,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705169:Treatment [Conceptual Entity]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "insulin's effect on the association of eIF4E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "with 4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "occurred at the highest dose of insulin"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   762   C0444956:High dose [Quantitative Concept]
   757   C0020459:high insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1522410:Highest [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1709305:Occurred [Activity]
   714 E C0205250:High [Qualitative Concept]
   714 E C1299351:High [Qualitative Concept]
   714 E C2700149:HIGH [Intellectual Product]
   714 E C2745955:OCCUR [Temporal Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur at the intermediate dose"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0178602:Dose [Quantitative Concept]
   760   C0205103:Intermediate [Spatial Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1550465:intermediate [Idea or Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(P < 0.10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of euaminoacidemia."
Processing 00000000.tx.161: In the presence of hyperaminoacidemia, insulin's effect on the association of eIF4E with 4E-BP1 occurred at the low basal (P < 0.05), intermediate (P < 0.01), and high (P < 0.001) insulin doses. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperaminoacidemia,"

Phrase: "insulin's effect on the association of eIF4E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "with 4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "occurred at the low basal"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205112:Basal [Spatial Concept]
   760   C0205251:low [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   760   C1709305:Occurred [Activity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "insulin doses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]
Processing 00000000.tx.162: The effect of amino acids on the association of eIF4E with 4E-BP1 occurred at the low and intermediate doses of insulin (P < 0.05) and tended to occur at the high dose (P < 0.10). 

Phrase: "The effect of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "of eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "with 4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "occurred at the low"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   770   C1709305:Occurred [Activity]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "intermediate doses of insulin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0178602:Doses [Quantitative Concept]
   770   C0205103:Intermediate [Spatial Concept]
   770   C1550465:intermediate [Idea or Concept]
   770   C2827755:INTERMEDIATE [Laboratory or Test Result]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur at the high dose"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0444956:High dose [Quantitative Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1299351:High [Qualitative Concept]
   760   C1709305:Occur [Activity]
   760   C2700149:HIGH [Intellectual Product]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "(P < 0.10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.163: It is the reversible binding of eIF4G to eIF4E that primarily regulates the binding of mRNA to the 40S ribosomal subunit (22, 31, 35). 

Phrase: "It"

Phrase: "is"

Phrase: "the reversible binding of eIF4G"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622039:eIF4G binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "that primarily"

Phrase: "regulates"

Phrase: "the binding of mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1148853:mRNA binding [Genetic Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to the 40S ribosomal subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1753319:40S ribosomal subunit [Cell Component]
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "(22,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.164: In the present study, the amount of eIF4G bound to eIF4E was measured in the same eIF4E immunoprecipitates used to quantitate 4E-BP1 bound to eIF4E. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the amount of eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "bound to eIF4E"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332297:bound [Spatial Concept]
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1145667:Bound [Activity]
   753   C1158830:Initiation [Genetic Function]
   753   C1167622:Bound [Molecular Function]
   753   C1521761:Factor [Functional Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2349209:Bound [Conceptual Entity]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "measured in the same eIF4E immunoprecipitates"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   818   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0444706:Measured [Qualitative Concept]
   742   C0445247:Same [Qualitative Concept]
   742   C0450378:4e [Intellectual Product]
   742   C0589507:Initiation [Mental Process]
   742   C1158830:Initiation [Genetic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1704686:Initiation [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]
   708   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantitate"

Phrase: "4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "bound to eIF4E."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332297:bound [Spatial Concept]
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1145667:Bound [Activity]
   753   C1158830:Initiation [Genetic Function]
   753   C1167622:Bound [Molecular Function]
   753   C1521761:Factor [Functional Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2349209:Bound [Conceptual Entity]
   753   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.165: Both insulin (P < 0.001) and amino acids (P < 0.05) increased the amount of eIF4G associated with eIF4E (Fig. 1E), and there was significant interaction of insulin and amino acids on the amount of the active complex (P < 0.01). 

Phrase: "Both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "associated with eIF4E"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1158830:Initiation [Genetic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Fig. 1E"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "significant interaction of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "amino acids on the amount of the active complex"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.166: Analyzing differences between individual treatment groups revealed that the effect of insulin on the amount of eIF4G associated with eIF4E occurred at the highest dose of insulin in the presence of euaminoacidemia (P < 0.001). 

Phrase: "Analyzing differences between individual treatment groups"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0021228:Individual Differences [Mental Process]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with eIF4E"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1158830:Initiation [Genetic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "occurred at the highest dose of insulin"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   762   C0444956:High dose [Quantitative Concept]
   757   C0020459:high insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1522410:Highest [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1709305:Occurred [Activity]
   714 E C0205250:High [Qualitative Concept]
   714 E C1299351:High [Qualitative Concept]
   714 E C2700149:HIGH [Intellectual Product]
   714 E C2745955:OCCUR [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of euaminoacidemia"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.167: In the presence of hyperaminoacidemia, insulin tended to increase the association at the low basal insulin dose (P < 0.10) and significantly increased the association of eIF4G with eIF4E at the intermediate (P < 0.05) and highest insulin doses (P < 0.001). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperaminoacidemia,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the association at the low basal insulin dose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "(P < 0.10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the association of eIF4G"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "at the intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "highest insulin doses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   880   C0444956:High dose [Quantitative Concept]
   827   C0178602:Doses [Quantitative Concept]
   793 E C0869039:Dose [Quantitative Concept]
   793 E C1114758:Dose # [Clinical Attribute]
   793 E C1428722:DOS [Gene or Genome]
   717   C0020459:high insulin [Disease or Syndrome]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.168: Amino acids increased the association of eIF4G with eIF4E at the low and intermediate doses of insulin (P < 0.05). 

Phrase: "Amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the association of eIF4G"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "at the low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "intermediate doses of insulin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0178602:Doses [Quantitative Concept]
   770   C0205103:Intermediate [Spatial Concept]
   770   C1550465:intermediate [Idea or Concept]
   770   C2827755:INTERMEDIATE [Laboratory or Test Result]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.169: Both 4E-BP1 and S6K1 are downstream of mTOR and are thus dependent on the activity of this kinase for activation. 

Phrase: "Both 4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "S6K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are downstream of mTOR"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   831   C0293060:mammalian target of rapamycin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   831   C1307407:Mammalian Target of Rapamycin [Amino Acid, Peptide, or Protein,Enzyme]
   831   C1414805:MAMMALIAN TARGET OF RAPAMYCIN [Gene or Genome]
   748   C0024660:Mammalian [Mammal]
   748   C0072980:Rapamycin [Antibiotic,Organic Chemical]
   748   C0522506:Downstream [Spatial Concept]
   748   C1521840:Target [Functional Concept]
   748   C1551058:Are [Quantitative Concept]
   748   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "are"

Phrase: "thus dependent on the activity of this kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "for activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.170: Through protein immunoblot analysis, we determined the phosphorylation state of S6K1; 

Phrase: "Through protein immunoblot analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1514534:Protein Analysis [Molecular Biology Research Technique]
   901   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "determined"

Phrase: "the phosphorylation state of S6K1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: ";"
Processing 00000000.tx.171: the hyperphosphorylated form results in decreased mobility of the compound during SDS-polyacrylamide gel electrophoresis (54). 

Phrase: "the hyperphosphorylated form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "results in decreased mobility of the compound"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0700572:decreased mobility [Finding]
   748   C0205198:Compound [Qualitative Concept]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0425245:Mobility [Finding]
   748   C0442797:decreased [Qualitative Concept]
   748   C0449580:Mobility [Qualitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1706082:Compound [Chemical]
   748   C2825142:Result [Finding]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "during SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   923   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.172: Insulin (P < 0.001) and amino acids (P < 0.01) increased S6K1 phosphorylation (Fig. 1F), and there was no interaction between the effects of insulin and those of amino acids on S6K1 phosphorylation. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increased S6K1 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 1F"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "no interaction between the effects of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "those of amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799 E C2917660:Amino Acid [Pharmacologic Substance]
   770   C0001128:Acids [Chemical]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "on S6K1 phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.173: Examination of individual treatment groups revealed that S6K1 phosphorylation was increased at the highest dose of insulin in the presence of euaminoacidemia (P < 0.005) and hyperaminoacidemia (P < 0.001). 

Phrase: "Examination of individual treatment groups"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "increased at the highest dose of insulin"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   774   C0020459:increased insulin [Disease or Syndrome]
           high insulin
   774   C1707810:Dose Increased [Therapeutic or Preventive Procedure]
   762   C0444956:High dose [Quantitative Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0178602:Dose [Quantitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1522410:Highest [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   732   C0557899:Height increased [Finding]
   714 E C0205250:High [Qualitative Concept]
   714 E C1299351:High [Qualitative Concept]
   714 E C2700149:HIGH [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of euaminoacidemia"

Phrase: "(P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "hyperaminoacidemia"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.174: Amino acids further increased S6K1 phosphorylation at the highest insulin dose (P < 0.05). 

Phrase: "Amino acids further increased S6K1 phosphorylation at the highest insulin dose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0031715:Phosphorylation [Molecular Function]
   736   C1158886:Phosphorylation [Molecular Function]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.175: Amino acid dose response of translation initiation factors. 

Phrase: "Amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "dose response of translation initiation factors."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.176: Figure 2 shows the dose-response effect of below fasting, fasting, and fed amino acid levels, when insulin is infused to simulate the fed level, on translation initiation factor modulation. 

Phrase: "Figure 2"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the dose-response effect of"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C0871261:Response [Organism Attribute]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1280500:Effect [Qualitative Concept]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2348382:Effect [Qualitative Concept]
   760   C2911692:Response [Mental Process]

Phrase: "below fasting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "fed amino acid levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "when"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "infused"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "simulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulate [Biomedical or Dental Material]

Phrase: "the fed level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "on translation initiation factor modulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0443264:Modulation [Spatial Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.177: We have previously shown (4) that muscle protein synthesis rates increase as circulating amino acid levels are increased from below fasting to the fasting level (P < 0.001) and tend to increase further when amino acids are increased to fed levels (P = 0.06); 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(4"

Phrase: ")"

Phrase: "that muscle protein synthesis rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "increase as circulating amino acid levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   779   C1291157:Increased amino acid [Finding]
   753   C0001128:Acid [Chemical]
   753   C0175630:Circulating [Functional Concept]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   753   C0442805:Increase [Functional Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased from"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   833   C0205217:Increased [Quantitative Concept]
   833   C0442805:Increased [Functional Concept]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C1301820:Obtain [Functional Concept]
   740 E C1706701:Acquire [Activity]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "below fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "to the fasting level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "when"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "increased to fed levels"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0205217:Increased [Quantitative Concept]
   770   C0342895:FED [Disease or Syndrome]
   770   C0441889:Levels [Qualitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0204695:Feed [Health Care Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
   737 E C2987508:Feed [Activity]

Phrase: "(P = 0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.178: the data are presented here (Fig. 2A) for comparison. 

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "for comparison."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]
Processing 00000000.tx.179: Amino acids had no significant effect on eIF2B activity. 

Phrase: "Amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "had"

Phrase: "no significant effect on eIF2B activity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.180: When amino acids were increased from below fasting to fasting levels in the presence of fed insulin concentrations, S6K1 phosphorylation and eIF4GeIF4E association were increased (P < 0.005). 

Phrase: "When"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "increased from"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   833   C0205217:Increased [Quantitative Concept]
   833   C0442805:Increased [Functional Concept]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C1301820:Obtain [Functional Concept]
   740 E C1706701:Acquire [Activity]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "below fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "to fasting levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fed insulin concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "eIF4GeIF4E association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.181: When amino acids were raised from fasting to fed levels, S6K1 phosphorylation and 4E-BP1 phosphorylation were increased, and the 4E-BP1eIF4E association was reduced (P < 0.05). 

Phrase: "When"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "raised from fasting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0015663:Fasting [Finding]
   790   C0442818:Raised [Quantitative Concept]
   790   C1550565:fasting [Intellectual Product]
   756 E C0456962:Fast [Qualitative Concept]

Phrase: "to fed levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "4E-BP1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "were"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "the 4E-BP1eIF4E association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.182: View larger version (31K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.183: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.184: Translation initiation activity in longissimus dorsi muscle of 7-day-old pigs in the presence of hyperinsulinemia (30 U/ml) is compared during hypoaminoacidemia (250 nmol BCAA/ml), euaminoacidemia (500 nmol BCAA/ml), or hyperaminoacidemia (1,000 nmol BCAA/ml, respectively). 

Phrase: "Translation initiation activity in longissimus dorsi muscle of 7-day-old pigs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   736   C0205177:Activity [Functional Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C1561536:*Activity [Idea or Concept]
   715   C0231484:Muscular activity [Organ or Tissue Function]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "(30 U/ml)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "is"

Phrase: "compared during hypoaminoacidemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "(250 nmol BCAA/ml"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C0439300:nmol/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]
   710   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "euaminoacidemia"

Phrase: "(500 nmol BCAA/ml"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C0439300:nmol/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]
   710   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "hyperaminoacidemia"

Phrase: "(1,000 nmol BCAA/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   864   C0439300:nmol/mL [Quantitative Concept]
   793   C0439526:/mL [Quantitative Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.185: Values are means  SE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE"

Phrase: ";"
Processing 00000000.tx.186: n = 812 per treatment group. 

Phrase: "n = 812 per treatment group."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   797   C0441848:Group N [Intellectual Product]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441833:Group [Idea or Concept]
   760   C0441922:N+ [Intellectual Product]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1552516:Group [Health Care Related Organization]
   760   C1553036:[n] [Quantitative Concept]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.187: Amino acids increased protein synthesis rates (P < 0.05). 

Phrase: "Amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "protein synthesis rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   734   C0597295:Protein Synthesis [Molecular Function]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.188: *Significantly different from hyperinsulinemic hypoaminoacidemic group (P < 0.05). 

Phrase: "*Significantly different from hyperinsulinemic hypoaminoacidemic group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.189: Significantly different from hyperinsulinemic euaminoacidemic group (P < 0.05). 

Phrase: "Significantly different from hyperinsulinemic euaminoacidemic group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.190: A, Ks; 

Phrase: "A,"

Phrase: "Ks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541894:ks [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.191: BF, translation initiation factor activity.  

Phrase: "BF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006409:BF [Geographic Area]
  1000   C1824728:BF [Gene or Genome]

Phrase: "translation initiation factor activity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.192: Effect of insulin in the absence of an amino acid clamp on translation initiation factors. 

Phrase: "Effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of an amino acid clamp"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0175721:Clamp [Medical Device]
   827   C1705942:Clamp [Manufactured Object]
   827   C1883710:Clamp [Functional Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "on translation initiation factors."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   966   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Initiation Factors
   901   C1519613:Translation Initiation [Genetic Function]
   896   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040712:Translation [Intellectual Product]
   827   C0589507:Initiation [Mental Process]
   827   C0597295:translation [Molecular Function]
   827   C1158830:Initiation [Genetic Function]
   827   C1519614:Translation [Genetic Function]
   827   C1704686:Initiation [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.193: We recently demonstrated (44) that the stimulation of muscle protein synthesis by insulin does not require concurrent amino acid stimulation in the neonate. 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "(44"

Phrase: ")"

Phrase: "that"

Phrase: "the stimulation of muscle protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1709098:STIMULATION OF MUSCLE [Finding]
           Muscle Stimulation
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "concurrent amino acid stimulation in the neonate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.194: In the current study, translation initiation factor activity was examined when insulin was infused to the fed level in the presence of fasting (500 nmol BCAA/ml) and less-than-fasting (250 nmol BCAA/ml) amino acid levels, and the results were compared with the basal fasting insulin and amino acid condition. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "translation initiation factor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "when"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "infused to the fed level"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0342895:FED [Disease or Syndrome]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
   726 E C0204695:Feed [Health Care Activity]
   726 E C2987508:Feed [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "(500 nmol BCAA/ml)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C0439300:nmol/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]
   710   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "less-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than-fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "(250 nmol BCAA/ml) amino acid levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "compared with the basal fasting insulin"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0015663:Fasting [Finding]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205112:Basal [Spatial Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1550565:fasting [Intellectual Product]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1707455:Compared [Activity]
   719 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "amino acid condition."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   755 E C0009647:Conditioned [Mental Process]
   755 E C1701901:Conditional [Qualitative Concept]
   755 E C1963686:Conditional [Functional Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]
   727 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.195: Similar to the effects on fractional protein synthesis rates (Fig. 3A), insulin increased the amount of eIF4G associated with eIF4E in the absence of an amino acid clamp (P < 0.001; Fig. 3E), although not to the level seen when amino acids were clamped at fasting levels (P < 0.001). 

Phrase: "Similar to the effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "on fractional protein synthesis rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "associated with eIF4E"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1158830:Initiation [Genetic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of an amino acid clamp"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0175721:Clamp [Medical Device]
   827   C1705942:Clamp [Manufactured Object]
   827   C1883710:Clamp [Functional Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 3E"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "not to the level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1518422:Not [Functional Concept]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "clamped at fasting levels"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0015663:Fasting [Finding]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550565:fasting [Intellectual Product]
   737   C0175721:Clamp [Medical Device]
   737 E C0456079:Level [Classification]
   737 E C0456962:Fast [Qualitative Concept]
   737 E C1547707:Level [Geographic Area]
   737   C1705942:Clamp [Manufactured Object]
   737   C1883710:Clamp [Functional Concept]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.196: Insulin increased S6K1 phosphorylation in the presence (P < 0.001), but not in the absence, of an amino acid clamp (Fig. 3F). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "S6K1 phosphorylation in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not in the absence, of an amino acid clamp"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0175721:Clamp [Medical Device]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0332197:absence [Quantitative Concept]
   742   C1518422:Not [Functional Concept]
   742   C1689985:Absence [Anatomical Abnormality]
   742   C1705942:Clamp [Manufactured Object]
   742   C1883710:Clamp [Functional Concept]

Phrase: "(Fig. 3F"

Phrase: ")."
Processing 00000000.tx.197: Although there were tendencies for similar changes in 4E-BP1 phosphorylation (Fig. 3C) and the association of 4E-BP1 with eIF4E (Fig. 3D), these were not statistically significant. 

Phrase: "Although"

Phrase: "there"

Phrase: "were"

Phrase: "tendencies for similar changes"

Phrase: "in 4E-BP1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "the association of 4E-BP1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "these"

Phrase: "were"

Phrase: "not statistically significant."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.198: eIF2B activity was unaffected by amino acids (Fig. 3B). 

Phrase: "eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "unaffected by amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.199: View larger version (41K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.200: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.201: Translation initiation factor activity in longissimus dorsi muscle of 7-day-old pigs in the presence of hyperinsulinemia (30 U/ml) and either euaminoacidemia or hypoaminoacidemia (500 or 250 nmol BCAA/ml) is compared with basal fasting condition (2 U insulin/ml + 500 nmol BCAA/ml). 

Phrase: "Translation initiation factor activity in longissimus dorsi muscle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1148909:translation initiation factor activity [Genetic Function]
   793   C1152945:translation factor activity [Genetic Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   731   C0231484:Muscular activity [Organ or Tissue Function]

Phrase: "of 7-day-old pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0039005:Pigs [Mammal]
   812   C1135183:pigs [Mammal]
   779 E C1136016:PIG [Mammal]
   779 E C1265533:Pig [Mammal]
   779 E C1270360:Pig [Mammal]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "(30 U/ml)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "either euaminoacidemia"

Phrase: "or"

Phrase: "hypoaminoacidemia"

Phrase: "(500"

Phrase: "or"

Phrase: "250 nmol BCAA/ml)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C0439300:nmol/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]
   710   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "compared with basal fasting condition"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0012634:condition [Disease or Syndrome]
   760   C0015663:Fasting [Finding]
   760   C0205112:Basal [Spatial Concept]
   760   C0348080:Condition [Qualitative Concept]
   760   C1550565:fasting [Intellectual Product]
   760   C1705253:Condition [Conceptual Entity]
   760   C1707455:Compared [Activity]
   726 E C0456962:Fast [Qualitative Concept]

Phrase: "(2 U insulin/ml + 500 nmol BCAA/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   860   C1623737:mL/mL [Quantitative Concept]
   860   C3539687:mL/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.202: Values are means  SE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE"

Phrase: ";"
Processing 00000000.tx.203: n = 812 per treatment group. 

Phrase: "n = 812 per treatment group."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   797   C0441848:Group N [Intellectual Product]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441833:Group [Idea or Concept]
   760   C0441922:N+ [Intellectual Product]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1552516:Group [Health Care Related Organization]
   760   C1553036:[n] [Quantitative Concept]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.204: *Significantly different from basal fasting condition (P < 0.05). 

Phrase: "*Significantly different from basal fasting condition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.205: Significantly different from hyperinsulinemic euaminoacidemic group (P < 0.05). 

Phrase: "Significantly different from hyperinsulinemic euaminoacidemic group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.206: A, Ks; 

Phrase: "A,"

Phrase: "Ks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541894:ks [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.207: BF, translation initiation factor activity.  

Phrase: "BF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006409:BF [Geographic Area]
  1000   C1824728:BF [Gene or Genome]

Phrase: "translation initiation factor activity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.208: Correlation of translation initiation factor activity with plasma insulin concentration during euaminoacidemia and hyperaminoacidemia. 

Phrase: "Correlation of translation initiation factor activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1707520:Correlation [Qualitative Concept]
   716   C1148909:translation initiation factor activity [Genetic Function]

Phrase: "with plasma insulin concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0683150:plasma concentration [Quantitative Concept]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0857690:plasma insulin [Laboratory Procedure]

Phrase: "during euaminoacidemia"

Phrase: "and"

Phrase: "hyperaminoacidemia."
Processing 00000000.tx.209: We have previously shown (44) a positive curvilinear relationship between protein synthesis and insulin that is influenced by amino acids; 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(44"

Phrase: ")"

Phrase: "a positive curvilinear relationship between protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "influenced by amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799 E C2917660:Amino Acid [Pharmacologic Substance]
   770   C0001128:Acids [Chemical]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.210: the data are shown here for comparison (Fig. 4A). 

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here for comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.211: In the current study, translation initiation factor activity and plasma insulin concentrations were related as indicated by the significance of first- and second-degree polynomial terms (Fig. 4, C-F). 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "translation initiation factor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "plasma insulin concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   896   C0683150:plasma concentration [Quantitative Concept]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0857690:plasma insulin [Laboratory Procedure]

Phrase: "were"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "as"

Phrase: "indicated by the significance of first-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205435:First [Quantitative Concept]
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "second-degree polynomial terms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1515273:Term [Temporal Concept]
   779   C1705313:Term [Idea or Concept]
   779   C2826302:TERM [Intellectual Product]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C-F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.212: There was a positive linear relationship between insulin and S6K1 phosphorylation (P < 0.001), 4E-BP1 phosphorylation (P < 0.05), and eIF4GeIF4E content (P < 0.01) and a negative linear relationship between insulin and 4E-BP1eIF4E content (P < 0.001). 

Phrase: "There"

Phrase: "was"

Phrase: "a positive linear relationship between insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "4E-BP1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "eIF4GeIF4E content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "a negative linear relationship between insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "4E-BP1eIF4E content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.213: The relationship between translation initiation factor activity and insulin was influenced by amino acids for eIF4GeIF4E association (P < 0.005) and 4E-BP1eIF4E association (P < 0.01). 

Phrase: "The relationship between translation initiation factor activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "influenced by amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799 E C2917660:Amino Acid [Pharmacologic Substance]
   770   C0001128:Acids [Chemical]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "for eIF4GeIF4E association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "(P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "4E-BP1eIF4E association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.214: Amino acids tended to influence the relationship between insulin and both 4E-BP1 phosphorylation and S6K1 phosphorylation (Fig. 4, C and F; P < 0.08). 

Phrase: "Amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the relationship between insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "both 4E-BP1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "; P < 0.08"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.215: There was no relationship (either linear or quadratic) between eIF2B activity and plasma insulin levels (Fig. 4B). 

Phrase: "There"

Phrase: "was"

Phrase: "no relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "(either linear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205132:Linear [Spatial Concept]

Phrase: "or"

Phrase: "quadratic"

Phrase: ")"

Phrase: "between eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.216: View larger version (35K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.217: 4. 

Phrase: "4."
Processing 00000000.tx.218: Correlations of muscle protein synthesis rates (A) and translation initiation factor activity (B-F) with plasma insulin levels in the presence of hyperaminoacidemia and euaminoacidemia in 7-day-old pigs. 

Phrase: "Correlations of muscle protein synthesis rates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707520:Correlation [Qualitative Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "translation initiation factor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(B-F) with plasma insulin levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C1553038:[f] [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperaminoacidemia"

Phrase: "and"

Phrase: "euaminoacidemia in 7-day-old pigs."
Processing 00000000.tx.219: Continuous line, correlation during hyperaminoacidemia (Hi AA); 

Phrase: "Continuous line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "correlation during hyperaminoacidemia (Hi AA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707520:Correlation [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.220: dotted line, correlation during euaminoacidemia (Fast AA).  

Phrase: "dotted line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "correlation during euaminoacidemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707520:Correlation [Qualitative Concept]

Phrase: "(Fast AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.221: Correlation of translation initiation factor activity with BCAA during hyperinsulinemia. 

Phrase: "Correlation of translation initiation factor activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1707520:Correlation [Qualitative Concept]
   716   C1148909:translation initiation factor activity [Genetic Function]

Phrase: "with BCAA"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "during hyperinsulinemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]
Processing 00000000.tx.222: In the presence of fed insulin levels, there was a significant positive linear correlation of plasma BCAA with protein synthesis rates, S6K1 phosphorylation, and 4E-BP1 phosphorylation (P < 0.01, P < 0.001, and P < 0.04, respectively; Fig. 5). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fed insulin levels,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "there"

Phrase: "was"

Phrase: "a significant positive linear correlation of plasma BCAA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1707520:Correlation [Qualitative Concept]

Phrase: "with protein synthesis rates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   734   C0597295:Protein Synthesis [Molecular Function]

Phrase: "S6K1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "4E-BP1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "(P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P < 0.04,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: "; Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.223: A negative linear correlation occurred between BCAA and 4E-BP1eIF4E complex content (P < 0.006). 

Phrase: "A negative linear correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]

Phrase: "occurred between BCAA"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   882   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0337112:Chain [Manufactured Object]
   753   C1253959:branched [Body Part, Organ, or Organ Component]
   753   C1524075:Chain [Idea or Concept]
   753   C1709305:Occurred [Activity]
   753   C2700384:Branched [Spatial Concept]
   719 E C1881507:Branch [Chemical Viewed Structurally]
   719 E C2700383:Branch [Plant]
   719 E C2745955:OCCUR [Temporal Concept]
   719 E C2826234:BRANCH [Intellectual Product]

Phrase: "and"

Phrase: "4E-BP1eIF4E complex content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "(P < 0.006"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.224: BCAA correlated with the amount of active eIF4GeIF4E complex in a quadratic manner (P < 0.02), and there was a tendency for BCAA and protein synthesis rates to be related in a quadratic manner (P < 0.10). 

Phrase: "BCAA"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "correlated with the amount of active eIF4GeIF4E complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205177:Active [Functional Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C1265611:Amount [Quantitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C1707520:Correlated [Qualitative Concept]

Phrase: "in a quadratic manner"

Phrase: "(P < 0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "a tendency for BCAA"

Phrase: "and"

Phrase: "protein synthesis rates to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0871208:Rate [Activity]
   779   C1521828:Rate [Quantitative Concept]

Phrase: "be"

Phrase: "related in a quadratic manner"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "(P < 0.10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.225: No significant correlation existed between BCAA and eIF2B activity. 

Phrase: "No significant correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707520:Correlation [Qualitative Concept]

Phrase: "existed between BCAA"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   882   C0002521:Branched-chain amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0337112:Chain [Manufactured Object]
   753   C1253959:branched [Body Part, Organ, or Organ Component]
   753   C1524075:Chain [Idea or Concept]
   753   C2700384:Branched [Spatial Concept]
   719 E C1881507:Branch [Chemical Viewed Structurally]
   719 E C2700383:Branch [Plant]
   719 E C2826234:BRANCH [Intellectual Product]
   719   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "eIF2B activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.226: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.227: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.228: Correlations of muscle protein synthesis rates (A) and translation initiation factor activity (B-F) with plasma BCAA concentration in 7-day-old pigs.  

Phrase: "Correlations of muscle protein synthesis rates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707520:Correlation [Qualitative Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "translation initiation factor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(B-F) with plasma BCAA concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   742   C0439133:(f) [Intellectual Product]
   742   C1553038:[f] [Quantitative Concept]

Phrase: "in 7-day-old pigs."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0039005:Pigs [Mammal]
   812   C1135183:pigs [Mammal]
   779 E C1136016:PIG [Mammal]
   779 E C1265533:Pig [Mammal]
   779 E C1270360:Pig [Mammal]
Processing 00000000.tx.229: Correlation of muscle protein synthesis rates and translation initiation factor modulation. 

Phrase: "Correlation of muscle protein synthesis rates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "translation initiation factor modulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0443264:Modulation [Spatial Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.230: The relationship between skeletal muscle protein synthesis rates and translation initiation factor activity in all pigs was examined (Fig. 6). 

Phrase: "The relationship between skeletal muscle protein synthesis rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "translation initiation factor activity in all pigs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C1148909:translation initiation factor activity [Genetic Function]
   804   C1152945:translation factor activity [Genetic Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.231: The relationships between protein synthesis rates and phosphorylation of 4E-BP1 (P < 0.001), 4E-BP1eIF4E (P < 0.02), and eIF4GeIF4E (P < 0.01) were quadratic. 

Phrase: "The relationships between protein synthesis rates"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0439849:Relationships [Qualitative Concept]
   719 E C1705630:Relationship [Idea or Concept]
   719 E C1706279:Relationship [Idea or Concept]
   719 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "phosphorylation of 4E-BP1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "4E-BP1eIF4E"

Phrase: "(P < 0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "eIF4GeIF4E"

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "quadratic."
Processing 00000000.tx.232: There was a positive linear relationship between protein synthesis rates and S6K1 phosphorylation (P < 0.001). 

Phrase: "There"

Phrase: "was"

Phrase: "a positive linear relationship between protein synthesis rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.233: There was no significant linear or quadratic relationship between protein synthesis rates and eIF2B activity. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant linear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205132:Linear [Spatial Concept]

Phrase: "or"

Phrase: "quadratic relationship between protein synthesis rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "eIF2B activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.234: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.235: 6. 

Phrase: "6."
Processing 00000000.tx.236: Correlations of protein synthesis rates with translation initiation factor activity (AE) in skeletal muscle of 7-day-old pigs.   

Phrase: "Correlations of protein synthesis rates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1707520:Correlation [Qualitative Concept]

Phrase: "with translation initiation factor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(AE) in skeletal muscle of 7-day-old pigs."
Processing 00000000.tx.237: DISCUSSION TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  Insulin has long been recognized for its key role in the regulation of protein synthesis in growing animals (16, 22, 24). 

Phrase: "DISCUSSION TOP ABSTRACT METHODS RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "been"

Phrase: "recognized for its key role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "in growing animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(16,"

Phrase: "22,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.238: Furthermore, previous studies from our laboratory have demonstrated that both insulin and amino acids play critical roles in the feeding-induced stimulation of protein synthesis in the neonate (5, 7, 56). 

Phrase: "Furthermore,"

Phrase: "previous studies from our laboratory"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0681827:Laboratory studies [Laboratory Procedure]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "critical roles in the feeding-induced stimulation of protein synthesis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0035820:Roles [Social Behavior]
   706 E C1705810:Role [Conceptual Entity]

Phrase: "in the neonate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.239: The results of a recent study (44) using pancreatic glucose-amino acid clamps suggest that insulin and amino acids independently stimulate skeletal muscle protein synthesis in neonates and that the effects of insulin and amino acids are additive until maximal rates are achieved. 

Phrase: "The results of a recent study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results study [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "(44"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pancreatic glucose-amino acid clamps"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C0079318:Glucose Clamps [Research Device]
   804   C0175721:clamps [Medical Device]
   771 E C1705942:Clamp [Manufactured Object]
   771 E C1883710:Clamp [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids independently"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "stimulate"

Phrase: "skeletal muscle protein synthesis in neonates"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0597295:Protein Synthesis [Molecular Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "that"

Phrase: "the effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "additive until maximal rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442796:Additive [Qualitative Concept]
   770   C1550602:Additive [Substance]

Phrase: "are"

Phrase: "achieved."
Processing 00000000.tx.240: Because the enhanced feeding-induced stimulation of muscle protein synthesis in the neonate involves the activation of key translation initiation factors (12, 31), we wished to define the roles of insulin and amino acids in this process. 

Phrase: "Because"

Phrase: "the enhanced feeding-induced stimulation of muscle protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1709098:STIMULATION OF MUSCLE [Finding]
           Muscle Stimulation
   742   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   742   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in the neonate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]

Phrase: "involves"

Phrase: "the activation of key translation initiation factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   817   C2249873:activation of translational initiation [Cell Function]
   748   C1879547:Activation [Activity]
   738   C1519616:Translational Activation [Genetic Function]

Phrase: "(12,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "wished"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1423524:WISH [Gene or Genome]
   966   C3273411:WISH [Gene or Genome]
   966   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the roles of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "amino acids in this process."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.241: The results of the present study show that both insulin and amino acids stimulate neonatal muscle protein synthesis via mechanisms that are associated with increased 4E-BP1 and S6K1 phosphorylation and enhanced assembly of the eIF4GeIF4E complex that regulates the binding of mRNA to the 43S preinitiation complex, as well as by mechanisms that are independent of this pathway. 

Phrase: "The results of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results study [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "stimulate"

Phrase: "neonatal muscle protein synthesis via mechanisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0597295:Protein Synthesis [Molecular Function]
   753   C0026845:Muscle [Tissue]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "are"

Phrase: "associated with increased 4E-BP1"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   778   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205217:Increased [Quantitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0450378:4e [Intellectual Product]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "enhanced assembly of the eIF4GeIF4E complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1706853:Assembly [Activity]
   753   C1879748:Assembly [Manufactured Object]

Phrase: "that"

Phrase: "regulates"

Phrase: "the binding of mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1148853:mRNA binding [Genetic Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to the 43S preinitiation complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "as well as by mechanisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205170:Well [Qualitative Concept]
   760   C0441712:Mechanisms [Functional Concept]
   760   C3146287:Well [Manufactured Object]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "are independent of this pathway."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332291:Independent of [Functional Concept]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C1551058:Are [Quantitative Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.242: Effects of amino acids on insulin dose response of translation initiation. 

Phrase: "Effects of amino acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "dose response of translation initiation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C0871261:Response [Organism Attribute]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]
Processing 00000000.tx.243: A major site in the regulation of translation initiation is the binding of met-tRNAi to the 40S ribosomal subunit, an event mediated by eIF2 (33, 46). 

Phrase: "A major site in the regulation of translation initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C2945843:Site of [Qualitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "the binding of met-tRNAi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to the 40S ribosomal subunit,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1753319:40S ribosomal subunit [Cell Component]
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "an event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "mediated by eIF2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0013729:EIF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C1166851:eIF-2 [Cell Component]
   790   C3539639:EIF2 [Gene or Genome]

Phrase: "(33,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.244: This step is regulated by eIF2B, which exchanges GTP for GDP on eIF2 (34). 

Phrase: "This step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "is"

Phrase: "regulated by eIF2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0606869:EIF 2B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "which"

Phrase: "exchanges"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678640:exchange [Social Behavior]

Phrase: "GTP for GDP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "on eIF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013729:EIF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1166851:eIF-2 [Cell Component]
  1000   C3539639:EIF2 [Gene or Genome]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.245: Studies in cell culture suggest that insulin and amino acids increase eIF2B activity (15, 25, 28, 53). 

Phrase: "Studies in cell culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007585:Cell Culture [Laboratory Procedure]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C2242979:Culture [Laboratory Procedure]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(15,"

Phrase: "25,"

Phrase: "28,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.246: Furthermore, studies in diabetic animals suggest that insulin plays an important role in increasing eIF2B activity (23). 

Phrase: "Furthermore,"

Phrase: "studies in diabetic animals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0683949:animals studies [Animal]
   770   C0003062:Animals [Animal]
   770   C0241863:DIABETIC [Finding]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in increasing eIF2B activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.247: In the current study, neither insulin nor amino acids had any effect on eIF2B activity. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "neither insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "nor"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "had"

Phrase: "any effect on eIF2B activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.248: However, this was not unexpected, as previous in vivo studies in both mature rats and neonatal pigs suggest that eIF2B activity may not be regulated by changes in nutritional status (12, 31, 57). 

Phrase: "However,"

Phrase: "this"

Phrase: "was"

Phrase: "not unexpected,"

Phrase: "as"

Phrase: "previous in vivo studies in both mature rats"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   783   C0681829:in vivo study [Research Activity]
           studies vivo
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "neonatal pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "regulated by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in nutritional status"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0392209:Nutritional status [Organism Attribute]
   861   C0449438:Status [Qualitative Concept]
   861   C1521739:Nutritional [Qualitative Concept]
   861   C2707262:Nutritional [Clinical Attribute]

Phrase: "(12,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.249: A second important regulatory step in translation initiation is the binding of mRNA to the 43S preinitiation complex, which is mediated by eIF4F, a complex of proteins that includes eIF4E. 

Phrase: "A second important regulatory step in translation initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C1519613:Translation Initiation [Genetic Function]
   795   C0589507:Initiation [Mental Process]
   795   C1158830:Initiation [Genetic Function]
   795   C1704686:Initiation [Functional Concept]

Phrase: "is"

Phrase: "the binding of mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1148853:mRNA binding [Genetic Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to the 43S preinitiation complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "which"

Phrase: "is"

Phrase: "mediated by eIF4F,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0058989:EIF4F [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C2826592:EIF4F [Gene or Genome]
   790   C3273427:EIF4F [Gene or Genome]
   790   C3539643:EIF4F [Gene or Genome]

Phrase: "a complex of proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   802   C1523872:protein complex [Cell Component]
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "eIF4E."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.250: Assembly of the eIF4F complex can be regulated by the phosphorylation (43) or availability (46) of eIF4E. 

Phrase: "Assembly of the eIF4F complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C3157044:eIF4F assembly [Molecular Function]
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: "can"

Phrase: "be"

Phrase: "regulated by the phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "(43"

Phrase: ")"

Phrase: "or"

Phrase: "availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Availability [Functional Concept]

Phrase: "(46"

Phrase: ")"

Phrase: "of eIF4E."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.251: The eIF4E phosphorylation status, as a percentage of the total eIF4E, was examined in the current study, as it has been shown in cell culture studies to influence mRNA binding to the 43S preinitiation complex, with ultimate increases in protein synthesis (42, 43, 47, 49). 

Phrase: "The eIF4E phosphorylation status,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0449438:Status [Qualitative Concept]
   734   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "a percentage of the total eIF4E,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0439165:Percentage [Quantitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "examined in the current study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332128:Examined [Finding]
   760   C0521116:Current [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1705970:Current [Natural Phenomenon or Process]
   760   C2603343:Study [Research Activity]

Phrase: "as"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "in cell culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "mRNA binding to the 43S preinitiation complex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1148853:mRNA binding [Genetic Function]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "with ultimate increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "in protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "(42,"

Phrase: "43,"

Phrase: "47,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.252: However, no effect of insulin and/or amino acids on eIF4E phosphorylation was observed in this study. 

Phrase: "However,"

Phrase: "no effect of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and/or"

Phrase: "amino acids on eIF4E phosphorylation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "observed in this study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1441672:Observed [Functional Concept]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.253: These results extend our previous study findings showing that feeding has no effect on eIF4E phosphorylation in the neonate. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "our previous study findings"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0683954:study findings [Finding]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "has"

Phrase: "no effect on eIF4E phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in the neonate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]
Processing 00000000.tx.254: Thus, in vivo, modulation of eIF4E phosphorylation status is not a key regulatory step in the feeding-induced stimulation of muscle protein synthesis by insulin and amino acids in neonatal pigs. 

Phrase: "Thus,"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "modulation of eIF4E phosphorylation status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443264:Modulation [Spatial Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a key regulatory step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "the feeding-induced stimulation of muscle protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C1709098:STIMULATION OF MUSCLE [Finding]
           Muscle Stimulation
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids in neonatal pigs."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.255: The best characterized regulatory step involved in the mRNA binding process is the reversible association of eIF4E with the translational repressor 4E-BP1, which competes with eIF4G to bind to eIF4E. 

Phrase: "The best characterized regulatory step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "involved in the mRNA binding process"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1148853:mRNA binding [Genetic Function]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1314939:Involved [Functional Concept]
   753   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "the reversible association of eIF4E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "with the translational repressor 4E-BP1,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   827   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0450378:4e [Intellectual Product]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1336789:Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1519614:Translational [Genetic Function]
   727 E C0040712:Translation [Intellectual Product]
   727 E C0597295:translation [Molecular Function]

Phrase: "which"

Phrase: "competes with eIF4G to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind to eIF4E."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1145667:Bind [Activity]
   753   C1158830:Initiation [Genetic Function]
   753   C1167622:bind [Molecular Function]
   753   C1521761:Factor [Functional Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.256: Phosphorylation of 4E-BP1 results in a decreased affinity of eIF4E for 4E-BP1 and an enhanced binding of eIF4E to eIF4G (18). 

Phrase: "Phosphorylation of 4E-BP1 results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]

Phrase: "in a decreased affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "of eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "for 4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "an enhanced binding of eIF4E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   855   C1149297:eukaryotic initiation factor 4E binding [Genetic Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "to eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.257: 4E-BP1 phosphorylation at the Thr70 site was stimulated by both insulin and amino acids. 

Phrase: "4E-BP1 phosphorylation at the Thr70 site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   762   C1519063:Phosphorylation Site [Amino Acid Sequence]
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "stimulated by both insulin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1948023:Stimulated [Natural Phenomenon or Process]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.258: However, the hormonal effect occurred only at elevated levels of insulin in the presence of hyperaminoacidemia, and an effect of amino acids was present only at the highest dose of insulin. 

Phrase: "However,"

Phrase: "the hormonal effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "only at elevated levels of insulin"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   783   C0202098:insulin levels [Laboratory Procedure]
   783   C0428405:insulin levels [Laboratory or Test Result]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205171:Only [Quantitative Concept]
   753   C0205250:Elevated [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1720467:Only [Intellectual Product]
   753   C3163633:Elevated [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperaminoacidemia,"

Phrase: "and"

Phrase: "an effect of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only at the highest dose of insulin."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   762   C0444956:High dose [Quantitative Concept]
   757   C0020459:high insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0178602:Dose [Quantitative Concept]
   748   C0205171:Only [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1522410:Highest [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1720467:Only [Intellectual Product]
   714 E C0205250:High [Qualitative Concept]
   714 E C1299351:High [Qualitative Concept]
   714 E C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.259: In contrast, protein synthesis rates were increased at each insulin dose, with a further increase in protein synthesis achieved at each dose of insulin by raising amino acids to simulate fed levels (44). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "protein synthesis rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   734   C0597295:Protein Synthesis [Molecular Function]

Phrase: "were"

Phrase: "increased at each insulin dose,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   797   C0020459:increased insulin [Disease or Syndrome]
   797   C1707810:Dose Increased [Therapeutic or Preventive Procedure]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0178602:Dose [Quantitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with a further increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "achieved at each dose of insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "by raising amino acids to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "simulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulate [Biomedical or Dental Material]

Phrase: "fed levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.260: It is noteworthy that the large variation in results may have precluded us from observing an effect of insulin and amino acids on 4E-BP1 phosphorylation at the Thr70 at the lower doses. 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "the large variation in results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "precluded"

Phrase: "us from observing"

Phrase: "an effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "amino acids on 4E-BP1 phosphorylation"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   804   C0033618:protein amino acid binding [Molecular Function]
   804   C1158886:protein amino acid phosphorylation [Molecular Function]
   789   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   776   C1148572:amino acid binding [Molecular Function]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "at the Thr70"

Phrase: "at the lower doses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]
Processing 00000000.tx.261: However, the findings suggest that low doses of insulin increase muscle protein synthesis independently of 4E-BP1 phosphorylation. 

Phrase: "However,"

Phrase: "the findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that low doses of insulin increase muscle protein synthesis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0445550:Low dose [Quantitative Concept]
   748   C1708745:Low-Dose [Research Activity]
   742   C0178602:Doses [Quantitative Concept]
   708 E C0869039:Dose [Quantitative Concept]
   708 E C1114758:Dose # [Clinical Attribute]
   708 E C1428722:DOS [Gene or Genome]

Phrase: "independently of 4E-BP1 phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]
Processing 00000000.tx.262: Furthermore, the results suggest that the increase in 4E-BP1 phosphorylation by amino acids requires insulin. 

Phrase: "Furthermore,"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the increase in 4E-BP1 phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "by amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "requires"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.263: This finding is consistent with a study in mature diabetic rats that showed that leucine enhanced skeletal muscle protein synthesis with no increase in 4E-BP1 phosphorylation and that leucine increased 4E-BP1 phosphorylation only in the presence of a high dose of insulin (2). 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with a study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in mature diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "skeletal muscle protein synthesis with no increase"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0597295:Protein Synthesis [Molecular Function]
   748   C0220781:synthesis [Biologic Function]
   748   C1883254:Synthesis [Activity]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "in 4E-BP1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "that leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "4E-BP1 phosphorylation only in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "of a high dose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0444956:High dose [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0205250:High [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.264: However, a study in mature nondiabetic rats revealed only partial attenuation of leucine-induced 4E-BP1 phosphorylation by somatostatin infusion and a failure of leucine to stimulate muscle protein synthesis in the presence of somatostatin (1). 

Phrase: "However,"

Phrase: "a study in mature nondiabetic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "only partial attenuation of leucine-induced 4E-BP1 phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0599946:Attenuation [Activity]

Phrase: "by somatostatin infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "and"

Phrase: "a failure of leucine to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231174:Failure [Functional Concept]
   760   C0680095:failure [Individual Behavior]

Phrase: "stimulate"

Phrase: "muscle protein synthesis in the presence of somatostatin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0597295:Protein Synthesis [Molecular Function]
   744   C0026845:Muscle [Tissue]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   731 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.265: The mechanism for the differences in the results using diabetes vs. somatostatin to reduce circulating insulin levels in mature rats may be model or dose dependent. 

Phrase: "The mechanism for the differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "in the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "vs. somatostatin to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   777 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "reduce"

Phrase: "circulating insulin levels in mature rats"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0202098:insulin levels [Laboratory Procedure]
   790   C0428405:insulin levels [Laboratory or Test Result]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "or"

Phrase: "dose dependent."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
Processing 00000000.tx.266: In adult rats (39), amino acids, but not insulin, increased 4E-BP1 phosphorylation, whereas, in a recent study in fetal lambs, an elevation in insulin increased 4E-BP1 (48). 

Phrase: "In adult rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "but"

Phrase: "not insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased 4E-BP1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]

Phrase: "whereas"

Phrase: ","

Phrase: "in a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "in fetal lambs,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1123019:lambs [Mammal]
   827 E C0452875:Lamb [Food]
   827 E C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "an elevation in insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439775:Elevation [Therapeutic or Preventive Procedure]
   770   C0702240:Elevation [Spatial Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.267: Together, the results suggest a developmental decline in insulin-stimulated 4E-BP1 phosphorylation may exist. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a developmental decline in insulin-stimulated 4E-BP1 phosphorylation"

Phrase: "may"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.268: An important regulatory step involved in the mRNA-binding process is the association of eIF4E with eIF4G following the dissociation of 4E-BP1 from eIF4E. 

Phrase: "An important regulatory step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "involved in the mRNA-binding process"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1148853:mRNA binding [Genetic Function]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1314939:Involved [Functional Concept]
   753   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "the association of eIF4E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the dissociation of 4E-BP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "from eIF4E."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.269: This results in active eIF4F complex assembly, thus enabling mRNA binding to the 43S preinitiation complex (18). 

Phrase: "This results in active eIF4F complex assembly,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C3157044:eIF4F assembly [Molecular Function]
   799   C1706853:Assembly [Activity]
   799   C1879748:Assembly [Manufactured Object]

Phrase: "thus"

Phrase: "enabling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1171285:Enabling [Mental Process]
   966 E C0562342:enable [Mental Process]

Phrase: "mRNA binding to the 43S preinitiation complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1148853:mRNA binding [Genetic Function]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.270: Previous studies in mature rats and neonatal pigs have shown an increase in the active eIF4GeIF4E complex in response to refeeding (12, 31, 57). 

Phrase: "Previous studies in mature rats"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "neonatal pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an increase in the active eIF4GeIF4E complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to refeeding"

Phrase: "(12,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.271: In the current study, both insulin and amino acids decreased the 4E-BP1eIF4E complex assembly. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the 4E-BP1eIF4E complex assembly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1706853:Assembly [Activity]
   812   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.272: This effect of insulin was most profound in the presence of the higher doses of insulin in the presence of euaminoacidemia but occurred at all doses of insulin in the presence of hyperaminoacidemia. 

Phrase: "This effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "most profound in the presence of the higher doses of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0439808:Profound [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of euaminoacidemia"

Phrase: "but"

Phrase: "occurred at all doses of insulin"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0178602:Doses [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1709305:Occurred [Activity]
   719 E C0869039:Dose [Quantitative Concept]
   719 E C1114758:Dose # [Clinical Attribute]
   719 E C1428722:DOS [Gene or Genome]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperaminoacidemia."
Processing 00000000.tx.273: Both insulin and amino acids increased the amount of eIF4G bound to eIF4E. 

Phrase: "Both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "bound to eIF4E."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332297:bound [Spatial Concept]
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1145667:Bound [Activity]
   753   C1158830:Initiation [Genetic Function]
   753   C1167622:Bound [Molecular Function]
   753   C1521761:Factor [Functional Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2349209:Bound [Conceptual Entity]
   753   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.274: However, the effect of insulin occurred only at the highest dose during euaminoacidemia and occurred at the intermediate and high doses of insulin during hyperaminoacidemia. 

Phrase: "However,"

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "only at the highest dose"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0444956:High dose [Quantitative Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0205171:Only [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1522410:Highest [Qualitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C0205250:High [Qualitative Concept]
   726 E C1299351:High [Qualitative Concept]
   726 E C2700149:HIGH [Intellectual Product]

Phrase: "during euaminoacidemia"

Phrase: "and"

Phrase: "occurred at the intermediate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205103:Intermediate [Spatial Concept]
   770   C1550465:intermediate [Idea or Concept]
   770   C1709305:Occurred [Activity]
   770   C2827755:INTERMEDIATE [Laboratory or Test Result]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "high doses of insulin"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   816   C0444956:High dose [Quantitative Concept]
   770   C0178602:Doses [Quantitative Concept]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "during hyperaminoacidemia."
Processing 00000000.tx.275: This finding contrasts with a stimulatory response of muscle protein synthesis to all doses of insulin and suggests that mechanisms other than an enhanced assembly of the active eIF4GeIF4E complex must be involved in the stimulation of muscle protein synthesis by insulin. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "contrasts with a stimulatory response of muscle protein synthesis"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0597295:Protein Synthesis [Molecular Function]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0026845:Muscle [Tissue]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0220781:synthesis [Biologic Function]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C1883254:Synthesis [Activity]
   742   C1979874:Contrast [Qualitative Concept]
   742   C2911692:Response [Mental Process]
   726 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "to all doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0178602:Doses [Quantitative Concept]
   966 E C0869039:Dose [Quantitative Concept]
   966 E C1114758:Dose # [Clinical Attribute]
   966 E C1428722:DOS [Gene or Genome]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mechanisms other than an enhanced assembly of the active eIF4GeIF4E complex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C0441712:Mechanisms [Functional Concept]
   703 E C1706376:Mechanism [Manufactured Object]

Phrase: "must"

Phrase: "be"

Phrase: "involved in the stimulation of muscle protein synthesis"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   800   C1709098:STIMULATION OF MUSCLE [Finding]
           Muscle Stimulation
   770   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0597295:Protein Synthesis [Molecular Function]
   767   C0449621:Muscle involved [Functional Concept]
   744   C0026845:Muscle [Tissue]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0220781:synthesis [Biologic Function]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1314939:Involved [Functional Concept]
   744   C1883254:Synthesis [Activity]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
   731 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.276: Because amino acids increased the amount of eIF4G bound to eIF4E at the low and intermediate doses of insulin, this suggests that amino acid-stimulated eIF4GeIF4E assembly requires at least basal fasting insulin levels. 

Phrase: "Because"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of eIF4G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "bound to eIF4E"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332297:bound [Spatial Concept]
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1145667:Bound [Activity]
   753   C1158830:Initiation [Genetic Function]
   753   C1167622:Bound [Molecular Function]
   753   C1521761:Factor [Functional Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2349209:Bound [Conceptual Entity]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "at the low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "intermediate doses of insulin,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0178602:Doses [Quantitative Concept]
   770   C0205103:Intermediate [Spatial Concept]
   770   C1550465:intermediate [Idea or Concept]
   770   C2827755:INTERMEDIATE [Laboratory or Test Result]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "this"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that amino acid-stimulated eIF4GeIF4E assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1706853:Assembly [Activity]
   804   C1879748:Assembly [Manufactured Object]

Phrase: "requires at least basal fasting insulin levels."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   778   C0202098:insulin levels [Laboratory Procedure]
   778   C0428405:insulin levels [Laboratory or Test Result]
   774   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0015663:Fasting [Finding]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205112:Basal [Spatial Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550565:fasting [Intellectual Product]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0456079:Level [Classification]
   714 E C0456962:Fast [Qualitative Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.277: However, the presence of variation may have precluded the observation of an effect of insulin at lower doses. 

Phrase: "However,"

Phrase: "the presence of variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "have"

Phrase: "precluded"

Phrase: "the observation of an effect of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0302523:Observation [Research Activity]
   748   C0700325:observation [Health Care Activity]
   748   C1964257:Observation [Diagnostic Procedure]

Phrase: "at lower doses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]
Processing 00000000.tx.278: In mature diabetic rats, leucine increased protein synthesis and tended to increase eIF4GeIF4E formation (2). 

Phrase: "In mature diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "eIF4GeIF4E formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.279: However, somatostatin treatment in adult rats suppressed leucine-induced protein synthesis but had no effect on 4E-BP1eIF4E or eIF4GeIF4E content (1). 

Phrase: "However,"

Phrase: "somatostatin treatment in adult rats"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "leucine-induced protein synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1156616:leucine synthesis [Molecular Function]
   861   C0597295:Protein Synthesis [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]

Phrase: "but"

Phrase: "had"

Phrase: "no effect on 4E-BP1eIF4E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "eIF4GeIF4E content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.280: S6K1 phosphorylation status is primarily mTOR dependent, as is the repressor protein 4E-BP1 (29, 52). 

Phrase: "S6K1 phosphorylation status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449438:Status [Qualitative Concept]

Phrase: "is"

Phrase: "primarily mTOR dependent, as is"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0293060:mammalian target of rapamycin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1307407:Mammalian Target of Rapamycin [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1414805:MAMMALIAN TARGET OF RAPAMYCIN [Gene or Genome]
   744   C1521840:Target [Functional Concept]
   744   C2986546:TARGET [Diagnostic Procedure]

Phrase: "the repressor protein 4E-BP1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   839   C0033618:Protein Binding [Molecular Function]
   827   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0450378:4e [Intellectual Product]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1336789:Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(29,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.281: Previous studies in neonatal pigs have shown that feeding, through its activation of mTOR, causes hyperphosphorylation of S6K1 (12, 31). 

Phrase: "Previous studies in neonatal pigs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that feeding,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "through its activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of mTOR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0024660:Mammalian [Mammal]
   804   C0072980:Rapamycin [Antibiotic,Organic Chemical]
   804   C0332285:Of [Spatial Concept]
   804   C1521840:Target [Functional Concept]
   804   C2986546:TARGET [Diagnostic Procedure]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "hyperphosphorylation of S6K1"

Phrase: "(12,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.282: Increases in the phosphorylation of S6K1 result in hyperphosphorylation of ribosomal protein S6 and thus facilitate the translation of mRNAs containing terminal oligopyrimidine tracts at the 5' end, which encode elements of the translation apparatus, including ribosomal proteins and elongation factors (35, 41). 

Phrase: "Increases in the phosphorylation of S6K1 result"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "in hyperphosphorylation"

Phrase: "of ribosomal protein S6"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0073336:Ribosomal Protein S6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419741:RIBOSOMAL PROTEIN S6 [Gene or Genome]
           S6
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   827   C1419024:S6 [Gene or Genome]
   827   C1861424:S6 [Gene or Genome]
   827   C2348600:S6+ [Element, Ion, or Isotope]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "facilitate"

Phrase: "the translation of mRNAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0597295:mRNA Translation [Molecular Function]
           translation
   770   C0040712:Translation [Intellectual Product]
   770   C1519614:Translation [Genetic Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "terminal oligopyrimidine tracts at the 5' end,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205088:Terminal [Temporal Concept]
   748   C1185740:tracts [Body Part, Organ, or Organ Component]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: "which"

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "elements of the translation apparatus,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0013879:Elements [Element, Ion, or Isotope]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "ribosomal proteins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0035552:Ribosomal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1622856:ribosomal protein [Genetic Function]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0035553:Ribosomal [Cell Component]
   789 E C2984240:Ribosome [Functional Concept]

Phrase: "and"

Phrase: "elongation factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0086206:Elongation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(35,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.283: Therefore, activation of S6K1 appears to increase the synthesis of proteins involved in mRNA translation. 

Phrase: "Therefore,"

Phrase: "activation of S6K1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the synthesis of proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0597295:Protein Synthesis [Molecular Function]
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]
   767 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "involved in mRNA translation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0597295:mRNA Translation [Molecular Function]
           translation
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0040712:Translation [Intellectual Product]
   770   C1314939:Involved [Functional Concept]
   770   C1519614:Translation [Genetic Function]
Processing 00000000.tx.284: In the present study, hyperinsulinemia increased S6K1 phosphorylation, and hyperaminoacidemia also had a stimulatory effect on S6K1. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "S6K1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "hyperaminoacidemia also"

Phrase: "had"

Phrase: "a stimulatory effect on S6K1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.285: However, the effect of amino acids on S6K1 phosphorylation was present only at the higher doses of insulin. 

Phrase: "However,"

Phrase: "the effect of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only at the higher doses of insulin."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   757   C0020459:high insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0178602:Doses [Quantitative Concept]
   748   C0205171:Only [Quantitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1720467:Only [Intellectual Product]
   745   C0444956:High dose [Quantitative Concept]
   714   C0205250:High [Qualitative Concept]
   714 E C0869039:Dose [Quantitative Concept]
   714 E C1114758:Dose # [Clinical Attribute]
   714   C1299351:High [Qualitative Concept]
   714 E C1428722:DOS [Gene or Genome]
   714   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.286: Our findings are consistent with the findings in mature rats and adult humans showing that increases in S6K1 activation by amino acids were facilitated by increases in insulin levels (1, 20), but they contrast with another study in adult rats (39), which showed that insulin did not enhance amino acid-stimulated S6K1 phosphorylation. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with the findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "in mature rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "adult humans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0001675:Human, Adult [Age Group]
   861   C0086418:Humans [Human]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that increases in S6K1 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "by amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "facilitated by increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:increases [Functional Concept]

Phrase: "in insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0202098:insulin levels [Laboratory Procedure]
  1000   C0428405:insulin levels [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "20"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "they"

Phrase: "contrast with another study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1979874:Contrast [Qualitative Concept]
   770   C2603343:Study [Research Activity]

Phrase: "in adult rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "amino acid-stimulated S6K1 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.287: Whether the differing conclusions involve differences in age, model, or dose is not discernable, but they suggest that a potentially interdependent mechanism for S6K1 activation by insulin and amino acids may exist. 

Phrase: "Whether"

Phrase: "the differing conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusions [Idea or Concept]

Phrase: "involve"

Phrase: "differences in age,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   858   C0699810:age differences [Age Group]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "or"

Phrase: "dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "is"

Phrase: "not discernable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205396:Discernible [Qualitative Concept]

Phrase: "but"

Phrase: "they"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a potentially interdependent mechanism for S6K1 activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "may"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.288: Nonetheless, the results of the current study implicate S6K1-dependent and -independent pathways for both insulin- and amino acid-stimulated protein synthesis in skeletal muscle of the neonate. 

Phrase: "Nonetheless,"

Phrase: "the results of the current study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results study [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "implicate"

Phrase: "S6K1-dependent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0851827:Dependent [Qualitative Concept]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "independent pathways for both insulin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2984427:Insulin Pathway [Functional Concept]
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "amino acid-stimulated protein synthesis in skeletal muscle of the neonate."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   772   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C0597295:Protein Synthesis [Molecular Function]
   754   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0220781:synthesis [Biologic Function]
   738   C1883254:Synthesis [Activity]
   738   C1948023:Stimulated [Natural Phenomenon or Process]
   718 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.289: Amino acid dose response of translation initiation factors. 

Phrase: "Amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "dose response of translation initiation factors."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.290: O'Connor et al. have recently shown (44) that amino acids increase muscle protein synthesis rates in a dose-response manner in neonatal muscle. 

Phrase: "O'Connor et al."

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(44"

Phrase: ")"

Phrase: "that amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "muscle protein synthesis rates in a dose-response manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0237629:rates response [Temporal Concept]
   745   C1512044:Dose Rate [Quantitative Concept]
   708   C0871208:Rate [Activity]
   708   C1521828:Rate [Quantitative Concept]

Phrase: "in neonatal muscle."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.291: The present work constitutes the first study to determine whether there is a dose-response effect of amino acids on translation initiation factor activity. 

Phrase: "The present work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "constitutes"

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "there"

Phrase: "is"

Phrase: "a dose-response effect of amino acids"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1280500:Effect [Qualitative Concept]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2348382:Effect [Qualitative Concept]
   748   C2911692:Response [Mental Process]

Phrase: "on translation initiation factor activity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.292: In the presence of fed insulin levels, amino acids increased S6K1 phosphorylation, 4E-BP1 phosphorylation, and eIF4GeIF4E content and reduced 4E-BP1eIF4E content as amino acids were increased from below fasting, to fasting, and/or fed levels. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fed insulin levels,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "S6K1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "4E-BP1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "eIF4GeIF4E content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "reduced 4E-BP1eIF4E content as amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "were"

Phrase: "increased from"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   833   C0205217:Increased [Quantitative Concept]
   833   C0442805:Increased [Functional Concept]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C1301820:Obtain [Functional Concept]
   740 E C1706701:Acquire [Activity]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "below fasting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "to fasting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "and/or"

Phrase: "fed levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.293: These data highlight the importance of amino acids in regulating the availability of eIF4E for 48S ribosomal complex assembly in skeletal muscle of neonates. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "highlight"

Phrase: "the importance of amino acids"

Phrase: "in"

Phrase: "regulating"

Phrase: "the availability of eIF4E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "for 48S ribosomal complex assembly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C1156141:ribosome assembly [Cell Function]
   812   C1706853:Assembly [Activity]
   812   C1879748:Assembly [Manufactured Object]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "of neonates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0021289:Neonates [Age Group]
   966 E C2239178:Neonate [Finding]
   966 E C2939425:Neonate, NOS [Temporal Concept]
Processing 00000000.tx.294: The lack of effect of reducing plasma amino acid concentrations to one-half of fasting levels on eIF2B activity in the current study contrasts with the reduction in eIF2B activity in the hindlimb of adult rats perfused with a leucine-deprived medium (51). 

Phrase: "The lack of effect of reducing plasma amino acid concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C0235198:Lack of concentration [Finding]
           concentration lack
   739   C0332268:lack [Qualitative Concept]

Phrase: "to one-half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825407:Half [Quantitative Concept]

Phrase: "of fasting levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "on eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "contrasts with the reduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   770   C1979874:Contrast [Qualitative Concept]

Phrase: "in eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in the hindlimb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023216:Hindlimb, NOS [Body Location or Region]
  1000   C1269079:Hind limb [Body Part, Organ, or Organ Component]
  1000   C1456800:Hindlimb [Body Part, Organ, or Organ Component]
  1000   C1522391:Hindlimb [Body Part, Organ, or Organ Component]

Phrase: "of adult rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "perfused with a leucine-deprived medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0009458:Medium [Intellectual Product]
   753   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C1549542:Perfuse [Functional Concept]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.295: This finding suggests that amino acids do not play a critical role in the modulation of eIF2B activity in vivo. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in the modulation of eIF2B activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.296: Effect of insulin on translation initiation factors in the absence of an amino acid clamp. 

Phrase: "Effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on translation initiation factors"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   966   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Initiation Factors
   901   C1519613:Translation Initiation [Genetic Function]
   896   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040712:Translation [Intellectual Product]
   827   C0589507:Initiation [Mental Process]
   827   C0597295:translation [Molecular Function]
   827   C1158830:Initiation [Genetic Function]
   827   C1519614:Translation [Genetic Function]
   827   C1704686:Initiation [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of an amino acid clamp."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0175721:Clamp [Medical Device]
   827   C1705942:Clamp [Manufactured Object]
   827   C1883710:Clamp [Functional Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]
Processing 00000000.tx.297: We have previously shown that insulin stimulates muscle protein synthesis in neonates in the presence of fasting and below fasting amino acids levels (44). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "muscle protein synthesis in neonates"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0597295:Protein Synthesis [Molecular Function]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0026845:Muscle [Tissue]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "and below fasting amino acids levels"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C0015663:Fasting [Finding]
   753   C0441889:Levels [Qualitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C1550565:fasting [Intellectual Product]
   750   C1318720:Acid fast [Indicator, Reagent, or Diagnostic Aid]
   719 E C0202406:Acid [Laboratory Procedure]
   719 E C0456079:Level [Classification]
   719 E C0456962:Fast [Qualitative Concept]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.298: In the present study, eIF4GeIF4E association was also increased by insulin in the absence of an amino acid clamp, and in the presence of a fasting level amino acid clamp. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "eIF4GeIF4E association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "also"

Phrase: "increased by insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   858   C0020459:increased insulin [Disease or Syndrome]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C1517378:Gain [Quantitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of an amino acid clamp,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0175721:Clamp [Medical Device]
   827   C1705942:Clamp [Manufactured Object]
   827   C1883710:Clamp [Functional Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "and in the presence of a fasting level amino acid clamp."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   790   C0428202:Presence of amino acid [Laboratory or Test Result]
   756   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C2917660:Amino Acid [Pharmacologic Substance]
   738   C0001128:Acid [Chemical]
   738   C0015663:Fasting [Finding]
   738   C0175721:Clamp [Medical Device]
   738   C0202406:Acid [Laboratory Procedure]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C0441889:Level [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C1515981:And [Idea or Concept]
   738   C1547707:Level [Geographic Area]
   738   C1550565:fasting [Intellectual Product]
   738   C1705942:Clamp [Manufactured Object]
   738   C1883710:Clamp [Functional Concept]
   738   C2946261:Level [Pharmacologic Substance]
   737   C1318720:Acid fast [Indicator, Reagent, or Diagnostic Aid]
   704 E C0456962:Fast [Qualitative Concept]
Processing 00000000.tx.299: However, the lack of a statistically significant effect of insulin on the activity of other translation initiation factors when amino acids were below fasting levels and, in some cases, in the presence of fasting amino acid levels is surprising and emphasizes the importance of amino acids to the postprandial stimulation of translation initiation. 

Phrase: "However,"

Phrase: "the lack of a statistically significant effect of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332268:lack [Qualitative Concept]

Phrase: "on the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "of other translation initiation factors"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   966   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Initiation Factors
   901   C1519613:Translation Initiation [Genetic Function]
   896   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040712:Translation [Intellectual Product]
   827   C0589507:Initiation [Mental Process]
   827   C0597295:translation [Molecular Function]
   827   C1158830:Initiation [Genetic Function]
   827   C1519614:Translation [Genetic Function]
   827   C1704686:Initiation [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "when"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were below fasting levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0015663:Fasting [Finding]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550565:fasting [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C0456962:Fast [Qualitative Concept]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: ","

Phrase: "in some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fasting amino acid levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "surprising"

Phrase: "and"

Phrase: "emphasizes"

Phrase: "the importance of amino acids"

Phrase: "to the postprandial stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of translation initiation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519613:Translation Initiation [Genetic Function]
   861   C0589507:Initiation [Mental Process]
   861   C1158830:Initiation [Genetic Function]
   861   C1704686:Initiation [Functional Concept]
Processing 00000000.tx.300: The results further suggest that insulin-dependent and -independent pathways are involved in the regulation of skeletal muscle protein synthesis in the neonate. 

Phrase: "The results further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin-dependent"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and -"

Phrase: "independent pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "involved in the regulation of skeletal muscle protein synthesis"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   807   C1157519:regulation of protein synthesis [Cell Function]
   784   C1157723:regulation of synthesis [Molecular Function]
   764   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0242692:Muscle, Skeletal [Tissue]
   764   C0597295:Protein Synthesis [Molecular Function]
   764   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   762   C0449621:Muscle involved [Functional Concept]
   742   C0026845:Muscle [Tissue]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0037253:skeletal [Body System]
   742   C0220781:synthesis [Biologic Function]
   742   C0521324:Skeletal [Spatial Concept]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1883254:Synthesis [Activity]
   726 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "in the neonate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]
Processing 00000000.tx.301: Correlations. 

Phrase: "Correlations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.302: Examination of the relationships between translation initiation factor activity and plasma insulin level, in the presence of euaminoacidemia and hyperaminoacidemia, showed a linear relationship between plasma insulin levels and S6K1 phosphorylation, 4E-BP1 phosphorylation, 4E-BP1eIF4E content, and eIF4GeIF4E complex assembly but a curvilinear relationship between plasma insulin and protein synthesis rates (44). 

Phrase: "Examination of the relationships"

Phrase: "between translation initiation factor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "plasma insulin level,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
  1000   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:Insulin level [Laboratory Procedure]
   901   C0428405:insulin level [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1547707:Level [Geographic Area]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of euaminoacidemia"

Phrase: "and"

Phrase: "hyperaminoacidemia,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a linear relationship between plasma insulin levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "S6K1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "4E-BP1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "4E-BP1eIF4E content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "eIF4GeIF4E complex assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "but"

Phrase: "a curvilinear relationship between plasma insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "protein synthesis rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   734   C0597295:Protein Synthesis [Molecular Function]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.303: This suggests that, although higher levels of insulin may increase translation initiation factor activity, no further increases in protein synthesis in skeletal muscle of the neonate may occur. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "although"

Phrase: "higher levels of insulin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C0202098:insulin levels [Laboratory Procedure]
   819   C0428405:insulin levels [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "translation initiation factor activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "no further increases in protein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "of the neonate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]

Phrase: "may"

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.304: This conclusion is supported by the curvilinear relationship between muscle protein synthesis and the activity of most translation initiation factors. 

Phrase: "This conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "supported by the curvilinear relationship"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1521721:Supported [Conceptual Entity]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]
   726 E C0183683:Support [Medical Device]

Phrase: "between muscle protein synthesis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0026845:Muscle [Tissue]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "the activity of most translation initiation factors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C1148909:translation initiation factor activity [Genetic Function]
   789   C1152945:translation factor activity [Genetic Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.305: Furthermore, the relationships between plasma insulin and muscle protein synthesis, 4E-BP1 phosphorylation, 4E-BP1eIF4E association, eIF4GeIF4E content, and S6K1 phosphorylation were influenced by the amino acid level in the blood. 

Phrase: "Furthermore,"

Phrase: "the relationships between plasma insulin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0439849:Relationships [Qualitative Concept]
   726 E C1705630:Relationship [Idea or Concept]
   726 E C1706279:Relationship [Idea or Concept]
   726 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "muscle protein synthesis,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0026845:Muscle [Tissue]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "4E-BP1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "4E-BP1eIF4E association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "eIF4GeIF4E content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "S6K1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "influenced by the amino acid level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "in the blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.306: This suggests that amino acids augment the insulin-induced activation of translation initiation factor activity in skeletal muscle of the neonate. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "the insulin-induced activation of translation initiation factor activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C2249873:activation of translational initiation [Cell Function]
   742   C1879547:Activation [Activity]
   726   C1519616:Translational Activation [Genetic Function]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "of the neonate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]
Processing 00000000.tx.307: Furthermore, the relationship between skeletal muscle translation initiation activity and circulating amino acid concentration, in the presence of hyperinsulinemia, revealed a linear relationship of amino acids with S6K1 phosphorylation, 4E-BP1 phosphorylation, and 4E-BP1eIF4E formation, but a curvilinear relationship with the amount of eIF4GeIF4E complex. 

Phrase: "Furthermore,"

Phrase: "the relationship between skeletal muscle translation initiation activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "circulating amino acid concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperinsulinemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a linear relationship of amino acids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "with S6K1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "4E-BP1 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "4E-BP1eIF4E formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "but"

Phrase: "a curvilinear relationship with the amount of eIF4GeIF4E complex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0439849:Relationship [Qualitative Concept]
   742   C1705630:Relationship [Idea or Concept]
   742   C1706279:Relationship [Idea or Concept]
   742   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.308: Protein synthesis rates were related linearly and tended to relate in a quadratic manner to amino acid levels, suggesting that higher amino acid concentrations may have no further effect on eIF4GeIF4E content or protein synthesis. 

Phrase: "Protein synthesis rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   734   C0597295:Protein Synthesis [Molecular Function]

Phrase: "were"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "linearly"

Phrase: "and"

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "relate in a quadratic manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0163712:Relate [Organic Chemical]

Phrase: "to amino acid levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that higher amino acid concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "may"

Phrase: "have"

Phrase: "no further effect on eIF4GeIF4E content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "protein synthesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.309: In contrast, eIF2B activity showed no relationship with plasma insulin or amino acid levels or with protein synthesis rates, consistent with the findings of previous feeding studies in neonatal pigs in which no effect on eIF2B activity was found after refeeding (12, 31). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no relationship with plasma insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "or"

Phrase: "amino acid levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "or with protein synthesis rates,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0597295:Protein Synthesis [Molecular Function]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "consistent with the findings of previous feeding studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
   714   C0332529:Consistency finding [Qualitative Concept]

Phrase: "in neonatal pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]

Phrase: "in which"

Phrase: "no effect on eIF2B activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "found after refeeding"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "(12,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.310: Together, the results suggest that modulation of binding of mRNA, but not met-tRNAi, to the 40S ribosomal subunit plays a critical role in the postprandial stimulation of skeletal muscle protein synthesis in the neonate. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that modulation of binding of mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "but"

Phrase: "not met-tRNAi,"

Phrase: "to the 40S ribosomal subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1753319:40S ribosomal subunit [Cell Component]
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a critical role in the postprandial stimulation of skeletal muscle protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0035820:Role [Social Behavior]
   736   C1705810:Role [Conceptual Entity]

Phrase: "in the neonate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]
Processing 00000000.tx.311: Perspectives. 

Phrase: "Perspectives."
Processing 00000000.tx.312: In a recent study using pancreatic glucose-amino acid clamps, we demonstrated the independent stimulatory roles of insulin and amino acids on skeletal muscle protein synthesis in the neonate (44). 

Phrase: "In a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pancreatic glucose-amino acid clamps,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C0079318:Glucose Clamps [Research Device]
   804   C0175721:clamps [Medical Device]
   771 E C1705942:Clamp [Manufactured Object]
   771 E C1883710:Clamp [Functional Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "the independent stimulatory roles of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "amino acids on skeletal muscle protein synthesis"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   800   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "in the neonate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.313: Herein, we show that, although neither insulin nor amino acids altered eIF2B activity or eIF4E phosphorylation, both insulin and amino acids increased phosphorylation of S6K1 and 4E-BP1, resulting in the release of eIF4E from the inactive association with 4E-BP1 and allowing eIF4G to bind to eIF4E, forming an active complex. 

Phrase: "Herein,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "although"

Phrase: "neither insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "nor"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "eIF2B activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "eIF4E phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
   771   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "phosphorylation of S6K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "4E-BP1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "resulting in the release of eIF4E"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   818   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332294:Resulting in [Functional Concept]
   762   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0450378:4e [Intellectual Product]
   742   C0589507:Initiation [Mental Process]
   742   C0678226:resulting [Functional Concept]
   742   C0680255:release [Health Care Activity]
   742   C1158830:Initiation [Genetic Function]
   742   C1283071:Release [Functional Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1704686:Initiation [Functional Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]
   742   C2827422:Factor [Conceptual Entity]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "from the inactive association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "with 4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "allowing eIF4G to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0058990:EIF-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind to eIF4E,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0450378:4e [Intellectual Product]
   753   C0589507:Initiation [Mental Process]
   753   C1145667:Bind [Activity]
   753   C1158830:Initiation [Genetic Function]
   753   C1167622:bind [Molecular Function]
   753   C1521761:Factor [Functional Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "an active complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.314: However, the response to insulin was present only at doses greater than fasting levels, and the effect of amino acids on translation initiation factor activity was seen only in the presence of insulin. 

Phrase: "However,"

Phrase: "the response to insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only at doses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0178602:Doses [Quantitative Concept]
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]
   756 E C0869039:Dose [Quantitative Concept]
   756 E C1114758:Dose # [Clinical Attribute]
   756 E C1428722:DOS [Gene or Genome]

Phrase: "greater than fasting levels,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "and"

Phrase: "the effect of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on translation initiation factor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148909:translation initiation factor activity [Genetic Function]
   923   C1152945:translation factor activity [Genetic Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0030943:Translation Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0597603:translation factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "only in the presence of insulin."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205171:Only [Quantitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1720467:Only [Intellectual Product]
Processing 00000000.tx.315: The results suggest that insulin and amino acids stimulate muscle protein synthesis in the neonate by mechanisms that are associated with enhanced 4E-BP1 and S6K1 phophorylation and eIF4F complex formation and by mechanisms independent of this pathway.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "stimulate"

Phrase: "muscle protein synthesis in the neonate"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0597295:Protein Synthesis [Molecular Function]
   753   C0026845:Muscle [Tissue]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "by mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "are"

Phrase: "associated with enhanced 4E-BP1"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   778   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C0450378:4e [Intellectual Product]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C2349975:Enhanced [Activity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "S6K1 phophorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "eIF4F complex formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and by mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0441712:Mechanisms [Functional Concept]
   790   C1515981:And [Idea or Concept]
   756 E C1706376:Mechanism [Manufactured Object]

Phrase: "independent of this pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.316: ACKNOWLEDGMENTS  We thank M. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.317: Fiorotto and D. 

Phrase: "Fiorotto"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.318: Burrin for helpful discussions, S. 

Phrase: "Burrin for helpful discussions,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.319: Nguyen, W. 

Phrase: "Nguyen,"

Phrase: "W."
Processing 00000000.tx.320: Liu, and J. 

Phrase: "Liu,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.321: Rosenberger for technical assistance, J. 

Phrase: "Rosenberger for technical assistance,"

Phrase: "J."
Processing 00000000.tx.322: Cunningham, F. 

Phrase: "Cunningham,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.323: Biggs, and J. 

Phrase: "Biggs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442992:Biggs [Intellectual Product]

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.324: Stubblefield for care of animals, E. 

Phrase: "Stubblefield for care of animals,"

Phrase: "E."
Processing 00000000.tx.325: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.326: Smith for statistical assistance, L. 

Phrase: "Smith for statistical assistance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0554249:Smith [Professional or Occupational Group]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.327: Loddeke for editorial assistance, A. 

Phrase: "Loddeke for editorial assistance,"

Phrase: "A."
Processing 00000000.tx.328: Gillum for graphics, and J. 

Phrase: "Gillum for graphics,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.329: Croom for secretarial assistance. 

Phrase: "Croom for secretarial assistance."
Processing 00000000.tx.330: We acknowledge Eli Lilly Co. for the generous donation of porcine insulin. 

Phrase: "We"

Phrase: "acknowledge"

Phrase: "Eli Lilly Co."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0331851:Eli Lilly [Health Care Related Organization]

Phrase: "for the generous donation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680854:donation [Quantitative Concept]

Phrase: "of porcine insulin."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0724601:Porcine Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0770206:Porcine insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0039005:porcine [Mammal]
   861   C1135183:Porcine, NOS [Mammal]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.331: This work is a publication of the US Department of Agriculture, Agricultural Research Service (USDA/ARS) Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "a publication of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034036:Publication [Intellectual Product,Manufactured Object]
   770   C0034037:Publication [Occupational Activity]
   770   C1704324:Publication [Intellectual Product]

Phrase: "US Department of Agriculture,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0085410:Agriculture Department [Organization]
   770   C1704729:Department [Organization]

Phrase: "Agricultural Research Service (USDA/ARS) Children's Nutrition Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   877   C0683939:research center [Manufactured Object,Organization]
   795   C0205099:Center [Spatial Concept]

Phrase: "Department of Pediatrics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587482:department pediatrics [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Baylor College of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "and"

Phrase: "Texas Children's Hospital,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0020017:Children's hospital [Health Care Related Organization]
   827   C0008059:Children [Age Group]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0039711:Texas [Geographic Area]
   827   C0680063:Children [Family Group]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Houston,"

Phrase: "TX."
Processing 00000000.tx.332: This project has been funded in part by National Institutes of Health (NIH) Grants RO1 AR-44474 and DK-15658 and by the USDA/ARS under Cooperative Agreement no. 

Phrase: "This project"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709701:Project [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "funded in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016820:funded [Quantitative Concept]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by National Institutes of Health (NIH) Grants RO1 AR-44474"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   793   C0018173:Grants [Quantitative Concept]
   793   C0018684:Health [Idea or Concept]
   793   C0021622:Institutes [Organization]
   793   C2986463:AR+ [Finding]
   793   C3245503:national [Intellectual Product]
   760 E C1272753:Institute [Idea or Concept]
   760 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "DK-15658"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "and by the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "USDA/ARS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0085410:Agriculture Department [Organization]
   770   C1704729:Department [Organization]

Phrase: "USDA/ARS under Cooperative Agreement"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0035168:research [Research Activity]
   753   C0242481:Research [Research Activity]
   753   C0557854:Service [Occupational Activity]
   753   C2825316:Service [Manufactured Object]
   753   C3245478:service [Idea or Concept]

Phrase: "no."
Processing 00000000.tx.333: 6250510000033. 

Phrase: "6250510000033."
Processing 00000000.tx.334: This research was also supported in part by NIH Training Grant T32 HD-07445. 

Phrase: "This research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "was"

Phrase: "also"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by NIH Training Grant T32 HD-07445."
Meta Candidates (Total=20; Excluded=7; Pruned=0; Remaining=13)
   849   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   807   C0555633:Training grant [Intellectual Product]
   791   C0018173:Grant [Quantitative Concept]
   791   C0018684:Health [Idea or Concept]
   791   C0021622:Institutes [Organization]
   791   C0040607:Training [Educational Activity]
   791   C0220931:Training [Educational Activity]
   791   C1548284:Grant [Idea or Concept]
   791   C2673163:training [Qualitative Concept]
   791   C3245503:national [Intellectual Product]
   772   C2707291:Health conditions [Clinical Attribute]
   772   C2707292:Health conditions [Finding]
   758 E C0336809:Train [Manufactured Object]
   758 E C1272753:Institute [Idea or Concept]
   758 E C1552514:Train [Manufactured Object]
   720 E C0009647:Conditioned [Mental Process]
   720 E C0012634:condition [Disease or Syndrome]
   720 E C0348080:Condition [Qualitative Concept]
   720 E C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.335: The contents of this publication do not necessarily reflect the views or policies of the US Department of Agriculture, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.  

Phrase: "The contents of this publication"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0456205:Contents [Conceptual Entity]
   760   C1552853:contents [Idea or Concept]
   726 E C0423896:Content [Mental Process]

Phrase: "do"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the views"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:Views [Spatial Concept]

Phrase: "or"

Phrase: "policies of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242456:Policies [Intellectual Product]

Phrase: "US Department of Agriculture,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0085410:Agriculture Department [Organization]
   770   C1704729:Department [Organization]

Phrase: "nor"

Phrase: "does"

Phrase: "mention of trade names,"

Phrase: "commercial products,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1547887:Commercial Product [Manufactured Object]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "or"

Phrase: "organizations"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0029246:Organizations [Organization]
   966 E C0029237:Organization [Physiologic Function]
   966 E C0220885:organization [Qualitative Concept]
   966 E C1300196:Organization [Functional Concept]
   966 E C1522486:Organization [Professional or Occupational Group]

Phrase: "imply"

Phrase: "endorsement by the"

Phrase: "US Government."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018104:Government [Organization]
Processing 00000000.tx.336: FOOTNOTES  Address for reprint requests and other correspondence: T. 

Phrase: "FOOTNOTES  Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.337: A. 

Phrase: "A."
Processing 00000000.tx.338: Davis, USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, 1100 Bates St., Houston, TX 77030 (E-mail: tdavis{at}bcm.tmc.edu ). 

Phrase: "Davis,"

Phrase: "USDA/ARS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0085410:Agriculture Department [Organization]
   770   C1704729:Department [Organization]

Phrase: "USDA/ARS Children's Nutrition Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   877   C0683939:research center [Manufactured Object,Organization]
   795   C0205099:Center [Spatial Concept]

Phrase: "Baylor College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "1100"

Phrase: "Bates"

Phrase: "St., Houston,"

Phrase: "TX 77030"

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "tdavis{at}bcm.tmc.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.339: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.340: The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.341: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.342: REFERENCES TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  Anthony JC, Lang CH, Crozier SJ, Anthony TG, MacLean DA, Kimball SR, and Jefferson LS. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0557061:Discussion [Therapeutic or Preventive Procedure]
   804   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Anthony JC,"

Phrase: "Lang CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Crozier SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Anthony TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337445:TG [Laboratory Procedure]

Phrase: "MacLean DA,"

Phrase: "Kimball SR,"

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.343: Contribution of insulin to the translation control of protein synthesis in skeletal muscle by leucine. 

Phrase: "Contribution of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880177:Contribution [Activity]

Phrase: "to the translation control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "by leucine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.344: Am J Physiol Endocrinol Metab 282: E1092E1101, 2002.[Abstract/Free FullText] Anthony JC, Reiter AK, Anthony TG, Crozier SJ, Lang CH, MacLean DA, Kimball SR, and Jefferson LS. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 282"

Phrase: ":"

Phrase: "E1092E1101,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Anthony JC,"

Phrase: "Reiter AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Anthony TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337445:TG [Laboratory Procedure]

Phrase: "Crozier SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Lang CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "MacLean DA,"

Phrase: "Kimball SR,"

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.345: Orally administered leucine enhances protein synthesis in skeletal muscle of diabetic rats in the absence of increases in 4E-BP1 or S6K1 phosphorylation. 

Phrase: "Orally administered leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "protein synthesis in skeletal muscle of diabetic rats"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0597295:Protein Synthesis [Molecular Function]
   767   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   731 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in 4E-BP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0450378:4e [Intellectual Product]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "or"

Phrase: "S6K1 phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.346: Diabetes 51: 928936, 2002.[Abstract/Free FullText] Beckett PR, Hardin DS, Davis TA, Nguyen HV, Wray-Cahen D, and Copeland KC. 

Phrase: "Diabetes 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "928936,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Beckett PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Hardin DS,"

Phrase: "Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Nguyen HV,"

Phrase: "Wray-Cahen D,"

Phrase: "and"

Phrase: "Copeland KC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022575:kc [Disease or Syndrome]
   861   C1705783:KC [Gene or Genome]
Processing 00000000.tx.347: Spectrophometric assay for measuring branched chain amino acid concentrations: application for measuring the sensitivity of protein metabolism to insulin. 

Phrase: "Spectrophometric assay for measuring branched chain amino acid concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0005507:Assay [Laboratory Procedure]
   742   C0243073:assay [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]

Phrase: ":"

Phrase: "application for measuring"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0185125:Application [Health Care Activity]
   790   C1947919:Application [Intellectual Product]
   790   C2347934:Application [Intellectual Product]
   790   C3539080:APPLICATION [Quantitative Concept]

Phrase: "the sensitivity of protein metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.348: Anal Biochem 240: 4853, 1996.[ISI][Medline] Davis TA, Burrin DG, Fiorotto ML, and Nguyen HV. 

Phrase: "Anal Biochem 240"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "4853,"

Phrase: "1996."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Burrin DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Fiorotto ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "Nguyen HV."
Processing 00000000.tx.349: Protein synthesis in skeletal muscle and jejunum is more responsive to feeding in 7-than in 26-day-old pigs. 

Phrase: "Protein synthesis in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0597295:Protein Synthesis [Molecular Function]
   797   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "jejunum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022378:Jejunum [Body Part, Organ, or Organ Component]
  1000   C1278922:Jejunum [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "more responsive to feeding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205342:Responsive [Functional Concept]

Phrase: "in 7-"

Phrase: "than"

Phrase: "in 26-day-old pigs."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0039005:Pigs [Mammal]
   812   C1135183:pigs [Mammal]
   779 E C1136016:PIG [Mammal]
   779 E C1265533:Pig [Mammal]
   779 E C1270360:Pig [Mammal]
Processing 00000000.tx.350: Am J Physiol Endocrinol Metab 270: E802E809, 1996.[Abstract/Free FullText] Davis TA, Burrin DG, Fiorotto ML, Reeds PJ, and Jahoor F. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 270"

Phrase: ":"

Phrase: "E802E809,"

Phrase: "1996."

Phrase: "[Abstract/Free FullText"

Phrase: "] Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Burrin DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Fiorotto ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Reeds PJ,"

Phrase: "and"

Phrase: "Jahoor F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.351: Role of insulin and amino acids in the regulation of protein synthesis in the neonate. 

Phrase: "Role of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "amino acids in the regulation of protein synthesis"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   789   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "in the neonate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021289:Neonate [Age Group]
  1000   C2239178:Neonate [Finding]
  1000   C2939425:Neonate, NOS [Temporal Concept]
Processing 00000000.tx.352: J Nutr 128: 347S350S, 1998.[ISI][Medline] Davis TA, Fiorotto ML, Beckett PR, Burrin DG, Reeds PJ, Wray-Cahen D, and Nguyen HV. 

Phrase: "J Nutr 128"

Phrase: ":"

Phrase: "347S350S,"

Phrase: "1998."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Fiorotto ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Beckett PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Burrin DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Reeds PJ,"

Phrase: "Wray-Cahen D,"

Phrase: "and"

Phrase: "Nguyen HV."
Processing 00000000.tx.353: Differential effects of insulin on peripheral and visceral tissue protein synthesis in neonatal pigs. 

Phrase: "Differential effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on peripheral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205100:Peripheral [Spatial Concept]

Phrase: "and"

Phrase: "visceral tissue protein synthesis in neonatal pigs."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0597295:Protein Synthesis [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220781:synthesis [Biologic Function]
   748   C1883254:Synthesis [Activity]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.354: Am J Physiol Endocrinol Metab 280: E770E779, 2001.[Abstract/Free FullText] Davis TA, Fiorotto ML, Burrin DG, Reeds PJ, Nguyen HV, Beckett PR, Vann RC, and O'Connor PMJ. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 280"

Phrase: ":"

Phrase: "E770E779,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Fiorotto ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Burrin DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Reeds PJ,"

Phrase: "Nguyen HV,"

Phrase: "Beckett PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Vann RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "and"

Phrase: "O'Connor PMJ."
Processing 00000000.tx.355: Stimulation of protein synthesis by both insulin and amino acids is unique to skeletal muscle in neonatal pigs. 

Phrase: "Stimulation of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "unique to skeletal muscle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710548:Unique [Qualitative Concept]

Phrase: "in neonatal pigs."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]
Processing 00000000.tx.356: Am J Physiol Endocrinol Metab 282: E880E890, 2002.[Abstract/Free FullText] Davis TA, Fiorotto ML, Nguyen HV, and Burrin DG. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 282"

Phrase: ":"

Phrase: "E880E890,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Fiorotto ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Nguyen HV,"

Phrase: "and"

Phrase: "Burrin DG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]
Processing 00000000.tx.357: Aminoacyl-tRNA and tissue free amino acid pools are equilibrated after flooding dose of phenylalanine. 

Phrase: "Aminoacyl-tRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035714:Amino Acyl T RNA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1537998:trnA [Gene or Genome]

Phrase: "and"

Phrase: "tissue free amino acid pools"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0337051:pools [Geographic Area]
   771 E C1509144:pool [Clinical Attribute]
   771 E C2349200:Pool [Functional Concept]

Phrase: "are"

Phrase: "equilibrated after flooding dose of phenylalanine."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0016248:Flooding [Natural Phenomenon or Process]
   753   C0021114:flooding [Therapeutic or Preventive Procedure]
   753   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   719 E C0375741:Flood [Injury or Poisoning]
Processing 00000000.tx.358: Am J Physiol Endocrinol Metab 277: E103E109, 1999.[Abstract/Free FullText] Davis TA, Fiorotto ML, Nguyen HV, and Reeds PJ. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 277"

Phrase: ":"

Phrase: "E103E109,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Fiorotto ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Nguyen HV,"

Phrase: "and"

Phrase: "Reeds PJ."
Processing 00000000.tx.359: Protein turnover in skeletal muscle of suckling rats. 

Phrase: "Protein turnover in skeletal muscle of suckling rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0597297:Protein Turnover [Molecular Function]
   744   C0031227:turnover [Quantitative Concept]
   744   C0243127:turnover [Functional Concept]
   744   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.360: Am J Physiol Regul Integr Comp Physiol 257: R1141R1146, 1989.[Abstract/Free FullText] Davis TA, Fiorotto ML, Nguyen HV, and Reeds PJ. 

Phrase: "Am"

Phrase: "J Physiol Regul Integr Comp Physiol 257"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0056167:COMP [Therapeutic or Preventive Procedure]
   795   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "R1141R1146,"

Phrase: "1989."

Phrase: "[Abstract/Free FullText"

Phrase: "] Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Fiorotto ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Nguyen HV,"

Phrase: "and"

Phrase: "Reeds PJ."
Processing 00000000.tx.361: Enhanced response of muscle protein synthesis and plasma insulin to food intake in suckled rats. 

Phrase: "Enhanced response of muscle protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "plasma insulin to food intake"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0857690:plasma insulin [Laboratory Procedure]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0032105:Plasma [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in suckled rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.362: Am J Physiol Regul Integr Comp Physiol 265: R334R340, 1993.[Abstract/Free FullText] Davis TA, Fiorotto ML, and Reeds PJ. 

Phrase: "Am"

Phrase: "J Physiol Regul Integr Comp Physiol 265"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0056167:COMP [Therapeutic or Preventive Procedure]
   795   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "R334R340,"

Phrase: "1993."

Phrase: "[Abstract/Free FullText"

Phrase: "] Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Fiorotto ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "Reeds PJ."
Processing 00000000.tx.363: Amino acid compositions of body and milk protein change during the suckling period in rats. 

Phrase: "Amino acid compositions of body"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   797   C0005885:Compositions, Body [Organism Attribute]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0486616:compositions [Clinical Attribute]
   726 E C1555710:composition [Idea or Concept]

Phrase: "and"

Phrase: "milk protein change during the suckling period"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.364: J Nutr 123: 947956, 1993.[ISI][Medline] Davis TA, Nguyen HV, Suryawan A, Bush JA, Jefferson LS, and Kimball SR. 

Phrase: "J Nutr 123"

Phrase: ":"

Phrase: "947956,"

Phrase: "1993."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Nguyen HV,"

Phrase: "Suryawan A,"

Phrase: "Bush JA,"

Phrase: "Jefferson LS,"

Phrase: "and"

Phrase: "Kimball SR."
Processing 00000000.tx.365: Developmental changes in the feeding-induced stimulation of translation initiation in skeletal muscle and liver of neonatal pigs. 

Phrase: "Developmental changes in the feeding-induced stimulation of translation initiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   739   C0458003:Developmental [Qualitative Concept]
   739   C0678723:Developmental [Organism Function]
   706 E C1705241:Change [Quantitative Concept]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "liver of neonatal pigs."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.366: Am J Physiol Endocrinol Metab 279: E1226E1234, 2000.[Abstract/Free FullText] Denne SC and Kalhan SC. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 279"

Phrase: ":"

Phrase: "E1226E1234,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Denne SC"

Phrase: "and"

Phrase: "Kalhan SC."
Processing 00000000.tx.367: Leucine metabolism in newborns. 

Phrase: "Leucine metabolism in newborns."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1156805:leucine metabolism [Molecular Function]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.368: Am J Physiol Endocrinol Metab 253: E608E615, 1987.[Abstract/Free FullText] DeFronzo RA, Tobin JD, and Andres R. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 253"

Phrase: ":"

Phrase: "E608E615,"

Phrase: "1987."

Phrase: "[Abstract/Free FullText"

Phrase: "] DeFronzo RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Tobin JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "and"

Phrase: "Andres R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.369: Glucose clamp technique: a method for quantifying insulin secretion and resistance. 

Phrase: "Glucose clamp technique"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0017728:Glucose Clamp Technique [Diagnostic Procedure,Research Activity]
   901   C0079318:Glucose Clamp [Research Device]
   827   C0175721:Clamp [Medical Device]
   827   C0449851:Technique [Functional Concept]
   827   C1705942:Clamp [Manufactured Object]
   827   C1883710:Clamp [Functional Concept]
   743 E C0025664:techniques [Intellectual Product]

Phrase: ":"

Phrase: "a method for quantifying insulin secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "resistance."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0237834:Resistance [Mental Process]
  1000   C1514892:Resistance [Physiologic Function]
   928 E C0332325:Resistant [Functional Concept]
   928 E C1550464:resistent [Idea or Concept]
   928 E C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.370: Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214E223, 1979.[Abstract/Free FullText] Everson WV, Flaim KE, Susco DM, Kimball SR, and Jefferson LS. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab Gastrointest Physiol 237"

Phrase: ":"

Phrase: "E214E223,"

Phrase: "1979."

Phrase: "[Abstract/Free FullText"

Phrase: "] Everson WV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043127:WV [Geographic Area]

Phrase: "Flaim KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Susco DM,"

Phrase: "Kimball SR,"

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.371: Effect of amino acid deprivation on initiation of protein synthesis in rat hepatocytes. 

Phrase: "Effect of amino acid deprivation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "in rat hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.372: Am J Physiol Cell Physiol 256: C18C27, 1989.[Abstract/Free FullText] Garlick PJ, Fern M, and Preedy VR. 

Phrase: "Am"

Phrase: "J Physiol Cell Physiol 256"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "C18C27,"

Phrase: "1989."

Phrase: "[Abstract/Free FullText"

Phrase: "] Garlick PJ,"

Phrase: "Fern M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Preedy VR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3476815:VR [Intellectual Product]
Processing 00000000.tx.373: The effect of insulin infusion and food intake on muscle protein synthesis in postabsorptive rats. 

Phrase: "The effect of insulin infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "food intake on muscle protein synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013470:Food Intake [Organism Function]
   783   C0489617:Protein intake [Clinical Attribute]
   753   C1512806:Intake [Functional Concept]

Phrase: "in postabsorptive rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.374: Biochem J 210: 669676, 1983.[ISI][Medline] Garlick PJ, McNurlan MA, and Preedy VR. 

Phrase: "Biochem J 210"

Phrase: ":"

Phrase: "669676,"

Phrase: "1983."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Garlick PJ,"

Phrase: "McNurlan MA,"

Phrase: "and"

Phrase: "Preedy VR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3476815:VR [Intellectual Product]
Processing 00000000.tx.375: A rapid and convenient technique for measuring the rate of protein synthesis in tissues by injection of [3H]phenylalanine. 

Phrase: "A rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "convenient technique for measuring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449851:Technique [Functional Concept]

Phrase: "the rate of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "in tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "by injection of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]phenylalanine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.376: Biochem J 192: 719723, 1980.[ISI][Medline] Gingras AC, Raught B, and Sonenburg N. 

Phrase: "Biochem J 192"

Phrase: ":"

Phrase: "719723,"

Phrase: "1980."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gingras AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Raught B,"

Phrase: "and"

Phrase: "Sonenburg N."
Processing 00000000.tx.377: eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. 

Phrase: "eIF4 initiation factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0030943:Initiation Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0589507:Initiation [Mental Process]
   827   C1158830:Initiation [Genetic Function]
   827   C1704686:Initiation [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: ":"

Phrase: "effectors of mRNA recruitment"

Phrase: "to ribosomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]

Phrase: "and"

Phrase: "regulators of translation."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0182953:regulators [Medical Device]
   756 E C1704734:Regulator [Medical Device]
   756 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.378: In: Annual Reviews in Biochemistry, edited by Richardson CC. 

Phrase: "In"

Phrase: ":"

Phrase: "Annual Reviews in Biochemistry,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0282443:reviews [Intellectual Product]
   737 E C1552617:Review [Idea or Concept]

Phrase: "edited by Richardson CC."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443048:Richardson [Intellectual Product]
   770   C3538933:CC [Cell Component]
   737   C0868955:Edit [Occupational Activity]
Processing 00000000.tx.379: Palo Alto, CA: Annual Reviews, 1999, p. 

Phrase: "Palo Alto,"

Phrase: "CA"

Phrase: ":"

Phrase: "Annual Reviews,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0282443:reviews [Intellectual Product]
   827 E C1552617:Review [Idea or Concept]

Phrase: "1999,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.380: 913963. 

Phrase: "913963."
Processing 00000000.tx.381: Goldspink DF and Kelly FJ. 

Phrase: "Goldspink DF"

Phrase: "and"

Phrase: "Kelly FJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]
Processing 00000000.tx.382: Protein turnover and growth in the whole body, liver and kidney of the rat from the fetus to senility. 

Phrase: "Protein turnover"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597297:Protein Turnover [Molecular Function]
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "growth in the whole body, liver"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0231256:Body growth [Organism Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "kidney of the rat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]

Phrase: "from the fetus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015965:Fetus [Embryonic Structure]
  1000   C0242291:FETUS [Tissue]
  1000   C1305737:Fetus [Anatomical Structure]

Phrase: "to senility."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0231337:Senility [Finding]
   928 E C0392079:Senile [Finding]
   907 E C1999167:Old age [Population Group]
Processing 00000000.tx.383: Biochem J 217: 507516, 1984.[ISI][Medline] Kimball SR, Antonetti DA, Brawley RM, and Jefferson LS. 

Phrase: "Biochem J 217"

Phrase: ":"

Phrase: "507516,"

Phrase: "1984."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kimball SR,"

Phrase: "Antonetti DA,"

Phrase: "Brawley RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.384: Mechanism of inhibition of peptide chain initiation by amino acid deprivation in perfused rat liver. 

Phrase: "Mechanism of inhibition of peptide chain initiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "by amino acid deprivation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0871712:Deprivation [Qualitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "in perfused rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.385: Regulation involving inhibition of eukaryotic initiation factor 2 alpha phosphatase activity. 

Phrase: "Regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "inhibition of eukaryotic initiation factor 2 alpha phosphatase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]
Processing 00000000.tx.386: J Biol Chem 266: 19691976, 1991.[Abstract/Free FullText] Greiwe JS, Kwon G, McDaniel ML, and Semenkovich CF. 

Phrase: "J Biol Chem 266"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "19691976,"

Phrase: "1991."

Phrase: "[Abstract/Free FullText"

Phrase: "] Greiwe JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Kwon G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "McDaniel ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "Semenkovich CF."
Processing 00000000.tx.387: Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. 

Phrase: "Leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "p70 S6 kinase through different pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1136240:p70 S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in human skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.388: Am J Physiol Endocrinol Metab 281: E466E471, 2001.[Abstract/Free FullText] Harmon CS, Proud CG, and Pain VM. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 281"

Phrase: ":"

Phrase: "E466E471,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Harmon CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Proud CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "Pain VM."
Processing 00000000.tx.389: Effects of starvation, diabetes, and acute insulin treatment on the regulation of polypeptide-chain initiation in rat skeletal muscle. 

Phrase: "Effects of starvation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "acute insulin treatment on the regulation of polypeptide-chain initiation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "in rat skeletal muscle."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.390: Biochem J 223: 687696, 1984.[ISI][Medline] Jefferson LS, Li JB, and Rannels SR. 

Phrase: "Biochem J 223"

Phrase: ":"

Phrase: "687696,"

Phrase: "1984."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jefferson LS,"

Phrase: "Li JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "and"

Phrase: "Rannels SR."
Processing 00000000.tx.391: Regulation by insulin of amino acid release and protein turnover in the perfused rat hemicorpus. 

Phrase: "Regulation by insulin of amino acid release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "protein turnover in the perfused rat hemicorpus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0597297:Protein Turnover [Molecular Function]
   748   C0031227:turnover [Quantitative Concept]
   748   C0243127:turnover [Functional Concept]
   748   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.392: J Biol Chem 252: 14761483, 1977.[Abstract] Karinch AM, Kimball SR, Vary TC, and Jefferson LS. 

Phrase: "J Biol Chem 252"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "14761483,"

Phrase: "1977."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Karinch"

Phrase: "AM"

Phrase: ","

Phrase: "Kimball SR,"

Phrase: "Vary"

Phrase: "TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041405:TC [Geographic Area]
  1000   C1824670:TC [Gene or Genome]
  1000   C3272447:TC [Gene or Genome]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.393: Regulation of eukaryotic initiation factor-2B activity in muscle of diabetic rats. 

Phrase: "Regulation of eukaryotic initiation factor-2B activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "of diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.394: Am J Physiol Endocrinol Metab 264: E101E108, 1993.[Abstract/Free FullText] Kelly FJ and Jefferson LS. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 264"

Phrase: ":"

Phrase: "E101E108,"

Phrase: "1993."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kelly FJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.395: Control of peptide chain initiation in rat skeletal muscle. 

Phrase: "Control of peptide chain initiation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "in rat skeletal muscle."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.396: Development of methods for preparation of native ribosomal subunits and analysis of the effect of insulin on formation of 40 S initiation complexes. 

Phrase: "Development of methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   841   C0178742:method development [Intellectual Product]
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "for preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of native ribosomal subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1956015:Ribosomal Subunits [Cell Component]
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "analysis of the effect of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "on formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of 40 S initiation complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.397: J Biol Chem 260: 66776683, 1985.[Abstract/Free FullText] Kimball SR, Everson WV, Flaim KE, and Jefferson LS. 

Phrase: "J Biol Chem 260"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "66776683,"

Phrase: "1985."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimball SR,"

Phrase: "Everson WV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043127:WV [Geographic Area]

Phrase: "Flaim KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.398: Initiation of protein synthesis in a cell-free system prepared from rat hepatocytes. 

Phrase: "Initiation of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C1157563:protein synthesis initiation [Genetic Function]
   770   C0589507:Initiation [Mental Process]
   770   C1158830:Initiation [Genetic Function]
   770   C1704686:Initiation [Functional Concept]

Phrase: "in a cell-free system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0007625:Cell-Free System [Cell Component]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "prepared from rat hepatocytes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0227525:Hepatocytes [Cell]
   737 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   737   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.399: Am J Physiol Cell Physiol 256: C28C34, 1989.[Abstract/Free FullText] Kimball SR, Farrell PA, Nguyen HV, Jefferson LS, and Davis TA. 

Phrase: "Am"

Phrase: "J Physiol Cell Physiol 256"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "C28C34,"

Phrase: "1989."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimball SR,"

Phrase: "Farrell PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Nguyen HV,"

Phrase: "Jefferson LS,"

Phrase: "and"

Phrase: "Davis TA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]
Processing 00000000.tx.400: Developmental decline in components of signal transduction pathways regulating protein synthesis in pig muscle. 

Phrase: "Developmental decline in components of signal transduction pathways"

Phrase: "regulating"

Phrase: "protein synthesis in pig muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0597295:Protein Synthesis [Molecular Function]
   797   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]
Processing 00000000.tx.401: Am J Physiol Endocrinol Metab 282: E585E592, 2002.[Abstract/Free FullText] Kimball SR, Horetesky RL, and Jefferson LS. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 282"

Phrase: ":"

Phrase: "E585E592,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimball SR,"

Phrase: "Horetesky RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.402: Implication of eIF2B rather than eIF4E in the regulation of protein synthesis by amino acids in L6 myoblasts. 

Phrase: "Implication of eIF2B"

Phrase: "rather than"

Phrase: "eIF4E in the regulation of protein synthesis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   777   C1157563:protein synthesis initiation [Genetic Function]
   760   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0450378:4e [Intellectual Product]
   739   C0589507:Initiation [Mental Process]
   739   C1158830:Initiation [Genetic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1704686:Initiation [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "by amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "in L6 myoblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596995:Myoblasts [Cell]
Processing 00000000.tx.403: J Biol Chem 273: 3094530953, 1998.[Abstract/Free FullText] Kimball SR, Horetesky RL, and Jefferson LS. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3094530953,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimball SR,"

Phrase: "Horetesky RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.404: Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts. 

Phrase: "Signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0086982:Signal Transduction Pathways [Molecular Function]
   913   C0037080:Signal Pathways [Molecular Function]
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "involved in the regulation of protein synthesis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   853   C1157519:regulation of protein synthesis [Cell Function]
   804   C1157723:regulation of synthesis [Molecular Function]
   778   C0597295:Protein Synthesis [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220781:synthesis [Biologic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1883254:Synthesis [Activity]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in L6 myoblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596995:Myoblasts [Cell]
Processing 00000000.tx.405: Am J Physiol Cell Physiol 274: C221C228, 1998.[Abstract/Free FullText] Kimball SR and Jefferson LS. 

Phrase: "Am"

Phrase: "J Physiol Cell Physiol 274"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "C221C228,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimball SR"

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.406: Cellular mechanisms involved in the action of insulin on protein synthesis. 

Phrase: "Cellular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in the action of insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0441472:Action [Functional Concept]
   753   C1314939:Involved [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3266814:Action [Activity]

Phrase: "on protein synthesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.407: Diabetes Metab Rev 4: 773787, 1988.[ISI][Medline] Kimball SR, Jefferson LS, Nguyen HV, Suryawan A, Bush JA, and Davis TA. 

Phrase: "Diabetes Metab Rev 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "773787,"

Phrase: "1988."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kimball SR,"

Phrase: "Jefferson LS,"

Phrase: "Nguyen HV,"

Phrase: "Suryawan A,"

Phrase: "Bush JA,"

Phrase: "and"

Phrase: "Davis TA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]
Processing 00000000.tx.408: Feeding stimulates protein synthesis in muscle and liver of neonatal pigs through an mTOR-dependent process. 

Phrase: "Feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "stimulates"

Phrase: "protein synthesis in muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0597295:Protein Synthesis [Molecular Function]
   819   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "liver of neonatal pigs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "through an mTOR-dependent process."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   861   C0293060:mammalian target of rapamycin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1307407:Mammalian Target of Rapamycin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414805:MAMMALIAN TARGET OF RAPAMYCIN [Gene or Genome]
   793   C0024660:Mammalian [Mammal]
   793   C0072980:Rapamycin [Antibiotic,Organic Chemical]
   793   C0332273:Through [Functional Concept]
   793   C0851827:Dependent [Qualitative Concept]
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1521840:Target [Functional Concept]
   793   C1522240:Process [Phenomenon or Process]
   793   C1550549:through [Idea or Concept]
   793   C1701901:Dependent [Qualitative Concept]
   793   C2986546:TARGET [Diagnostic Procedure]
   793   C3244310:dependent [Functional Concept]
Processing 00000000.tx.409: Am J Physiol Endocrinol Metab 279: E1080E1087, 2000.[Abstract/Free FullText] Kimball SR, Jurasinski CV, Lawrence JC, and Jefferson LS. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 279"

Phrase: ":"

Phrase: "E1080E1087,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimball SR,"

Phrase: "Jurasinski CV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538987:CV [Idea or Concept]

Phrase: "Lawrence JC,"

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.410: Insulin stimulated protein synthesis in skeletal muscle by enhancing the association of eIF-4E and eIF-4G. 

Phrase: "Insulin stimulated protein synthesis in skeletal muscle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0597295:Protein Synthesis [Molecular Function]
   774   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220781:synthesis [Biologic Function]
   748   C1883254:Synthesis [Activity]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "by enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "the association of eIF-4E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "eIF-4G."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0058990:Eukaryotic Initiation Factor-4G [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.411: Am J Physiol Cell Physiol 272: C754C759, 1997.[Abstract/Free FullText] Kimball SR, Karinch AM, Feldhoff RC, Mellor H, and Jefferson LS. 

Phrase: "Am"

Phrase: "J Physiol Cell Physiol 272"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "C754C759,"

Phrase: "1997."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimball SR,"

Phrase: "Karinch"

Phrase: "AM"

Phrase: ","

Phrase: "Feldhoff RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Mellor H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.412: Purification and characterization of eukaryotic translational initiation factor eIF-2B from liver. 

Phrase: "Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of eukaryotic translational initiation factor eIF-2B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]

Phrase: "from liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.413: Biochim Biophys Acta 1201: 473481, 1994.[ISI][Medline] Kimball SR, Mellor H, Flowers KM, and Jefferson LS. 

Phrase: "Biochim Biophys Acta 1201"

Phrase: ":"

Phrase: "473481,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kimball SR,"

Phrase: "Mellor H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Flowers KM,"

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.414: Role of translation initiation factor eIF-2B in the regulation of protein in mammalian cells. 

Phrase: "Role of translation initiation factor eIF-2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.415: Prog Nucleic Acid Res Mol Biol 54: 165196, 1996.[ISI][Medline] Kimball SR, Shantz LM, Horetsky RL, and Jefferson LS. 

Phrase: "Prog Nucleic Acid Res Mol Biol 54"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   818   C0028606:Nucleic acid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0001128:Acid [Chemical]
   795   C0007610:Nucleic [Cell Component]
   795   C0027960:Mole [Neoplastic Process]
   795   C0202406:Acid [Laboratory Procedure]
   795   C0324740:Mole [Mammal]
   795   C0439189:Mole [Quantitative Concept]
   795   C1456781:mole [Neoplastic Process]
   795   C1824986:mol [Gene or Genome]
   795   C2347379:RES [Finding]
   712 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "165196,"

Phrase: "1996."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kimball SR,"

Phrase: "Shantz LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Horetsky RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.416: Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. 

Phrase: "Leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "regulates"

Phrase: "translation of specific mRNAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0597295:mRNA Translation [Molecular Function]
           translation
   770   C0040712:Translation [Intellectual Product]
   770   C1519614:Translation [Genetic Function]

Phrase: "in L6 myoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596995:Myoblasts [Cell]

Phrase: "through mTOR-mediated changes"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   877   C0293060:mammalian target of rapamycin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1307407:Mammalian Target of Rapamycin [Amino Acid, Peptide, or Protein,Enzyme]
   877   C1414805:MAMMALIAN TARGET OF RAPAMYCIN [Gene or Genome]
   795   C0024660:Mammalian [Mammal]
   795   C0072980:Rapamycin [Antibiotic,Organic Chemical]
   795   C0086597:mediated [Social Behavior]
   795   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   795   C0332273:Through [Functional Concept]
   795   C0392747:changes [Functional Concept]
   795   C0443172:changes [Quantitative Concept]
   795   C1521840:Target [Functional Concept]
   795   C1550549:through [Idea or Concept]
   795   C2986546:TARGET [Diagnostic Procedure]
   762 E C1705241:Change [Quantitative Concept]

Phrase: "in availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Availability [Functional Concept]

Phrase: "of eIF4E"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450378:4e [Intellectual Product]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "phosphorylation of ribosomal protein S6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   760   C0031715:Phosphorylation [Molecular Function]
Processing 00000000.tx.417: J Biol Chem 274: 1164711652, 1999.[Abstract/Free FullText] Kimball SR, Vary TC, and Jefferson LS. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1164711652,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimball SR,"

Phrase: "Vary"

Phrase: "TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041405:TC [Geographic Area]
  1000   C1824670:TC [Gene or Genome]
  1000   C3272447:TC [Gene or Genome]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.418: Regulation of protein synthesis by insulin. 

Phrase: "Regulation of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157519:regulation of protein synthesis [Cell Function]
   881   C1157723:regulation of synthesis [Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.419: Annu Rev Physiol 56: 321348, 1994.[ISI][Medline] Laemmli UK. 

Phrase: "Annu Rev Physiol 56"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "321348,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Laemmli UK."
Processing 00000000.tx.420: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. 

Phrase: "Cleavage of structural proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0597304:Protein Cleavage [Molecular Function]
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "during the assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "of the head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: "of the bacteriophage T4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162570:Bacteriophage T4 [Virus]
Processing 00000000.tx.421: Nature 227: 680685, 1970.[ISI][Medline] Lin RA, Kong X, Haystead TAJ, Pause A, Belsham G, Soneburg N, and Lawrence JC. 

Phrase: "Nature 227"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "680685,"

Phrase: "1970."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lin RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Kong X,"

Phrase: "Haystead TAJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420811:TAJ [Gene or Genome]

Phrase: "Pause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0489607:pause [Temporal Concept]
  1000   C1550026:Pause [Idea or Concept]

Phrase: "A,"

Phrase: "Belsham G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Soneburg N,"

Phrase: "and"

Phrase: "Lawrence JC."
Processing 00000000.tx.422: PHAS-1 as a link between mitogen-activated protein kinase and translation initiation. 

Phrase: "PHAS-1 as a link"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]
   726   C0030779:PHA [Disease or Syndrome]
   726   C0031858:PHA [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "between mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "translation initiation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519613:Translation Initiation [Genetic Function]
   861   C0589507:Initiation [Mental Process]
   861   C1158830:Initiation [Genetic Function]
   861   C1704686:Initiation [Functional Concept]
Processing 00000000.tx.423: Science 266: 653656, 1994.[ISI][Medline] Long W, Saffer L, Wei L, and Barrett EJ. 

Phrase: "Science 266"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "653656,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Long W,"

Phrase: "Saffer L,"

Phrase: "Wei L,"

Phrase: "and"

Phrase: "Barrett EJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]
Processing 00000000.tx.424: Amino acids regulate skeletal muscle PHAS-1 and p70 S6-kinase phosphorylation independently of insulin. 

Phrase: "Amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "regulate"

Phrase: "skeletal muscle PHAS-1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0242692:Muscle, Skeletal [Tissue]
   861   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   812   C0026845:Muscle [Tissue]
   812   C0037253:skeletal [Body System]
   812   C0521324:Skeletal [Spatial Concept]
   779   C0030779:PHA [Disease or Syndrome]
   779   C0031858:PHA [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "p70 S6-kinase phosphorylation independently of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.425: Am J Physiol Endocrinol Metab 279: E301E306, 2000.[Abstract/Free FullText] McKendrick L, Morley SJ, Pain VM, Jagus R, and Joshi B. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 279"

Phrase: ":"

Phrase: "E301E306,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] McKendrick L,"

Phrase: "Morley SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Pain VM,"

Phrase: "Jagus R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Joshi B."
Processing 00000000.tx.426: Phosphorylation of eukaryotic initiation factor 4E (eIF4E) at Ser 209 is not required for protein synthesis in vitro and in vivo. 

Phrase: "Phosphorylation of eukaryotic initiation factor 4E (eIF4E)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at Ser 209"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for protein synthesis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0597295:Protein Synthesis [Molecular Function]
   783 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0220781:synthesis [Biologic Function]
   770   C1514873:Required [Functional Concept]
   770   C1883254:Synthesis [Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.427: Eur J Biochem 268: 53755385, 2001.[Abstract/Free FullText] Meyuhas O and Hornstein E. 

Phrase: "Eur J Biochem 268"

Phrase: ":"

Phrase: "53755385,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Meyuhas O"

Phrase: "and"

Phrase: "Hornstein E."
Processing 00000000.tx.428: Translational control of TOP mRNAs. 

Phrase: "Translational control of TOP mRNAs."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0243148:control [Qualitative Concept]
   760   C1519614:Translational [Genetic Function]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   745   C0597295:mRNA Translation [Molecular Function]
Processing 00000000.tx.429: In: Translational Control of Gene Expression, edited by Sonenberg N, Hershey JWB, and Matthews MB. 

Phrase: "In"

Phrase: ":"

Phrase: "Translational Control of Gene Expression,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1519614:Translational [Genetic Function]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "edited by Sonenberg N,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0868955:Edit [Occupational Activity]

Phrase: "Hershey JWB,"

Phrase: "and"

Phrase: "Matthews MB."
Processing 00000000.tx.430: Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 2000, p. 

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ":"

Phrase: "Cold Spring Harbor Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C3244292:laboratory [Functional Concept]

Phrase: "2000,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.431: 671693. 

Phrase: "671693."
Processing 00000000.tx.432: Minich WB, Balasta ML, Goss DJ, and Rhoads RE. 

Phrase: "Minich WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582525:Wb [Quantitative Concept]

Phrase: "Balasta ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Goss DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "Rhoads RE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]
Processing 00000000.tx.433: Chromatographic resolution of in vivo phosphorylated and non phosphoylated eukaryotic initiation factor eIF-4E: increased cap affinity of the phosphorylation form. 

Phrase: "Chromatographic resolution of in vivo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514893:Resolution [Idea or Concept]
   760   C1706463:Resolution [Quantitative Concept]
   760   C2699488:Resolution [Conceptual Entity]

Phrase: "phosphorylated"

Phrase: "and"

Phrase: "non phosphoylated eukaryotic initiation factor eIF-4E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   877   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0450378:4e [Intellectual Product]

Phrase: ":"

Phrase: "increased cap affinity of the phosphorylation form."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.434: Proc Natl Acad Sci USA 91: 76687772, 1994.[Abstract] Morley SJ, Rau M, Kay JE, and Pain VM. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "76687772,"

Phrase: "1994."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Morley SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Rau M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kay JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "and"

Phrase: "Pain VM."
Processing 00000000.tx.435: Increased phosphorylation of eukaryotic initiation factor 4 during early activation of T lymphocytes correlates with increased initiation factor 4F complex formation. 

Phrase: "Increased phosphorylation of eukaryotic initiation factor 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "during early activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of T lymphocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039194:T-Lymphocytes [Cell]
   861   C0024264:Lymphocytes [Cell]

Phrase: "correlates with increased initiation factor 4F complex formation."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205217:Increased [Quantitative Concept]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0450379:4f [Intellectual Product]
   744   C0589507:Initiation [Mental Process]
   744   C1158830:Initiation [Genetic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C1704686:Initiation [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.436: Eur J Biochem 218: 3948, 1993.[Abstract] O'Connor PMJ, Bush JA, Suryawan A, Nguyen HV, and Davis TA. 

Phrase: "Eur J Biochem 218"

Phrase: ":"

Phrase: "3948,"

Phrase: "1993."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] O'Connor PMJ,"

Phrase: "Bush JA,"

Phrase: "Suryawan A,"

Phrase: "Nguyen HV,"

Phrase: "and"

Phrase: "Davis TA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]
Processing 00000000.tx.437: Insulin and amino acids independently stimulate skeletal muscle protein synthesis in neonatal pigs. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids independently"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "stimulate"

Phrase: "skeletal muscle protein synthesis in neonatal pigs."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0597295:Protein Synthesis [Molecular Function]
   748   C0220781:synthesis [Biologic Function]
   748   C1883254:Synthesis [Activity]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.438: Am J Physiol Endocrinol Metab 284: E110E119, 2003.[Abstract/Free FullText] Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence JC, and Sonenberg N. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 284"

Phrase: ":"

Phrase: "E110E119,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0489607:pause [Temporal Concept]
  1000   C1550026:Pause [Idea or Concept]

Phrase: "A,"

Phrase: "Belsham GJ,"

Phrase: "Gingras AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Donze O,"

Phrase: "Lin TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Lawrence JC,"

Phrase: "and"

Phrase: "Sonenberg N."
Processing 00000000.tx.439: Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. 

Phrase: "Insulin-dependent stimulation of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of a regulator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182953:REGULATOR [Medical Device]
  1000   C1704734:Regulator [Medical Device]
  1000   C1704735:Regulator [Conceptual Entity]

Phrase: "of 5'-cap function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.440: Nature 371: 762767, 1994.[ISI][Medline] Proud CG and Denton RM. 

Phrase: "Nature 371"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "762767,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Proud CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "Denton RM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]
Processing 00000000.tx.441: Molecular mechanisms for the control of translation by insulin. 

Phrase: "Molecular mechanisms for the control of translation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.442: Biochem J 328: 329341, 1997.[ISI][Medline] Rhoads RE. 

Phrase: "Biochem J 328"

Phrase: ":"

Phrase: "329341,"

Phrase: "1997."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rhoads RE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]
Processing 00000000.tx.443: Regulation of eukaryotic protein synthesis by initiation factors in the recruitment of mRNA to ribosomes. 

Phrase: "Regulation of eukaryotic protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   891   C1157519:regulation of protein synthesis [Cell Function]
   844   C1157723:regulation of synthesis [Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by initiation factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030943:Initiation Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0589507:Initiation [Mental Process]
   861   C1158830:Initiation [Genetic Function]
   861   C1704686:Initiation [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "in the recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "of mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to ribosomes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035553:Ribosomes [Cell Component]
   966 E C2984240:Ribosome [Functional Concept]
Processing 00000000.tx.444: Biochemie 76: 831838, 1994.[ISI][Medline] Shen W, Malon D, Boyle DW, and Liechty EA. 

Phrase: "Biochemie 76"

Phrase: ":"

Phrase: "831838,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shen W,"

Phrase: "Malon D,"

Phrase: "Boyle DW,"

Phrase: "and"

Phrase: "Liechty EA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]
Processing 00000000.tx.445: IGF-I and insulin regulate eIF4E formation by different mechanisms in muscle and liver in the ovine fetus. 

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulate"

Phrase: "eIF4E formation by different mechanisms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "liver in the ovine fetus."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.446: Am J Physiol Endocrinol Metab 283: E593E603, 2002.[Abstract/Free FullText] Sonenburg N. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 283"

Phrase: ":"

Phrase: "E593E603,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sonenburg N."
Processing 00000000.tx.447: Regulation of translation and cell growth by eIF4E. 

Phrase: "Regulation of translation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157519:regulation of translation [Cell Function]
   822   C3537096:Translational Regulation [Genetic Function]
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "cell growth by eIF4E."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0007595:Cell Growth [Cell Function]
   774   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
Processing 00000000.tx.448: Biochemie 76: 839846, 1994.[ISI][Medline] Suryawan A, Nguyen HV, Bush JA, and Davis TA. 

Phrase: "Biochemie 76"

Phrase: ":"

Phrase: "839846,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Suryawan A,"

Phrase: "Nguyen HV,"

Phrase: "Bush JA,"

Phrase: "and"

Phrase: "Davis TA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]
Processing 00000000.tx.449: Developmental changes in the feeding-induced activation of the insulin-signaling pathway in neonatal pigs. 

Phrase: "Developmental changes in the feeding-induced activation of the insulin-signaling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   736   C0392747:changes [Functional Concept]
   736   C0443172:changes [Quantitative Concept]
   736   C0458003:Developmental [Qualitative Concept]
   736   C0678723:Developmental [Organism Function]
   703 E C1705241:Change [Quantitative Concept]

Phrase: "in neonatal pigs."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]
Processing 00000000.tx.450: Am J Physiol Endocrinol Metab 281: E908E915, 2001.[Abstract/Free FullText] Vary TC, Jefferson LS, and Kimball SR. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 281"

Phrase: ":"

Phrase: "E908E915,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Vary"

Phrase: "TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041405:TC [Geographic Area]
  1000   C1824670:TC [Gene or Genome]
  1000   C3272447:TC [Gene or Genome]

Phrase: "Jefferson LS,"

Phrase: "and"

Phrase: "Kimball SR."
Processing 00000000.tx.451: Amino acid-induced stimulation of translation initiation in rat skeletal muscle. 

Phrase: "Amino acid-induced stimulation of translation initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C2249874:stimulation of translational initiation [Genetic Function]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in rat skeletal muscle."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.452: Am J Physiol Endocrinol Metab 277: E1077E1086, 1999.[Abstract/Free FullText] Von Manteuffel SR, Dennis PB, Pullen N, Gingras AC, Sonenberg N, and Thomas G. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 277"

Phrase: ":"

Phrase: "E1077E1086,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Von Manteuffel SR,"

Phrase: "Dennis PB,"

Phrase: "Pullen N,"

Phrase: "Gingras AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Sonenberg N,"

Phrase: "and"

Phrase: "Thomas G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.453: The insulin-induced signalling pathway leading to S6 and initiation factor 4E-binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70S6k. 

Phrase: "The insulin-induced signalling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   902   C2984427:Insulin Pathway [Functional Concept]
   861   C0037083:signalling pathway [Cell Function]
   844 E C0037080:Signal Pathway [Molecular Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "leading to S6"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C0332152:Leading [Temporal Concept]
   790   C1419024:S6 [Gene or Genome]
   790   C1419741:S6 [Gene or Genome]
   790   C1522538:Leading [Functional Concept]
   790   C1861424:S6 [Gene or Genome]
   790   C2348600:S6+ [Element, Ion, or Isotope]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "initiation factor 4E-binding protein 1 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]

Phrase: "bifurcates at a rapamycin-sensitive point immediately"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C2924612:Point A [Body Location or Region]
   748   C0072980:Rapamycin [Antibiotic,Organic Chemical]
   748   C0205383:bifurcate [Spatial Concept]
   748   C0205548:Immediately [Temporal Concept]
   748   C0332324:Sensitive [Functional Concept]
   748   C1550474:sensitive [Idea or Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]

Phrase: "upstream of p70S6k."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]
Processing 00000000.tx.454: Mol Cell Biol 17: 54265436, 1997.[Abstract] Welsh GI and Proud CG. 

Phrase: "Mol Cell Biol 17"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "54265436,"

Phrase: "1997."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Welsh GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "and"

Phrase: "Proud CG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]
Processing 00000000.tx.455: Regulation of protein synthesis in Swiss 3T3 fibroblasts. 

Phrase: "Regulation of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157519:regulation of protein synthesis [Cell Function]
   881   C1157723:regulation of synthesis [Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "in Swiss 3T3 fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.456: Rapid activation of the guanine-nucleotide-exchange factor by insulin and growth factors. 

Phrase: "Rapid activation of the guanine-nucleotide-exchange factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "growth factors."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.457: Biochem J 284: 1923, 1992.[ISI][Medline] Weng QP, Kozlowski M, Belham C, Zhang A, Comb MJ, and Avruch J. 

Phrase: "Biochem J 284"

Phrase: ":"

Phrase: "1923,"

Phrase: "1992."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weng QP,"

Phrase: "Kozlowski M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Belham C,"

Phrase: "Zhang"

Phrase: "A,"

Phrase: "Comb MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "and"

Phrase: "Avruch J."
Processing 00000000.tx.458: Regulation of the p70 S6 kinase by phosphorylation in vivo. 

Phrase: "Regulation of the p70 S6 kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.459: Analysis using site specific antiphosphopeptide antibodies. 

Phrase: "Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "site specific antiphosphopeptide antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   858   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.460: J Biol Chem 273: 1662116629, 1998.[Abstract/Free FullText] Wray-Cahen D, Beckett PR, Nguyen HV, and Davis TA. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1662116629,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wray-Cahen D,"

Phrase: "Beckett PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Nguyen HV,"

Phrase: "and"

Phrase: "Davis TA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]
Processing 00000000.tx.461: Insulin-stimulated amino acid utilization during glucose and amino acid clamps decreases with development. 

Phrase: "Insulin-stimulated amino acid utilization during glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "amino acid clamps"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0175721:clamps [Medical Device]
   793 E C1705942:Clamp [Manufactured Object]
   793 E C1883710:Clamp [Functional Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "decreases with development."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0243107:development [Physiologic Function]
   790   C0392756:Decrease [Qualitative Concept]
   790   C0547047:Decrease [Quantitative Concept]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.462: Am J Physiol Endocrinol Metab 273: E305E314, 1997.[Abstract/Free FullText] Wray-Cahen D, Nguyen HV, Burrin DG, Beckett PR, Fiorotto ML, Reeds PJ, Wester TJ, and Davis TA. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 273"

Phrase: ":"

Phrase: "E305E314,"

Phrase: "1997."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wray-Cahen D,"

Phrase: "Nguyen HV,"

Phrase: "Burrin DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Beckett PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Fiorotto ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Reeds PJ,"

Phrase: "Wester"

Phrase: "TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039247:TJ [Geographic Area]

Phrase: "and"

Phrase: "Davis TA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]
Processing 00000000.tx.463: Response of skeletal muscle protein synthesis to insulin in suckling pigs decreases with development. 

Phrase: "Response of skeletal muscle protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in suckling pigs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]

Phrase: "decreases with development."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0243107:development [Physiologic Function]
   790   C0392756:Decrease [Qualitative Concept]
   790   C0547047:Decrease [Quantitative Concept]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.464: Am J Physiol Endocrinol Metab 275: E602E609, 1998.[Abstract/Free FullText] Yoshizawa F, Kimball SR, Vary TC, and Jefferson LS. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 275"

Phrase: ":"

Phrase: "E602E609,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yoshizawa F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Kimball SR,"

Phrase: "Vary"

Phrase: "TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041405:TC [Geographic Area]
  1000   C1824670:TC [Gene or Genome]
  1000   C3272447:TC [Gene or Genome]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.465: Effect of dietary protein on translation initiation in rat skeletal muscle and liver. 

Phrase: "Effect of dietary protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on translation initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519613:Translation Initiation [Genetic Function]
   861   C0589507:Initiation [Mental Process]
   861   C1158830:Initiation [Genetic Function]
   861   C1704686:Initiation [Functional Concept]

Phrase: "in rat skeletal muscle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.466: Am J Physiol Endocrinol Metab 275: E814E820, 1998.[Abstract/Free FullText] Young VR. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 275"

Phrase: ":"

Phrase: "E814E820,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Young VR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3476815:VR [Intellectual Product]
Processing 00000000.tx.467: The role of skeletal and cardiac muscle in the regulation of protein metabolism. 

Phrase: "The role of skeletal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "cardiac muscle in the regulation of protein metabolism."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0027061:Muscle, Cardiac [Tissue]
   767   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0596984:metabolism muscle [Organ or Tissue Function]
   744   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   744   C0026845:Muscle [Tissue]
   744   C1522601:Cardiac [Spatial Concept]
Processing 00000000.tx.468: In: Mammalian Protein Metabolism, edited by Munro HN. 

Phrase: "In"

Phrase: ":"

Phrase: "Mammalian Protein Metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0597299:Protein Metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "edited by Munro HN."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019905:HN [Geographic Area]
   770   C1537997:HN [Gene or Genome]
   770   C1853668:HN [Gene or Genome]
   737   C0868955:Edit [Occupational Activity]
Processing 00000000.tx.469: New York: Academic, 1970, vol. 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "Academic, 1970,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1510747:Academic [Organization]
   861   C1550724:academic [Idea or Concept]
   861   C3242376:academic [Intellectual Product]

Phrase: "vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.470: 4, p. 

Phrase: "4,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.471: 585674.

Phrase: "585674."

